Sample Name	Sample ID	Gene Name	Transcript	Census Gene	Drug Name	MUTATION_ID	GENOMIC_MUTATION_ID	LEGACY_MUTATION_ID	AA Mutation	CDS Mutation	Primary Tissue	Tissue Subtype 1	Tissue Subtype 2	Histology	Histology Subtype 1	Histology Subtype 2	Pubmed Id	CGP Study	Somatic Status	Sample Type	Zygosity	Genome Coordinates (GRCh37)	Tier	HGVSP	HGVSC	HGVSG
15	1069276	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	large_intestine	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
898242	898242	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	15728811		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
903866	903866	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Previously Reported	Tumour Sample	Heterozygous	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
904111	904111	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
905196	905196	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471254	COSV59323752	COSM12602	p.D276G	c.827A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Previously Reported	Tumour Sample	Unknown	9:133747520..133747520		ENSP00000323315.5:p.Asp276Gly	ENST00000318560.5:c.827A>G	9:g.133747520A>G
905447	905447	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27477568	COSV59324372	COSM12610	p.Y253F	c.758A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358		ENSP00000323315.5:p.Tyr253Phe	ENST00000318560.5:c.758A>T	9:g.133738358A>T
MGH045	2275265	ALK	ENST00000389048.3	Yes	Ceritinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Previously Reported	Cultured	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
1024768	1024768	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1103805	1103805	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1278400	1278400	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1350431	1350431	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1350438	1350438	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1350469	1350469	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1355277	1355277	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1355303	1355303	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869074		COSM43460	p.P480L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown					
1431326	1431326	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869699		COSM49140	p.A397P	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1468085	1468085	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469786	1469786	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469799	1469799	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479867	1479867	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1498605	1498605	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543113	1543113	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1543744	1543744	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173872275		COSM97193	p.D444Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown					
1552656	1552656	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1565836	1565836	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27476103	COSV59325302	COSM131577	p.M388L	c.1162A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133750331..133750331		ENSP00000323315.5:p.Met388Leu	ENST00000318560.5:c.1162A>T	9:g.133750331A>T
1576785	1576785	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1584479	1584479	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1591009	1591009	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655321	1655321	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
1795110	1795110	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1795122	1795122	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1815800	1815800	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844077	1844077	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1928076	1928076	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1989321	1989321	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
1992092	1992092	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1996286	1996286	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2007327	2007327	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868025		COSM43387	p.S417Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Ser417Tyr		
2007330	2007330	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863944		COSM12627	p.V379I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown					
2032252	2032252	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2313152	2313152	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2318496	2318496	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2358405	2358405	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25740611		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
2429151	2429151	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429221	2429221	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429265	2429265	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
2429764	2429764	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right	NS	carcinoma	adenocarcinoma	transformed_to_small_cell_carcinoma	26400668		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2432718	2432718	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	22299775		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
2476868	2476868	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531246	2531246	SMO	ENST00000249373.3	Yes	Vismodegib	173871659		COSM5885168	p.W535R	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1			
2531279	2531279	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706366	COSV54042636	COSM785	p.?	c.2419-2804G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>C	13:g.28592642C>G
2546230	2546230	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59863320	COSV52784978	COSM1074635	p.Y425N	c.1273T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000415934.2:p.Tyr425Asn	ENST00000456483.2:c.1273T>A	6:g.152419922T>A
2605904	2605904	MET	ENST00000318493.6	Yes	Erlotinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28271038		Previously Reported	Tumour Sample	Unknown		1			
2611052	2611052	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2637198	2637198	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654364	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Cys	ENST00000206249.3:c.1610A>G	6:g.152419923A>G
2637199	2637199	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210425	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Cys	ENST00000443427.1:c.1610A>G	6:g.152419923A>G
2664352	2664352	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664378	2664378	CTNNB1	ENST00000349496.5	Yes	Imatinib	32706207	COSV62687839	COSM5677	p.S33C	c.98C>G	skin	NS	NS	malignant_melanoma	acral_lentiginous	NS	28421416		Previously Reported	Tumour Sample	Unknown	3:41266101..41266101	1	ENSP00000344456.5:p.Ser33Cys	ENST00000349496.5:c.98C>G	3:g.41266101C>G
2823657	2823657	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31157314		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2832841	2832841	ALK	ENST00000389048.3	Yes	Lorlatinib	173867168		COSM9311666	p.L1198F	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1198Phe		
GIST-R8	2607431	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	27997714		Previously Reported	Cultured	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
SC-her2-019	2313843	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
IIIA	1179821	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19181917		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
904116	904116	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
905486	905486	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
909213	909213	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
1135555	1135555	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18676761		Previously Reported	NS	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1235125	1235125	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1278399	1278399	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1351676	1351676	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1352436	1352436	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1431269	1431269	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1431283	1431283	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1469823	1469823	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469853	1469853	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498571	1498571	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1543091	1543091	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1543109	1543109	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1552650	1552650	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1576781	1576781	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1767080	1767080	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1795098	1795098	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862940		COSM53182	p.?	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown					
1844072	1844072	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844110	1844110	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1863619	1863619	FLT3	ENST00000241453.7	Yes	Quizartinib	20035400	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359	1	ENSP00000241453.7:p.Phe691Leu	ENST00000241453.7:c.2073T>G	13:g.28601359A>C
1874589	1874589	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1928077	1928077	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992095	1992095	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1992095	1992095	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2071714	2071714	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2071735	2071735	ABL1	ENST00000372348.2	Yes	Imatinib	36322959	COSV59326146	COSM1732691	p.F378C	c.1133T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748415..133748415	1	ENSP00000361423.2:p.Phe378Cys	ENST00000372348.2:c.1133T>G	9:g.133748415T>G
2161695	2161695	NF2_ENST00000403999	ENST00000403999.3	No	Afatinib	46700399	COSV58519797	COSM22432	p.R198*	c.592C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000384797.3:p.Arg198Ter	ENST00000403999.3:c.592C>T	22:g.30051658C>T
2255303	2255303	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2275307	2275307	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	right	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
2293725	2293725	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51311329	COSV66556242	COSM28498	p.?	c.792-14302T>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	25393796		Previously Reported	Tumour Sample	Heterozygous	2:29445213..29445213			ENST00000431873.1:c.792-14302T>A	2:g.29445213A>T
2293730	2293730	ALK	ENST00000389048.3	Yes	Alectinib	40285352	COSV66556242	COSM28498	p.I1171N	c.3512T>A	lung	right_upper_lobe	NS	carcinoma	non_small_cell_carcinoma	NS	25393798		Previously Reported	Tumour Sample	Heterozygous	2:29445213..29445213	1	ENSP00000373700.3:p.Ile1171Asn	ENST00000389048.3:c.3512T>A	2:g.29445213A>T
2313150	2313150	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2318502	2318502	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2318503	2318503	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2426850	2426850	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2429127	2429127	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429208	2429208	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1			
2429235	2429235	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2462443	2462443	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2462447	2462447	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864263		COSM5415894	p.Y537N	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Asn		
2483249	2483249	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2531203	2531203	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
2546461	2546461	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	12860943		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2585234	2585234	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173863388		COSM25878	p.G12C	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Cys		
2585244	2585244	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	173862744		COSM14201	p.Q61H	c.?	large_intestine	colon	right	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61His		
2591449	2591449	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2635719	2635719	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59120518	COSV51832120	COSM6493935	p.G751R	c.2251G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249088..55249088		ENSP00000415559.1:p.Gly751Arg	ENST00000455089.1:c.2251G>C	7:g.55249088G>C
2664356	2664356	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2664374	2664374	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2823495	2823495	TET2_ENST00000380013	ENST00000380013.4	No	Sunitinib	41067710	COSV54407618	COSM3598847	p.P46L	c.137C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236		ENSP00000369351.4:p.Pro46Leu	ENST00000380013.4:c.137C>T	4:g.106155236C>T
2835709	2835709	BTK_ENST00000372880	ENST00000372880.1	No	Acalabrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2840774	2840774	KRAS	ENST00000256078.4	Yes	Cetuximab	21552111	COSV55499223	COSM555	p.Q61H	c.183A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>T	12:g.25380275T>A
2840778	2840778	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
2840784	2840784	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85397552	COSV55498802	COSM554	p.?	c.112-17430A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275			ENST00000557334.1:c.112-17430A>C	12:g.25380275T>G
SC-her2-025	2313847	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
SC-her2-025	2313847	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
SC-her2-071	2313875	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
904071	904071	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
905487	905487	ABL1	ENST00000372348.2	Yes	Imatinib	36318911	COSV59323765	COSM12609	p.Q271H	c.813G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>C	9:g.133738356G>C
WHIM20	2367160	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
1167342	1167342	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1211141	1211141	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350400	1350400	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1350403	1350403	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350474	1350474	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1355305	1355305	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1426041	1426041	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1431293	1431293	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864313		COSM49139	p.F359X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1498495	1498495	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	epithelioid	NS	20568982		Previously Reported	Tumour Sample	Heterozygous	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
1498632	1498632	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543095	1543095	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1547754	1547754	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1552647	1552647	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1584472	1584472	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1618791	1618791	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767057	1767057	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1795121	1795121	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844097	1844097	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844107	1844107	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1863605	1863605	FLT3	ENST00000241453.7	Yes	Quizartinib	20035319	COSV54045249	COSM19844	p.D835F	c.2503_2504delinsTT	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Variant of unknown origin	Tumour Sample	Unknown	13:28592641..28592642	1	ENSP00000241453.7:p.Asp835Phe	ENST00000241453.7:c.2503_2504delinsTT	13:g.28592641_28592642delinsAA
1874587	1874587	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1968558	1968558	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	ascending	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
1968570	1968570	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
2032190	2032190	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032220	2032220	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071721	2071721	ABL1	ENST00000372348.2	Yes	Imatinib	36329130	COSV59338309	COSM1732688	p.D295N	c.883G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133747519..133747519	1	ENSP00000361423.2:p.Asp295Asn	ENST00000372348.2:c.883G>A	9:g.133747519G>A
2255301	2255301	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2275308	2275308	ALK	ENST00000389048.3	Yes	Ceritinib	173865245		COSM4422791	p.F1174V	c.?	lung	left	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Val		
2426832	2426832	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2468266	2468266	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2483314	2483314	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2521264	2521264	SMO	ENST00000249373.3	Yes	Vismodegib	22234504	COSV50825992	COSM3942016	p.A459V	c.1376C>T	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Previously Reported	Tumour Sample	Unknown	7:128849148..128849148	1	ENSP00000249373.3:p.Ala459Val	ENST00000249373.3:c.1376C>T	7:g.128849148C>T
2525708	2525708	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531201	2531201	FLT3	ENST00000241453.7	Yes	Quizartinib	20035400	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23392356		Confirmed Somatic	Tumour Sample	Heterozygous	13:28601359..28601359	1	ENSP00000241453.7:p.Phe691Leu	ENST00000241453.7:c.2073T>G	13:g.28601359A>C
2531518	2531518	SMO	ENST00000249373.3	Yes	Vismodegib	173868322		COSM5885188	p.S533N	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000249373.3:p.Ser533Asn		
2546463	2546463	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	12860943		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2585569	2585569	KRAS	ENST00000256078.4	Yes	Cetuximab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
2591383	2591383	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2616296	2616296	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2621333	2621333	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2635652	2635652	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51798494	COSV52784978	COSM1074635	p.?	c.851-26479T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922			ENST00000427531.2:c.851-26479T>A	6:g.152419922T>A
2635721	2635721	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22660300	COSV52795259	COSM6843697	p.L536H	c.1607T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920		ENSP00000206249.3:p.Leu536His	ENST00000206249.3:c.1607T>A	6:g.152419920T>A
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55431740	COSV51832120	COSM6493935	p.?	c.*28+8467G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249088..55249088			ENST00000442591.1:c.*28+8467G>C	7:g.55249088G>C
2664378	2664378	CTNNB1_ENST00000405570	ENST00000405570.1	No	Imatinib	46131830	COSV62687839	COSM5677	p.S33C	c.98C>G	skin	NS	NS	malignant_melanoma	acral_lentiginous	NS	28421416		Previously Reported	Tumour Sample	Unknown	3:41266101..41266101		ENSP00000385604.1:p.Ser33Cys	ENST00000405570.1:c.98C>G	3:g.41266101C>G
2824345	2824345	ALK	ENST00000389048.3	Yes	Lorlatinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
2824345	2824345	ALK	ENST00000389048.3	Yes	Lorlatinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
2835721	2835721	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2835740	2835740	BTK_ENST00000372880	ENST00000372880.1	No	Acalabrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2838948	2838948	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
2840307	2840307	EGFR	ENST00000275493.2	Yes	Osimertinib	23286043	COSV51766493	COSM6493937	p.C797S	c.2389T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249091..55249091	1	ENSP00000275493.2:p.Cys797Ser	ENST00000275493.2:c.2389T>A	7:g.55249091T>A
2840786	2840786	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648459	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Val	ENST00000311936.3:c.35G>T	12:g.25398284C>A
2840786	2840786	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85397552	COSV55498802	COSM554	p.?	c.112-17430A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275			ENST00000557334.1:c.112-17430A>C	12:g.25380275T>G
2841745	2841745	ALK	ENST00000389048.3	Yes	Crizotinib	173868062		COSM9413100	p.T1151M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Thr1151Met		
2841750	2841750	ALK	ENST00000389048.3	Yes	Crizotinib	173868062		COSM9413100	p.T1151M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Thr1151Met		
SC-her2-025	2313847	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
904263	904263	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
904291	904291	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
905448	905448	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
905453	905453	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1047910	1047910	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	17335935		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1167332	1167332	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
1235142	1235142	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350465	1350465	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869541		COSM43366	p.E355A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1351673	1351673	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1351681	1351681	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1351701	1351701	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864444		COSM43363	p.E292V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1355282	1355282	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1355307	1355307	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355308	1355308	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355312	1355312	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1426028	1426028	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1469794	1469794	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498603	1498603	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1543089	1543089	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864293		COSM43364	p.L298V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown					
1545599	1545599	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474640	COSV59325261	COSM12631	p.L248V	c.742C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	17008892		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738342..133738342		ENSP00000323315.5:p.Leu248Val	ENST00000318560.5:c.742C>G	9:g.133738342C>G
1547753	1547753	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1552631	1552631	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863335		COSM12668	p.Y353H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1591006	1591006	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1633985	1633985	ALK	ENST00000389048.3	Yes	Crizotinib	40319412	COSV66558491	COSM144252	p.T1151dup	c.3451_3453dup	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Variant of unknown origin	Tumour Sample	Unknown	2:29445275..29445276	1	ENSP00000373700.3:p.Thr1151dup	ENST00000389048.3:c.3451_3453dup	2:g.29445273_29445275dup
1635869	1635869	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	22228822		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655341	1655341	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
1731088	1731088	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22815900		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1744517	1744517	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1795107	1795107	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1844075	1844075	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844098	1844098	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1874596	1874596	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Variant of unknown origin	Tumour Sample	Homozygous	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
1968562	1968562	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
2027859	2027859	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032250	2032250	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071735	2071735	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470960	COSV59326146	COSM1732691	p.F359C	c.1076T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748415..133748415		ENSP00000323315.5:p.Phe359Cys	ENST00000318560.5:c.1076T>G	9:g.133748415T>G
2088659	2088659	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
2161695	2161695	NF2_ENST00000361676	ENST00000361676.4	No	Afatinib	34611991	COSV58519797	COSM22432	p.R156*	c.466C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000355183.4:p.Arg156Ter	ENST00000361676.4:c.466C>T	22:g.30051658C>T
2161695	2161695	EGFR_ENST00000454757	ENST00000454757.2	No	Afatinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2313880	2313880	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2429262	2429262	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429263	2429263	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2430139	2430139	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26130666		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2466823	2466823	BRAF	ENST00000288602.6	Yes	Vemurafenib	173864391		COSM5546574	p.?	c.505-?_1140+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2501810	2501810	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	27045755		Variant of unknown origin	Tumour Sample	Homozygous	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2531276	2531276	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39661484	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835His	ENST00000380982.4:c.2503G>C	13:g.28592642C>G
2546461	2546461	AR	ENST00000374690.3	Yes	Flutamide	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	12860943		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2584892	2584892	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862913		COSM25879	p.G12V	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Val		
2585346	2585346	MET	ENST00000318493.6	Yes	Afatinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27694386		Confirmed Somatic	Tumour Sample	Unknown		1			
2611059	2611059	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2616264	2616264	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2619738	2619738	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	27199251		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2621274	2621274	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2635721	2635721	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55288024	COSV52795259	COSM6843697	p.L536H	c.1607T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920	1	ENSP00000405330.1:p.Leu536His	ENST00000440973.1:c.1607T>A	6:g.152419920T>A
2642912	2642912	MET	ENST00000318493.6	Yes	Crizotinib	173862936		COSM6024205	p.Y1248H	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28522754		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Tyr1248His		
2757342	2757342	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	right	NS	carcinoma	adenocarcinoma	NS	28274743		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2816899	2816899	FGFR4_ENST00000393637	ENST00000393637.1	No	Fisogatinib	44076206	COSV52804538	COSM6163	p.V510M	c.1528G>A	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000377254.1:p.Val510Met	ENST00000393637.1:c.1528G>A	5:g.176522551G>A
2819306	2819306	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2823733	2823733	ALK	ENST00000389048.3	Yes	Lorlatinib	173863718		COSM9278044	p.I1171N	c.?	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	31616196		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Asn		
2824230	2824230	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2824232	2824232	BRAF	ENST00000288602.6	Yes	Osimertinib	173862544		COSM1131	p.V600E	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288602.6:p.Val600Glu		
2835713	2835713	BTK	ENST00000308731.7	Yes	Ibrutinib	26369574	COSV58117643	COSM6053936	p.C481R	c.1441T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Arg	ENST00000308731.7:c.1441T>C	X:g.100611165A>G
2835717	2835717	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2835720	2835720	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2838948	2838948	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648522	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Ala	ENST00000311936.3:c.35G>C	12:g.25398284C>G
2838948	2838948	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395965	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Cys	ENST00000557334.1:c.34G>T	12:g.25398285C>A
2840307	2840307	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59108752	COSV51766493	COSM6493937	p.C752S	c.2254T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249091..55249091		ENSP00000415559.1:p.Cys752Ser	ENST00000455089.1:c.2254T>A	7:g.55249091T>A
2840786	2840786	KRAS	ENST00000256078.4	Yes	Panitumumab	21547675	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Arg	ENST00000256078.4:c.34G>C	12:g.25398285C>G
2841750	2841750	ALK	ENST00000389048.3	Yes	Crizotinib	173863820		COSM9112561	p.T1151R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1			
2841754	2841754	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2841762	2841762	ALK	ENST00000389048.3	Yes	Crizotinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
Pat_63_B	2492903	MAP2K2	ENST00000262948.5	Yes	Vemurafenib	20971599	COSV53565416	COSM5855814	p.C125S	c.373T>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4110584..4110584	1	ENSP00000262948.3:p.Cys125Ser	ENST00000262948.5:c.373T>A	19:g.4110584A>T
904297	904297	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
909219	909219	KIT	ENST00000288135.5	Yes	Imatinib	25237435	COSV55392817	COSM12707	p.D716N	c.2146G>A	soft_tissue	fibrous_tissue_and_uncertain_origin	large_intestine	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55597498..55597498	1	ENSP00000288135.5:p.Asp716Asn	ENST00000288135.5:c.2146G>A	4:g.55597498G>A
MGH051	2824323	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
MGH910	2831768	ALK	ENST00000389048.3	Yes	Alectinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1024758	1024758	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1024776	1024776	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211134	1211134	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211143	1211143	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1278400	1278400	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350425	1350425	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1351677	1351677	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1351687	1351687	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1351721	1351721	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869236		COSM43390	p.D482V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1352409	1352409	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355281	1355281	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1355313	1355313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1431266	1431266	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1431272	1431272	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431329	1431329	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1479875	1479875	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173874698		COSM85793	p.Q252K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown					
1498495	1498495	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	epithelioid	NS	20568982		Previously Reported	Tumour Sample	Heterozygous	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
1543741	1543741	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1547760	1547760	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552640	1552640	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868084		COSM100087	p.V289F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1584490	1584490	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864294		COSM133072	p.E282K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown					
1655329	1655329	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471758	COSV59325471	COSM131574	p.L387M	c.1159T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133750328..133750328		ENSP00000323315.5:p.Leu387Met	ENST00000318560.5:c.1159T>A	9:g.133750328T>A
1767039	1767039	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1794540	1794540	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1878637	1878637	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23407566		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1885380	1885380	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23434628		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
1928071	1928071	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1928100	1928100	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992094	1992094	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2019523	2019523	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	24029120		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000275493.2:p.Thr790Met		
2071724	2071724	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
2076938	2076938	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088646	2088646	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2156363	2156363	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2275295	2275295	ALK	ENST00000389048.3	Yes	Ceritinib	173870679		COSM4422790	p.F1174C	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Cys		
2293730	2293730	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51311329	COSV66556242	COSM28498	p.?	c.792-14302T>A	lung	right_upper_lobe	NS	carcinoma	non_small_cell_carcinoma	NS	25393798		Previously Reported	Tumour Sample	Heterozygous	2:29445213..29445213			ENST00000431873.1:c.792-14302T>A	2:g.29445213A>T
2318492	2318492	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2429184	2429184	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2429238	2429238	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429271	2429271	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2430095	2430095	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2465699	2465699	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	left	NS	carcinoma	adenocarcinoma	transformed_to_squamous_cell_carcinoma	26746366		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2466829	2466829	MAP2K2	ENST00000262948.5	Yes	Vemurafenib	20972079	COSV53562150	COSM5546577	p.F57C	c.170T>G	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	19:4117550..4117550	1	ENSP00000262948.3:p.Phe57Cys	ENST00000262948.5:c.170T>G	19:g.4117550A>C
2471408	2471408	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20971926	COSV53563396	COSM5487841	p.C125S	c.374G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	19:4110583..4110583	1	ENSP00000262948.3:p.Cys125Ser	ENST00000262948.5:c.374G>C	19:g.4110583C>G
2479256	2479256	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2479270	2479270	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2483276	2483276	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2521246	2521246	SMO	ENST00000249373.3	Yes	Vismodegib	22234504	COSV50825992	COSM3942016	p.A459V	c.1376C>T	skin	face	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Previously Reported	Tumour Sample	Unknown	7:128849148..128849148	1	ENSP00000249373.3:p.Ala459Val	ENST00000249373.3:c.1376C>T	7:g.128849148C>T
2522064	2522064	ALK	ENST00000389048.3	Yes	Alectinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27130468		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
2525689	2525689	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531217	2531217	FLT3	ENST00000241453.7	Yes	Sorafenib	20035351	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835His	ENST00000241453.7:c.2503G>C	13:g.28592642C>G
2537730	2537730	AR_ENST00000396043	ENST00000396043.2	No	Androgen	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2537731	2537731	AR	ENST00000374690.3	Yes	Androgen	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2542369	2542369	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25649957	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	26644315		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>C	12:g.25380275T>G
2591431	2591431	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2608487	2608487	BTK	ENST00000308731.7	Yes	Ibrutinib	26369574	COSV58117643	COSM6053936	p.C481R	c.1441T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Arg	ENST00000308731.7:c.1441T>C	X:g.100611165A>G
2609321	2609321	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2616267	2616267	BTK	ENST00000308731.7	Yes	Ibrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Variant of unknown origin	Tumour Sample	Heterozygous	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2621336	2621336	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2628606	2628606	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37813750	COSV58119120	COSM6196566	p.?	c.1039-1482_1039-1481delinsCT	haematopoietic_and_lymphoid_tissue	lymph_node	NS	lymphoid_neoplasm	mantle_cell_lymphoma	NS	25082755		Confirmed Somatic	Tumour Sample	Unknown	X:100611163..100611164			ENST00000372880.1:c.1039-1482_1039-1481delinsCT	X:g.100611163_100611164delinsAG
2628609	2628609	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	lymph_node	NS	lymphoid_neoplasm	mantle_cell_lymphoma	NS	25082755		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2637199	2637199	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797513	COSV52782924	COSM1074637	p.?	c.851-26478A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>G	6:g.152419923A>G
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23286043	COSV51766493	COSM6493937	p.C797S	c.2389T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091	1	ENSP00000275493.2:p.Cys797Ser	ENST00000275493.2:c.2389T>A	7:g.55249091T>A
2664329	2664329	MET	ENST00000318493.6	Yes	Crizotinib	27419172	COSV59256836	COSM690	p.Y1248H	c.3742T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413	1	ENSP00000317272.6:p.Tyr1248His	ENST00000318493.6:c.3742T>C	7:g.116423413T>C
2780956	2780956	FGFR2_ENST00000358487	ENST00000358487.5	No	BGJ398	173865513		COSM7412637	p.V564F	c.?	biliary_tract	bile_duct	NS	carcinoma	adenocarcinoma	NS	28034880		Confirmed Somatic	Tumour Sample	Unknown					
2804448	2804448	KRAS_ENST00000311936	ENST00000311936.3	No	Crizotinib	173862913		COSM25879	p.G12V	c.?	lung	left	NS	carcinoma	adenocarcinoma	NS	31200822		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Val		
2835711	2835711	BTK	ENST00000308731.7	Yes	Ibrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2840776	2840776	KRAS	ENST00000256078.4	Yes	Panitumumab	21584402	COSV55502677	COSM550	p.Q61E	c.181C>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380277..25380277	1	ENSP00000256078.4:p.Gln61Glu	ENST00000256078.4:c.181C>G	12:g.25380277G>C
2840778	2840778	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
2841766	2841766	ALK	ENST00000389048.3	Yes	Crizotinib	173863820		COSM9112561	p.T1151R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1			
TG95755	2823143	NF1_ENST00000356175	ENST00000356175.3	No	Tyrosine kinase inhibitor - NS	31665066	COSV104420542	COSM9274129	p.G2371E	c.7112G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown	17:29670139..29670139		ENSP00000348498.3:p.Gly2371Glu	ENST00000356175.3:c.7112G>A	17:g.29670139G>A
TG95755	2823143	NF1_ENST00000444181	ENST00000444181.2	No	Tyrosine kinase inhibitor - NS	54864397	COSV104420542	COSM9274129	p.G185E	c.554G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown	17:29670139..29670139		ENSP00000396481.2:p.Gly185Glu	ENST00000444181.2:c.554G>A	17:g.29670139G>A
Metastasis3	1620043	KIT	ENST00000288135.5	Yes	Sunitinib	25227346	COSV55387147	COSM1322	p.N822K	c.2466T>G	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	21394667		Previously Reported	Tumour Sample	Heterozygous	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>G	4:g.55599340T>G
SC-her2-045	2313865	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51798494	COSV52784978	COSM1074635	p.?	c.851-26479T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922			ENST00000427531.2:c.851-26479T>A	6:g.152419922T>A
RPC-9	1083085	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17699786		Previously Reported	Cultured	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
904108	904108	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
904116	904116	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
905451	905451	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
905453	905453	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905456	905456	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471079	COSV59325892	COSM12611	p.E355G	c.1064A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403		ENSP00000323315.5:p.Glu355Gly	ENST00000318560.5:c.1064A>G	9:g.133748403A>G
905486	905486	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27483925	COSV59343946	COSM12634	p.E459K	c.1375G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133753906..133753906		ENSP00000323315.5:p.Glu459Lys	ENST00000318560.5:c.1375G>A	9:g.133753906G>A
1024780	1024780	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1031893	1031893	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55408396	COSV51772923	COSM21984	p.?	c.*28+1890G>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Confirmed Somatic	Tumour Sample	Heterozygous	7:55242511..55242511			ENST00000442591.1:c.*28+1890G>T	7:g.55242511G>T
1031900	1031900	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1040049	1040049	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	17180521		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1227034	1227034	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1235127	1235127	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350452	1350452	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351724	1351724	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1355281	1355281	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431258	1431258	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1431287	1431287	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1468062	1468062	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498646	1498646	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498648	1498648	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547784	1547784	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1576791	1576791	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1576792	1576792	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1633983	1633983	ALK	ENST00000389048.3	Yes	Crizotinib	40290752	COSV66556435	COSM99137	p.L1196M	c.3586C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Previously Reported	Tumour Sample	Unknown	2:29443631..29443631	1	ENSP00000373700.3:p.Leu1196Met	ENST00000389048.3:c.3586C>A	2:g.29443631G>T
1655329	1655329	ABL1	ENST00000372348.2	Yes	Imatinib	36324786	COSV59325471	COSM131574	p.L406M	c.1216T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133750328..133750328	1	ENSP00000361423.2:p.Leu406Met	ENST00000372348.2:c.1216T>A	9:g.133750328T>A
1815785	1815785	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1844085	1844085	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173870527		COSM1169208	p.T315A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1928092	1928092	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1989317	1989317	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Variant of unknown origin	Tumour Sample	Unknown					
1992093	1992093	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1996313	1996313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2007326	2007326	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
2032224	2032224	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071717	2071717	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
2071729	2071729	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
2076940	2076940	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	squamous_cell_carcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088640	2088640	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2104642	2104642	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	24555578		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2156364	2156364	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2161695	2161695	NF2_ENST00000353887	ENST00000353887.4	No	Afatinib	32843858	COSV58519797	COSM22432	p.R115*	c.343C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000340626.4:p.Arg115Ter	ENST00000353887.4:c.343C>T	22:g.30051658C>T
2161695	2161695	NF2_ENST00000413209	ENST00000413209.2	No	Afatinib	49671356	COSV58519797	COSM22432	p.?	c.447+13384C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658			ENST00000413209.2:c.447+13384C>T	22:g.30051658C>T
2255315	2255315	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
2255324	2255324	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2313156	2313156	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2318502	2318502	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2368723	2368723	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	25807654		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2396137	2396137	ALK_ENST00000431873	ENST00000431873.1	No	Ceritinib	51337550	COSV66561781	COSM5045108	p.?	c.792-14555G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	26134233		Variant of unknown origin	Tumour Sample	Homozygous	2:29445466..29445466			ENST00000431873.1:c.792-14555G>A	2:g.29445466C>T
2428971	2428971	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2431488	2431488	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2468264	2468264	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864263		COSM5415894	p.Y537N	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Asn		
2471425	2471425	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928723	COSV54736383	COSM564	p.G12D	c.35G>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	1:115258747..115258747	1	ENSP00000358548.4:p.Gly12Asp	ENST00000369535.4:c.35G>A	1:g.115258747C>T
2531281	2531281	FLT3	ENST00000241453.7	Yes	Sunitinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
2537729	2537729	AR_ENST00000396044	ENST00000396044.3	No	Enzalutamide	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2539014	2539014	EGFR_ENST00000455089	ENST00000455089.1	No	HM61713	59104332	COSV51766509	COSM5945664	p.C752S	c.2255G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	26749488		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092		ENSP00000415559.1:p.Cys752Ser	ENST00000455089.1:c.2255G>C	7:g.55249092G>C
2546229	2546229	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457813	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000342630.5:p.Tyr537Asn	ENST00000338799.5:c.1609T>A	6:g.152419922T>A
2546230	2546230	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55281546	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922	1	ENSP00000405330.1:p.Tyr537Asn	ENST00000440973.1:c.1609T>A	6:g.152419922T>A
2564943	2564943	MET_ENST00000539704	ENST00000539704.1	No	Crizotinib	80944237	COSV59256021	COSM5015794	p.D98N	c.292G>A	lung	NS	NS	carcinoma	squamous_cell_carcinoma	NS	27343442		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000445020.1:p.Asp98Asn	ENST00000539704.1:c.292G>A	7:g.116423407G>A
2585234	2585234	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862658		COSM25877	p.G12D	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Asp		
2591477	2591477	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2616292	2616292	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2635719	2635719	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2664334	2664334	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2822956	2822956	EGFR	ENST00000275493.2	Yes	Icotinib	173862575		COSM21943	p.T790M	c.?	lung	right_upper_lobe	NS	carcinoma	hepatoid_adenocarcinoma	NS	31558230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2823714	2823714	FLT3	ENST00000241453.7	Yes	Sorafenib	173862921		COSM28772	p.D835Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	27908881		Previously Reported	Tumour Sample	Unknown		1	ENSP00000241453.7:p.Asp835Tyr		
2824255	2824255	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2831754	2831754	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2841746	2841746	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2841771	2841771	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
Metastasis5	1620045	KIT	ENST00000288135.5	Yes	Sunitinib	25226166	COSV55389584	COSM1321	p.N822K	c.2466T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	21394667		Previously Reported	Tumour Sample	Heterozygous	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>A	4:g.55599340T>A
S_TBL200_R3	2757767	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29106415		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
MOLM-13-RES-AC	1741691	FLT3	ENST00000241453.7	Yes	Quizartinib	173862921		COSM28772	p.D835Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22354205		Confirmed Somatic	Cultured	Homozygous		1	ENSP00000241453.7:p.Asp835Tyr		
904067	904067	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
904078	904078	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
905596	905596	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	15381060		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
WHIM23	2367162	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
1024766	1024766	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1103805	1103805	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211133	1211133	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211133	1211133	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1211145	1211145	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350414	1350414	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350416	1350416	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350448	1350448	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1350489	1350489	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864565		COSM43374	p.E459Q	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1351690	1351690	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1351694	1351694	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1352428	1352428	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1352434	1352434	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1352435	1352435	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1355284	1355284	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1355290	1355290	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355297	1355297	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426021	1426021	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1426024	1426024	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1431257	1431257	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1431259	1431259	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1469791	1469791	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479874	1479874	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1479975	1479975	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1552649	1552649	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1565816	1565816	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
1576783	1576783	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1584473	1584473	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1655337	1655337	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864009		COSM43368	p.L364I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown					
1767042	1767042	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1844079	1844079	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864293		COSM43364	p.L298V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844085	1844085	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2027730	2027730	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071713	2071713	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
2313147	2313147	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2367159	2367159	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2429233	2429233	KIT	ENST00000288135.5	Yes	Imatinib	173863174		COSM28999	p.D820A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Ala		
2462448	2462448	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2525724	2525724	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2538518	2538518	AR	ENST00000374690.3	Yes	Abiraterone	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2550053	2550053	AR	ENST00000374690.3	Yes	Abiraterone	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2584878	2584878	NRAS	ENST00000369535.4	Yes	Cetuximab	173863128		COSM46506	p.G12S	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gly12Ser		
2611072	2611072	PDGFRA	ENST00000257290.5	Yes	Imatinib	173874617		COSM6056875	p.D842_D846delinsG	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842_Asp846delinsGly		
2730698	2730698	EGFR	ENST00000275493.2	Yes	Osimertinib	23267285	COSV51782925	COSM24267	p.L747P	c.2239_2240delinsCC	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29673089		Previously Reported	Tumour Sample	Unknown	7:55242469..55242470	1	ENSP00000275493.2:p.Leu747Pro	ENST00000275493.2:c.2239_2240delinsCC	7:g.55242469_55242470delinsCC
2824309	2824309	ALK	ENST00000389048.3	Yes	Crizotinib	173864601		COSM4422788	p.S1206Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ser1206Tyr		
2840307	2840307	EGFR	ENST00000275493.2	Yes	Osimertinib	23300949	COSV51832111	COSM6493934	p.L792H	c.2375T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249077..55249077	1	ENSP00000275493.2:p.Leu792His	ENST00000275493.2:c.2375T>A	7:g.55249077T>A
2840782	2840782	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85402564	COSV55499223	COSM555	p.?	c.112-17430A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275			ENST00000557334.1:c.112-17430A>T	12:g.25380275T>A
2841752	2841752	ALK	ENST00000389048.3	Yes	Crizotinib	173867633		COSM9413101	p.C1156F	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1			
2841770	2841770	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
SC-her2-045	2313865	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59863320	COSV52784978	COSM1074635	p.Y425N	c.1273T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000415934.2:p.Tyr425Asn	ENST00000456483.2:c.1273T>A	6:g.152419922T>A
M5A	2468203	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
904115	904115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904277	904277	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904289	904289	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
MGH023	2824314	ALK	ENST00000389048.3	Yes	Ceritinib	173870679		COSM4422790	p.F1174C	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Cys		
WHIM20	2367160	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
1103807	1103807	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1211134	1211134	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211145	1211145	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1227066	1227066	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1350421	1350421	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1351683	1351683	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1351699	1351699	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869838		COSM43382	p.E282G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1355298	1355298	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431271	1431271	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1431286	1431286	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1431328	1431328	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1498634	1498634	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543092	1543092	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1547749	1547749	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1552629	1552629	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1744514	1744514	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1767044	1767044	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1815802	1815802	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844080	1844080	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1859892	1859892	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51316332	COSV66556435	COSM99137	p.?	c.792-12720C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	23344087		Previously Reported	Tumour Sample	Unknown	2:29443631..29443631			ENST00000431873.1:c.792-12720C>A	2:g.29443631G>T
1928083	1928083	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968570	1968570	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
1996280	1996280	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1996313	1996313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
2027732	2027732	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071726	2071726	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
2142055	2142055	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24468202		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2144804	2144804	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24675505		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2275291	2275291	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
2318494	2318494	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2426842	2426842	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2470933	2470933	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	173863042		COSM1315806	p.E203K	c.?	skin	NS	NS	malignant_melanoma	NS	NS	23569304		Previously Reported	Tumour Sample	Unknown		1	ENSP00000302486.4:p.Glu203Lys		
2476832	2476832	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2493037	2493037	SMO	ENST00000249373.3	Yes	Vismodegib	22235154	COSV50828671	COSM3942015	p.V321M	c.961G>A	skin	shoulder	NS	carcinoma	basal_cell_carcinoma	NS	25199678		Confirmed Somatic	Tumour Sample	Heterozygous	7:128846031..128846031	1	ENSP00000249373.3:p.Val321Met	ENST00000249373.3:c.961G>A	7:g.128846031G>A
2525675	2525675	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2525681	2525681	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2538636	2538636	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2539199	2539199	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	14618630		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2546229	2546229	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59863320	COSV52784978	COSM1074635	p.Y425N	c.1273T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000415934.2:p.Tyr425Asn	ENST00000456483.2:c.1273T>A	6:g.152419922T>A
2585248	2585248	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862744		COSM14201	p.Q61H	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61His		
2585897	2585897	KIT	ENST00000288135.5	Yes	Nilotinib	173873837		COSM6019354	p.N655T	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	27864817		Confirmed Somatic	Tumour Sample	Unknown		1			
2591475	2591475	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2609321	2609321	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55413343	COSV51766509	COSM5945664	p.?	c.*28+8471G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092			ENST00000442591.1:c.*28+8471G>C	7:g.55249092G>C
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59120521	COSV51832145	COSM6493936	p.C752G	c.2254T>G	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091		ENSP00000415559.1:p.Cys752Gly	ENST00000455089.1:c.2254T>G	7:g.55249091T>G
2651873	2651873	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2816899	2816899	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	27240994	COSV52804538	COSM6163	p.V510M	c.1528G>A	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000292410.3:p.Val510Met	ENST00000292410.3:c.1528G>A	5:g.176522551G>A
2835739	2835739	BTK	ENST00000308731.7	Yes	Acalabrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2841738	2841738	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30683630		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
Case_2-Relapse-M464	2730739	JAK2_ENST00000544510	ENST00000544510.1	No	Pembrolizumab	81765706	COSV67689878	COSM7337170	p.?	c.1194+2T>G	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Cultured	Homozygous	9:5070054..5070054			ENST00000544510.1:c.1194+2T>G	9:g.5070054T>G
4	1330180	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
19	1069280	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
T2111	2823148	MET	ENST00000318493.6	Yes	Tyrosine kinase inhibitor - NS	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Previously Reported	Tumour Sample	Unknown		1			
904120	904120	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
905488	905488	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469595	COSV59323765	COSM12609	p.Q252H	c.756G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>C	9:g.133738356G>C
WHIM20	2367160	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
1103803	1103803	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1227032	1227032	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1227045	1227045	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1350423	1350423	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1350437	1350437	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1351678	1351678	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1355295	1355295	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426033	1426033	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864993		COSM43380	p.L273M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown					
1428810	1428810	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Variant of unknown origin	Tumour Sample	Unknown					
1431268	1431268	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1469796	1469796	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469802	1469802	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498578	1498578	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543094	1543094	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1547780	1547780	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1656923	1656923	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1795094	1795094	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1815800	1815800	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1816951	1816951	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1859887	1859887	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23344087		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2027784	2027784	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2027858	2027858	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032253	2032253	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071714	2071714	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
2071737	2071737	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470710	COSV59323744	COSM12604	p.H396R	c.1187A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356		ENSP00000323315.5:p.His396Arg	ENST00000318560.5:c.1187A>G	9:g.133750356A>G
2239182	2239182	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2318494	2318494	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2318503	2318503	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2431469	2431469	KIT	ENST00000288135.5	Yes	Imatinib	173868052		COSM5352272	p.T670E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	spindle	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Glu		
2483289	2483289	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2531524	2531524	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	NS	Unknown		1	ENSP00000249373.3:p.Trp535Leu		
2539198	2539198	AR	ENST00000374690.3	Yes	Flutamide	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	14618630		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2550054	2550054	AR	ENST00000374690.3	Yes	Abiraterone	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2635723	2635723	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2638656	2638656	EGFR	ENST00000275493.2	Yes	Osimertinib	173867717		COSM4389219	p.G796D	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28572531		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Gly796Asp		
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55431754	COSV51832145	COSM6493936	p.?	c.*28+8470T>G	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091			ENST00000442591.1:c.*28+8470T>G	7:g.55249091T>G
2819289	2819289	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2823658	2823658	MET	ENST00000318493.6	Yes	Erlotinib	27432105	COSV104627086	COSM9277029	p.?	c.2942-1G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31157314		Variant of unknown origin	Tumour Sample	Unknown	7:116411902..116411902	1		ENST00000318493.6:c.2942-1G>A	7:g.116411902G>A
2835705	2835705	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2840774	2840774	KRAS	ENST00000256078.4	Yes	Cetuximab	21547675	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Arg	ENST00000256078.4:c.34G>C	12:g.25398285C>G
2841757	2841757	ALK	ENST00000389048.3	Yes	Crizotinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
2841758	2841758	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2841769	2841769	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2843081	2843081	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
2843085	2843085	ALK	ENST00000389048.3	Yes	Alectinib	40315342	COSV104692577	COSM9501647	p.G1202R	c.3604G>C	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Variant of unknown origin	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>C	2:g.29443613C>G
TG74187	2823154	MTOR	ENST00000361445.4	Yes	Gefitinib	173864179		COSM7410546	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown		1			
Pat_02_B	2492914	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45629051	COSV53562779	COSM3534173	p.?	c.-156C>T	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4117584..4117584			ENST00000394867.4:c.-156C>T	19:g.4117584G>A
SC-her2-025	2313847	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
SC-her2-071	2313875	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
Pt55_resistant_DP2	1545630	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928730	COSV54736340	COSM584	p.Q61R	c.182A>G	skin	NS	NS	malignant_melanoma	NS	NS	21107323		Confirmed Somatic	Tumour Sample	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.182A>G	1:g.115256529T>C
4C	2529060	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
BCC13	2531240	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Confirmed Somatic	Tumour Sample	Unknown		1			
904112	904112	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
905446	905446	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469595	COSV59323765	COSM12609	p.Q252H	c.756G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>C	9:g.133738356G>C
909245	909245	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
E29960	762043	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	14645423		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
1000816	1000816	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1167396	1167396	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211138	1211138	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211145	1211145	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1217444	1217444	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	19096980		Previously Reported	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
1350433	1350433	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864444		COSM43363	p.E292V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1350435	1350435	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1350478	1350478	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
1355260	1355260	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868025		COSM43387	p.S417Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Ser417Tyr		
1431278	1431278	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1479871	1479871	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1498626	1498626	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543090	1543090	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1656924	1656924	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1767026	1767026	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1795097	1795097	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844074	1844074	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1844086	1844086	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173874310		COSM1169207	p.V338F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844090	1844090	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1844091	1844091	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1844093	1844093	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1863619	1863619	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39662068	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359		ENSP00000370369.4:p.Phe691Leu	ENST00000380982.4:c.2073T>G	13:g.28601359A>C
1992087	1992087	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1996283	1996283	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869688		COSM1666895	p.E453G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown					
2027726	2027726	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032254	2032254	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2156367	2156367	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	left_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2255321	2255321	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
2318496	2318496	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2318496	2318496	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2367159	2367159	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2396139	2396139	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	left_bronchus	NS	carcinoma	adenocarcinoma	NS	24942894		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2430144	2430144	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	26130666		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2431435	2431435	KIT	ENST00000288135.5	Yes	Imatinib	25232396	COSV55394297	COSM12709	p.D820E	c.2460T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	spindle	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown	4:55599334..55599334	1	ENSP00000288135.5:p.Asp820Glu	ENST00000288135.5:c.2460T>A	4:g.55599334T>A
2483239	2483239	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2537731	2537731	AR_ENST00000396043	ENST00000396043.2	No	Androgen	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2546229	2546229	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57211241	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000387500.1:p.Tyr537Asn	ENST00000443427.1:c.1609T>A	6:g.152419922T>A
2621495	2621495	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869597		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2635719	2635719	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58444403	COSV51766509	COSM5945664	p.C744S	c.2231G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092		ENSP00000395243.2:p.Cys744Ser	ENST00000454757.2:c.2231G>C	7:g.55249092G>C
2651873	2651873	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2816901	2816901	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865048		COSM9274137	p.V510M	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000292410.3:p.Val510Met		
2819309	2819309	ALK	ENST00000389048.3	Yes	Crizotinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	epithelioid_inflammatory_myofibroblastic_sarcoma	NS	NS	30675302		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
2831753	2831753	ALK	ENST00000389048.3	Yes	Lorlatinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
2838946	2838946	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648459	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Val	ENST00000311936.3:c.35G>T	12:g.25398284C>A
2840307	2840307	EGFR	ENST00000275493.2	Yes	Osimertinib	23270837	COSV51834362	COSM6503269	p.L718Q	c.2153T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Unknown	7:55241705..55241705	1	ENSP00000275493.2:p.Leu718Gln	ENST00000275493.2:c.2153T>A	7:g.55241705T>A
Pat_32_B	2492873	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	24778647	COSV61068483	COSM1517232	p.G128V	c.383G>T	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	15:66729175..66729175	1	ENSP00000302486.4:p.Gly128Val	ENST00000307102.5:c.383G>T	15:g.66729175G>T
905455	905455	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
E30651	762157	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	12949711		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
MGH032	2831778	ALK	ENST00000389048.3	Yes	Brigatinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1024766	1024766	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1031893	1031893	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58439165	COSV51772923	COSM21984	p.D708Y	c.2122G>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Confirmed Somatic	Tumour Sample	Heterozygous	7:55242511..55242511		ENSP00000395243.2:p.Asp708Tyr	ENST00000454757.2:c.2122G>T	7:g.55242511G>T
1211130	1211130	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211140	1211140	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1235127	1235127	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350458	1350458	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1351696	1351696	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1351714	1351714	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
1428809	1428809	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1431298	1431298	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1468081	1468081	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479972	1479972	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1543737	1543737	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1547792	1547792	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1576791	1576791	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1633981	1633981	ALK	ENST00000389048.3	Yes	Crizotinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
1816950	1816950	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1844092	1844092	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1874588	1874588	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1890243	1890243	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22773810		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1989313	1989313	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1996271	1996271	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2027862	2027862	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088645	2088645	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2088663	2088663	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869699		COSM49140	p.A397P	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown					
2156364	2156364	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2161695	2161695	NF2_ENST00000361452	ENST00000361452.4	No	Afatinib	33780838	COSV58528760	COSM3735038	p.?	c.688-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000361452.4:c.688-2A>T	22:g.30060977A>T
2255320	2255320	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2255325	2255325	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2255325	2255325	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
2290930	2290930	MTOR_ENST00000376838	ENST00000376838.1	No	Everolimus	39044605	COSV63877299	COSM4439845	p.F313L	c.939C>A	thyroid	NS	NS	carcinoma	anaplastic_carcinoma	NS	25295501		Confirmed Somatic	Tumour Sample	Heterozygous	1:11187094..11187094		ENSP00000366034.1:p.Phe313Leu	ENST00000376838.1:c.939C>A	1:g.11187094G>T
2293725	2293725	ALK	ENST00000389048.3	Yes	Alectinib	40285352	COSV66556242	COSM28498	p.I1171N	c.3512T>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	25393796		Previously Reported	Tumour Sample	Heterozygous	2:29445213..29445213	1	ENSP00000373700.3:p.Ile1171Asn	ENST00000389048.3:c.3512T>A	2:g.29445213A>T
2429158	2429158	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
2431473	2431473	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	large_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2466801	2466801	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2466812	2466812	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2468257	2468257	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2483282	2483282	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2525579	2525579	KIT	ENST00000288135.5	Yes	Crizotinib	25226717	COSV55408930	COSM12711	p.D816G	c.2447A>G	lung	NS	NS	carcinoma	adenocarcinoma	NS	27068398		Confirmed Somatic	Tumour Sample	Heterozygous	4:55599321..55599321	1	ENSP00000288135.5:p.Asp816Gly	ENST00000288135.5:c.2447A>G	4:g.55599321A>G
2531203	2531203	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
2583444	2583444	AR	ENST00000374690.3	Yes	LHRH	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	10363963		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2585569	2585569	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85396070	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Ala	ENST00000557334.1:c.35G>C	12:g.25398284C>G
2608492	2608492	BTK	ENST00000308731.7	Yes	Ibrutinib	26369574	COSV58117643	COSM6053936	p.C481R	c.1441T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Arg	ENST00000308731.7:c.1441T>C	X:g.100611165A>G
2611057	2611057	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2616290	2616290	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2616304	2616304	BTK	ENST00000308731.7	Yes	Ibrutinib	173871413		COSM6188654	p.C481Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Tyr		
2664336	2664336	MET_ENST00000397752	ENST00000397752.3	No	Capmatinib	44820287	COSV59256836	COSM690	p.Y1230H	c.3688T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413		ENSP00000380860.3:p.Tyr1230His	ENST00000397752.3:c.3688T>C	7:g.116423413T>C
2684447	2684447	MET	ENST00000318493.6	Yes	Crizotinib	173862936		COSM6024205	p.Y1248H	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Tyr1248His		
2832843	2832843	ALK	ENST00000389048.3	Yes	Lorlatinib	173865913		COSM9311667	p.L1204V	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Variant of unknown origin	Tumour Sample	Unknown		1			
2835722	2835722	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2840306	2840306	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2841752	2841752	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2843081	2843081	ALK	ENST00000389048.3	Yes	Alectinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
CTCM112	2468211	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
SC-her2-005	2313835	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
T1751	2823156	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
903853	903853	ABL1	ENST00000372348.2	Yes	Imatinib	36319367	COSV59325003	COSM12574	p.E274V	c.821A>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738364..133738364	1	ENSP00000361423.2:p.Glu274Val	ENST00000372348.2:c.821A>T	9:g.133738364A>T
904086	904086	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
904107	904107	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
905165	905165	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
905174	905174	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905455	905455	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905493	905493	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
1167337	1167337	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
1211131	1211131	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211147	1211147	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1214793	1214793	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18488000		Confirmed Somatic	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
1235127	1235127	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1235138	1235138	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350402	1350402	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1350459	1350459	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1351709	1351709	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1351718	1351718	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866792		COSM43388	p.I418V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1355300	1355300	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431270	1431270	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1431319	1431319	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866792		COSM43388	p.I418V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1469825	1469825	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479973	1479973	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1552627	1552627	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1565818	1565818	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
1565828	1565828	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36332995	COSV59325287	COSM131573	p.F336L	c.1008C>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>A	9:g.133748290C>A
1576795	1576795	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1584476	1584476	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1590996	1590996	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1656921	1656921	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476308	COSV59326265	COSM211677	p.K294delinsRGG	c.880_881delinsCGGGGGGG	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown	9:133747573..133747574		ENSP00000323315.5:p.Lys294delinsArgGlyGly	ENST00000318560.5:c.880_881delinsCGGGGGGG	9:g.133747573_133747574delinsCGGGGGGG
1795099	1795099	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173870093		COSM957502	p.Y320C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1844099	1844099	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1863609	1863609	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
1874590	1874590	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1874597	1874597	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868084		COSM100087	p.V289F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Variant of unknown origin	Tumour Sample	Unknown					
1996298	1996298	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1996322	1996322	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1996324	1996324	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2007332	2007332	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
2007333	2007333	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2007335	2007335	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2027742	2027742	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2230327	2230327	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24781527		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2255304	2255304	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2255311	2255311	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
2313879	2313879	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2324036	2324036	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	27480923	COSV59329005	COSM4767371	p.T315V	c.943_944inv	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133748282..133748283		ENSP00000323315.5:p.Thr315Val	ENST00000318560.5:c.943_944inv	9:g.133748282_133748283inv
2367159	2367159	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2426840	2426840	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2429893	2429893	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	26413254		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
2429894	2429894	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863944		COSM12627	p.V379I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	26413254		Variant of unknown origin	Tumour Sample	Unknown					
2431467	2431467	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2432354	2432354	ALK	ENST00000389048.3	Yes	Alectinib	173866448		COSM5352215	p.I1171S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	26464158		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Ser		
2483238	2483238	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2531244	2531244	SMO	ENST00000249373.3	Yes	Vismodegib	173867430		COSM5885157	p.H231R	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1			
2531264	2531264	SMO	ENST00000249373.3	Yes	Vismodegib	173868380		COSM5885159	p.W281C	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Trp281Cys		
2591493	2591493	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2616284	2616284	BTK	ENST00000308731.7	Yes	Ibrutinib	173871009		COSM6188650	p.C481F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Phe		
2664350	2664350	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664358	2664358	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2664362	2664362	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2819299	2819299	MET	ENST00000318493.6	Yes	Tyrosine kinase inhibitor - NS	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Confirmed Somatic	Tumour Sample	Unknown		1			
2823716	2823716	FLT3	ENST00000241453.7	Yes	Quizartinib	173867043		COSM46499	p.D835I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	27908881		Previously Reported	Tumour Sample	Unknown		1			
2832845	2832845	ALK	ENST00000389048.3	Yes	Lorlatinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2835713	2835713	BTK	ENST00000308731.7	Yes	Ibrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2835737	2835737	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2840778	2840778	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648459	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Val	ENST00000311936.3:c.35G>T	12:g.25398284C>A
2840786	2840786	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25649957	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>C	12:g.25380275T>G
2841765	2841765	ALK	ENST00000389048.3	Yes	Crizotinib	173868062		COSM9413100	p.T1151M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Thr1151Met		
CTCM150	2468200	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
Hep3B_6	2816910	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865048		COSM9274137	p.V510M	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Met		
SNU-2535	1859888	ALK	ENST00000389048.3	Yes	Crizotinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23344087		Variant of unknown origin	Cultured	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
LoVo-MEK-R	1927245	MAP2K2	ENST00000262948.5	Yes	PD0325901	173869777		COSM1570286	p.V215E	c.?	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22402123		Variant of unknown origin	Cultured	Heterozygous		1			
SC-her2-014	2313840	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
SC-her2-019	2313843	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
904140	904140	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863944		COSM12627	p.V379I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown					
905176	905176	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
909235	909235	KIT	ENST00000288135.5	Yes	Imatinib	25226717	COSV55408930	COSM12711	p.D816G	c.2447A>G	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55599321..55599321	1	ENSP00000288135.5:p.Asp816Gly	ENST00000288135.5:c.2447A>G	4:g.55599321A>G
E30649	762155	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	12949711		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
MGH056	2831757	ALK	ENST00000389048.3	Yes	Alectinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
1194997	1194997	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	epithelioid	NS	18830121		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211144	1211144	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350418	1350418	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1350454	1350454	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351677	1351677	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1351695	1351695	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1351697	1351697	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1355315	1355315	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355321	1355321	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1431274	1431274	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431313	1431313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1468065	1468065	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469859	1469859	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1517598	1517598	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21573178		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547788	1547788	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655333	1655333	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
1816950	1816950	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1844098	1844098	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1968570	1968570	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
1989311	1989311	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1989312	1989312	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
2007334	2007334	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866846		COSM1667034	p.D276A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown					
2071719	2071719	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
2071733	2071733	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470960	COSV59326146	COSM1732691	p.F359C	c.1076T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748415..133748415		ENSP00000323315.5:p.Phe359Cys	ENST00000318560.5:c.1076T>G	9:g.133748415T>G
2161695	2161695	NF2_ENST00000403435	ENST00000403435.1	No	Afatinib	45738028	COSV58528760	COSM3735038	p.?	c.811-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000403435.1:c.811-2A>T	22:g.30060977A>T
2255302	2255302	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2318502	2318502	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2429250	2429250	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429258	2429258	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2431449	2431449	KIT	ENST00000288135.5	Yes	Imatinib	25228178	COSV55387376	COSM19109	p.N822Y	c.2464A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55599338..55599338	1	ENSP00000288135.5:p.Asn822Tyr	ENST00000288135.5:c.2464A>T	4:g.55599338A>T
2468261	2468261	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864263		COSM5415894	p.Y537N	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Asn		
2470929	2470929	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	173866393		COSM1236223	p.Q56P	c.?	skin	NS	NS	malignant_melanoma	NS	NS	23569304		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000302486.4:p.Gln56Pro		
2471708	2471708	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	173867179		COSM5574324	p.Q60P	c.?	skin	NS	NS	malignant_melanoma	NS	NS	25705882		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000262948.3:p.Gln60Pro		
2471712	2471712	PTEN	ENST00000371953.3	Yes	Vemurafenib	173871104		COSM5574325	p.R159S	c.?	skin	NS	NS	malignant_melanoma	NS	NS	25705882		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000361021.3:p.Arg159Ser		
2476844	2476844	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2483259	2483259	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2531279	2531279	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39661484	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835His	ENST00000380982.4:c.2503G>C	13:g.28592642C>G
2584880	2584880	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862913		COSM25879	p.G12V	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Val		
2591469	2591469	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2616266	2616266	BTK	ENST00000308731.7	Yes	Ibrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Variant of unknown origin	Tumour Sample	Heterozygous	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2635697	2635697	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2637198	2637198	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862599	COSV52782924	COSM1074637	p.Y425C	c.1274A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Cys	ENST00000456483.2:c.1274A>G	6:g.152419923A>G
2664374	2664374	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2824345	2824345	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2831754	2831754	ALK	ENST00000389048.3	Yes	Lorlatinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
2832002	2832002	ALK	ENST00000389048.3	Yes	Lorlatinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
MOLM-13-RES-xeno	2842302	FLT3	ENST00000241453.7	Yes	Quizartinib	173862921		COSM28772	p.D835Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22354205		Confirmed Somatic	Cultured	Heterozygous		1	ENSP00000241453.7:p.Asp835Tyr		
7A	2479672	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	23348204		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
903854	903854	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469857	COSV59325003	COSM12574	p.E255V	c.764A>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738364..133738364		ENSP00000323315.5:p.Glu255Val	ENST00000318560.5:c.764A>T	9:g.133738364A>T
903870	903870	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
904082	904082	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
904142	904142	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
904265	904265	ABL1	ENST00000372348.2	Yes	Imatinib	36318911	COSV59323765	COSM12609	p.Q271H	c.813G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>C	9:g.133738356G>C
905170	905170	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
905177	905177	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863945		COSM12606	p.F359A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown					
905486	905486	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
909227	909227	KIT	ENST00000288135.5	Yes	Imatinib	25232396	COSV55394297	COSM12709	p.D820E	c.2460T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15685537		Variant of unknown origin	Tumour Sample	Heterozygous	4:55599334..55599334	1	ENSP00000288135.5:p.Asp820Glu	ENST00000288135.5:c.2460T>A	4:g.55599334T>A
1103809	1103809	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350434	1350434	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864293		COSM43364	p.L298V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1350453	1350453	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351688	1351688	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1351703	1351703	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173872127		COSM43383	p.R328M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1355275	1355275	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355309	1355309	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1445188	1445188	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	20682976		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479866	1479866	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1543114	1543114	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1543748	1543748	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1547764	1547764	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547768	1547768	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1565820	1565820	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
1565822	1565822	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
1576781	1576781	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1618762	1618762	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655321	1655321	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
1655327	1655327	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
1655343	1655343	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
1794539	1794539	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1795102	1795102	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862881		COSM133069	p.A399T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1815770	1815770	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815811	1815811	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815813	1815813	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844065	1844065	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1874596	1874596	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Variant of unknown origin	Tumour Sample	Homozygous	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
1968570	1968570	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
1992091	1992091	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1992095	1992095	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2007325	2007325	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
2032239	2032239	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032265	2032265	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071720	2071720	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
2071725	2071725	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
2313147	2313147	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2313150	2313150	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2313880	2313880	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2367159	2367159	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2426848	2426848	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2428985	2428985	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429139	2429139	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1			
2429180	2429180	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429892	2429892	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866902		COSM49031	p.L384M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	26413254		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu384Met		
2444259	2444259	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2466807	2466807	MAP2K1	ENST00000307102.5	Yes	Dabrafenib	24778681	COSV61070134	COSM5369532	p.K57E	c.169A>G	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	15:66727453..66727453	1	ENSP00000302486.4:p.Lys57Glu	ENST00000307102.5:c.169A>G	15:g.66727453A>G
2471409	2471409	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45630124	COSV53563396	COSM5487841	p.C28S	c.83G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	19:4110583..4110583		ENSP00000378336.1:p.Cys28Ser	ENST00000394867.4:c.83G>C	19:g.4110583C>G
2471417	2471417	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20971926	COSV53563396	COSM5487841	p.C125S	c.374G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	19:4110583..4110583	1	ENSP00000262948.3:p.Cys125Ser	ENST00000262948.5:c.374G>C	19:g.4110583C>G
2479264	2479264	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
2483262	2483262	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1			
2531223	2531223	FLT3	ENST00000241453.7	Yes	Sorafenib	173862554		COSM19521	p.D835X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous		1			
2531281	2531281	FLT3_ENST00000380982	ENST00000380982.4	No	Sunitinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
2539014	2539014	EGFR_ENST00000442591	ENST00000442591.1	No	HM61713	55413343	COSV51766509	COSM5945664	p.?	c.*28+8471G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	26749488		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092			ENST00000442591.1:c.*28+8471G>C	7:g.55249092G>C
2550052	2550052	AR	ENST00000374690.3	Yes	Ketoconazole	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2585344	2585344	MET_ENST00000539704	ENST00000539704.1	No	Crizotinib	80944029	COSV59257466	COSM699	p.Y100C	c.299A>G	lung	NS	NS	carcinoma	adenocarcinoma	NS	27666659		Previously Reported	Tumour Sample	Unknown	7:116423414..116423414		ENSP00000445020.1:p.Tyr100Cys	ENST00000539704.1:c.299A>G	7:g.116423414A>G
2585347	2585347	MET	ENST00000318493.6	Yes	Savolitinib	27431099	COSV59260821	COSM6018872	p.D1246V	c.3737A>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27694386		Confirmed Somatic	Tumour Sample	Unknown	7:116423408..116423408	1	ENSP00000317272.6:p.Asp1246Val	ENST00000318493.6:c.3737A>T	7:g.116423408A>T
2591371	2591371	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2611053	2611053	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2664330	2664330	MET_ENST00000397752	ENST00000397752.3	No	Crizotinib	44820287	COSV59256836	COSM690	p.Y1230H	c.3688T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413		ENSP00000380860.3:p.Tyr1230His	ENST00000397752.3:c.3688T>C	7:g.116423413T>C
2664334	2664334	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2812141	2812141	BRAF	ENST00000288602.6	Yes	Osimertinib	173862544		COSM1131	p.V600E	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29596911		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288602.6:p.Val600Glu		
2819291	2819291	MET	ENST00000318493.6	Yes	Tyrosine kinase inhibitor - NS	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown		1			
2831753	2831753	ALK	ENST00000389048.3	Yes	Lorlatinib	40309001	COSV66567934	COSM4440758	p.I1171S	c.3512T>G	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29445213..29445213	1	ENSP00000373700.3:p.Ile1171Ser	ENST00000389048.3:c.3512T>G	2:g.29445213A>C
2831754	2831754	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51330296	COSV66567934	COSM4440758	p.?	c.792-14302T>G	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29445213..29445213			ENST00000431873.1:c.792-14302T>G	2:g.29445213A>C
2835705	2835705	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2838948	2838948	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648472	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Cys	ENST00000311936.3:c.34G>T	12:g.25398285C>A
2840784	2840784	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648522	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Ala	ENST00000311936.3:c.35G>C	12:g.25398284C>G
2841752	2841752	ALK	ENST00000389048.3	Yes	Crizotinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
2841759	2841759	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
CTCM106	2468199	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
MOLM-13-RES-cell	2842301	FLT3	ENST00000241453.7	Yes	Quizartinib	173862921		COSM28772	p.D835Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22354205		Confirmed Somatic	Cultured	Heterozygous		1	ENSP00000241453.7:p.Asp835Tyr		
T4499	2823144	MET	ENST00000318493.6	Yes	Tyrosine kinase inhibitor - NS	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Previously Reported	Tumour Sample	Unknown		1			
904079	904079	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904135	904135	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
909221	909221	KIT	ENST00000288135.5	Yes	Imatinib	25231390	COSV55410040	COSM12708	p.T670I	c.2009C>T	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55595519..55595519	1	ENSP00000288135.5:p.Thr670Ile	ENST00000288135.5:c.2009C>T	4:g.55595519C>T
E29959	762042	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	14645423		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
Pt55_R	1545629	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	21107323		Confirmed Somatic	Cultured	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
WHIM23	2367162	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
1024765	1024765	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1024768	1024768	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1024775	1024775	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1162976	1162976	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18992959		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1227041	1227041	KIT	ENST00000288135.5	Yes	Imatinib	25227346	COSV55387147	COSM1322	p.N822K	c.2466T>G	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>G	4:g.55599340T>G
1350429	1350429	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1431280	1431280	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431294	1431294	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864313		COSM49139	p.F359X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1431302	1431302	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1431322	1431322	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173873883		COSM49143	p.E453L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1469793	1469793	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547751	1547751	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1552652	1552652	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1565832	1565832	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
1795125	1795125	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1815826	1815826	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844066	1844066	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844067	1844067	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866902		COSM49031	p.L384M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu384Met		
1859881	1859881	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	23344087		Variant of unknown origin	Tumour Sample	Homozygous	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
1863607	1863607	FLT3	ENST00000241453.7	Yes	Quizartinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
1878635	1878635	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23407566		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1992085	1992085	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2007329	2007329	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866714		COSM330656	p.T277A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown					
2027748	2027748	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2161695	2161695	NF2_ENST00000334961	ENST00000334961.7	No	Afatinib	29100451	COSV58519797	COSM22432	p.R115*	c.343C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000335652.7:p.Arg115Ter	ENST00000334961.7:c.343C>T	22:g.30051658C>T
2313156	2313156	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2313876	2313876	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48231377	COSV52784978	COSM1074635	p.Y276N	c.826T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000384064.1:p.Tyr276Asn	ENST00000406599.1:c.826T>A	6:g.152419922T>A
2313878	2313878	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797513	COSV52782924	COSM1074637	p.?	c.851-26478A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>G	6:g.152419923A>G
2318502	2318502	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2429130	2429130	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2462444	2462444	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864582		COSM5415893	p.L536_D538>P	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Variant of unknown origin	Tumour Sample	Unknown		1			
2551720	2551720	AR	ENST00000374690.3	Yes	Flutamide	38851617	COSV65953243	COSM3094417	p.V716M	c.2146G>A	prostate	NS	NS	carcinoma	NS	NS	19366804		Confirmed Somatic	Tumour Sample	Unknown	X:66931504..66931504	1	ENSP00000363822.3:p.Val716Met	ENST00000374690.3:c.2146G>A	X:g.66931504G>A
2585569	2585569	NRAS	ENST00000369535.4	Yes	Cetuximab	173863060		COSM17611	p.Q61H	c.?	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61His		
2585570	2585570	NRAS	ENST00000369535.4	Yes	Cetuximab	173862550		COSM36378	p.Q61L	c.?	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Leu		
2591337	2591337	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2611055	2611055	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2621333	2621333	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2621340	2621340	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2635721	2635721	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57216997	COSV52795259	COSM6843697	p.L536H	c.1607T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920		ENSP00000387500.1:p.Leu536His	ENST00000443427.1:c.1607T>A	6:g.152419920T>A
2664335	2664335	MET	ENST00000318493.6	Yes	Capmatinib	27420710	COSV59256021	COSM5015794	p.D1246N	c.3736G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407	1	ENSP00000317272.6:p.Asp1246Asn	ENST00000318493.6:c.3736G>A	7:g.116423407G>A
2816899	2816899	FGFR4	ENST00000292408.4	Yes	Fisogatinib	27232218	COSV52804538	COSM6163	p.V550M	c.1648G>A	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551	1	ENSP00000292408.4:p.Val550Met	ENST00000292408.4:c.1648G>A	5:g.176522551G>A
2838944	2838944	KRAS	ENST00000256078.4	Yes	Panitumumab	21547123	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Ala	ENST00000256078.4:c.35G>C	12:g.25398284C>G
2841742	2841742	ALK	ENST00000389048.3	Yes	Crizotinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
TG95755	2823143	NF1_ENST00000417592	ENST00000417592.2	No	Tyrosine kinase inhibitor - NS	48687240	COSV104420542	COSM9274129	p.G105E	c.314G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown	17:29670139..29670139		ENSP00000398991.2:p.Gly105Glu	ENST00000417592.2:c.314G>A	17:g.29670139G>A
Pat_02_B	2492914	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20971433	COSV53562779	COSM3534173	p.L46F	c.136C>T	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4117584..4117584	1	ENSP00000262948.3:p.Leu46Phe	ENST00000262948.5:c.136C>T	19:g.4117584G>A
3C	2529057	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
19B	2529063	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
904095	904095	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
904130	904130	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
905445	905445	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905457	905457	ABL1	ENST00000372348.2	Yes	Imatinib	36334864	COSV59325186	COSM12630	p.F505S	c.1514T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133755488..133755488	1	ENSP00000361423.2:p.Phe505Ser	ENST00000372348.2:c.1514T>C	9:g.133755488T>C
E30649	762155	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	12949711		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
1135554	1135554	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18676761		Previously Reported	NS	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1227055	1227055	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1235132	1235132	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350472	1350472	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1428809	1428809	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431263	1431263	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431279	1431279	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1498603	1498603	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1498626	1498626	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1543725	1543725	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1543744	1543744	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863335		COSM12668	p.Y353H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown					
1552644	1552644	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1552646	1552646	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1584474	1584474	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1655323	1655323	ABL1	ENST00000372348.2	Yes	Imatinib	36329816	COSV59325261	COSM12631	p.L267V	c.799C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738342..133738342	1	ENSP00000361423.2:p.Leu267Val	ENST00000372348.2:c.799C>G	9:g.133738342C>G
1656924	1656924	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1744515	1744515	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1795098	1795098	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1815823	1815823	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1844069	1844069	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866724		COSM97192	p.F311L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Leu		
1844070	1844070	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844082	1844082	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1844096	1844096	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844102	1844102	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1885388	1885388	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51316332	COSV66556435	COSM99137	p.?	c.792-12720C>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23434628		Previously Reported	Tumour Sample	Unknown	2:29443631..29443631			ENST00000431873.1:c.792-12720C>A	2:g.29443631G>T
1928088	1928088	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1928097	1928097	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992086	1992086	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2007337	2007337	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866724		COSM97192	p.F311L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Leu		
2027861	2027861	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2161695	2161695	NF2_ENST00000397789	ENST00000397789.3	No	Afatinib	44930600	COSV58528760	COSM3735038	p.?	c.811-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000397789.3:c.811-2A>T	22:g.30060977A>T
2255323	2255323	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2313154	2313154	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2429114	2429114	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
2476900	2476900	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2479272	2479272	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2483273	2483273	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
2531242	2531242	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1			
2531510	2531510	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Unknown		1			
2537729	2537729	AR_ENST00000396043	ENST00000396043.2	No	Enzalutamide	43286838	COSV65955698	COSM5945752	p.F345L	c.1033T>C	prostate	NS	NS	carcinoma	NS	NS	25712683		Variant of unknown origin	Tumour Sample	Unknown	X:66943549..66943549		ENSP00000379358.2:p.Phe345Leu	ENST00000396043.2:c.1033T>C	X:g.66943549T>C
2537730	2537730	AR_ENST00000396044	ENST00000396044.3	No	Androgen	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2550054	2550054	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2584900	2584900	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173864878		COSM1169551	p.Q61L	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61Leu		
2605860	2605860	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	27997714		Previously Reported	NS	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2608492	2608492	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812030	COSV58117643	COSM6053936	p.?	c.1039-1483T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>C	X:g.100611165A>G
2611073	2611073	PDGFRA	ENST00000257290.5	Yes	Imatinib	173864749		COSM29002	p.I843_S847delinsT	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Ile843_Ser847delinsThr		
2616300	2616300	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2623674	2623674	BTK	ENST00000308731.7	Yes	Ibrutinib	26370964	COSV58118015	COSM6191212	p.T316A	c.946A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	27626698		Variant of unknown origin	Tumour Sample	Heterozygous	X:100613633..100613633	1	ENSP00000308176.7:p.Thr316Ala	ENST00000308731.7:c.946A>G	X:g.100613633T>C
2664354	2664354	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664360	2664360	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2835715	2835715	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2840774	2840774	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85149412	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Arg	ENST00000556131.1:c.34G>C	12:g.25398285C>G
2841749	2841749	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
H3122-CHR-A1	2245572	ALK	ENST00000389048.3	Yes	Alectinib	40323969	COSV66587894	COSM4381101	p.V1180L	c.3538G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	25228534		Variant of unknown origin	Cultured	Unknown	2:29443679..29443679	1	ENSP00000373700.3:p.Val1180Leu	ENST00000389048.3:c.3538G>C	2:g.29443679C>G
904104	904104	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
904119	904119	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
905486	905486	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27483918	COSV59343940	COSM12633	p.S417Y	c.1250C>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133750419..133750419		ENSP00000323315.5:p.Ser417Tyr	ENST00000318560.5:c.1250C>A	9:g.133750419C>A
1043871	1043871	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	17192902		Previously Reported	NS	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1167336	1167336	KIT	ENST00000288135.5	Yes	Imatinib	173863869		COSM28693	p.D820E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Glu		
1167388	1167388	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1227054	1227054	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1235144	1235144	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1350413	1350413	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350427	1350427	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1351672	1351672	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1351700	1351700	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869838		COSM43382	p.E282G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1352408	1352408	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1352433	1352433	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173874649		COSM43398	p.N374Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown					
1355262	1355262	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173872174		COSM43459	p.E450K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown					
1355329	1355329	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1426034	1426034	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1426035	1426035	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1431281	1431281	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431310	1431310	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1469822	1469822	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479868	1479868	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173873123		COSM43370	p.A433T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown					
1498573	1498573	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1543754	1543754	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1547750	1547750	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1547770	1547770	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1565830	1565830	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
1576781	1576781	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1576792	1576792	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1584479	1584479	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1655309	1655309	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
1655325	1655325	ABL1	ENST00000372348.2	Yes	Imatinib	36318911	COSV59323765	COSM12609	p.Q271H	c.813G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>C	9:g.133738356G>C
1767092	1767092	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1803420	1803420	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	23139670		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1813215	1813215	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	23079729		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1816947	1816947	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1844083	1844083	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844099	1844099	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1844105	1844105	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1928087	1928087	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968560	1968560	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
1992086	1992086	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2032212	2032212	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071712	2071712	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
2088637	2088637	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2088650	2088650	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2161695	2161695	NF2_ENST00000334961	ENST00000334961.7	No	Afatinib	29103789	COSV58528760	COSM3735038	p.?	c.562-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000334961.7:c.562-2A>T	22:g.30060977A>T
2318502	2318502	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2324033	2324033	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471250	COSV59324514	COSM133668	p.F359I	c.1075T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133748414..133748414		ENSP00000323315.5:p.Phe359Ile	ENST00000318560.5:c.1075T>A	9:g.133748414T>A
2367159	2367159	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2426830	2426830	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2444261	2444261	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2471704	2471704	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	25705882		Variant of unknown origin	Tumour Sample	Unknown		1			
2483268	2483268	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2501806	2501806	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51324562	COSV66562303	COSM99136	p.?	c.792-14347G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	27045755		Previously Reported	Tumour Sample	Heterozygous	2:29445258..29445258			ENST00000431873.1:c.792-14347G>A	2:g.29445258C>T
2525683	2525683	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531221	2531221	FLT3	ENST00000241453.7	Yes	Sorafenib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
2611060	2611060	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2635719	2635719	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2635720	2635720	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2635721	2635721	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30462866	COSV52795259	COSM6843697	p.L536H	c.1607T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920		ENSP00000342630.5:p.Leu536His	ENST00000338799.5:c.1607T>A	6:g.152419920T>A
2816899	2816899	FGFR4	ENST00000292408.4	Yes	Fisogatinib	27236022	COSV104624868	COSM9274136	p.C552R	c.1654T>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Tumour Sample	Unknown	5:176522557..176522557	1	ENSP00000292408.4:p.Cys552Arg	ENST00000292408.4:c.1654T>C	5:g.176522557T>C
2824254	2824254	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2824345	2824345	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
2831754	2831754	ALK	ENST00000389048.3	Yes	Lorlatinib	40309001	COSV66567934	COSM4440758	p.I1171S	c.3512T>G	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29445213..29445213	1	ENSP00000373700.3:p.Ile1171Ser	ENST00000389048.3:c.3512T>G	2:g.29445213A>C
2835715	2835715	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2840776	2840776	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25687231	COSV55502677	COSM550	p.Q61E	c.181C>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380277..25380277		ENSP00000308495.3:p.Gln61Glu	ENST00000311936.3:c.181C>G	12:g.25380277G>C
2840784	2840784	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25649957	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>C	12:g.25380275T>G
2840786	2840786	KRAS	ENST00000256078.4	Yes	Panitumumab	21548455	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>C	12:g.25380275T>G
2841753	2841753	ALK	ENST00000389048.3	Yes	Crizotinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
CTCM159	2468196	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
Hep3B_4	2816908	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865400		COSM9274138	p.V510L	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Leu		
M249_R4	1545619	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	21107323		Confirmed Somatic	Cultured	Heterozygous	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
904109	904109	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
904271	904271	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
909231	909231	KIT	ENST00000288135.5	Yes	Imatinib	25226166	COSV55389584	COSM1321	p.N822K	c.2466T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Homozygous	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>A	4:g.55599340T>A
915621	915621	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16014893		Confirmed Somatic	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
MGH087	2831761	ALK	ENST00000389048.3	Yes	Alectinib	173866759		COSM5991608	p.V1180L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Val1180Leu		
1167383	1167383	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211135	1211135	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1235125	1235125	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350406	1350406	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350410	1350410	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350480	1350480	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1351421	1351421	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1352413	1352413	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355270	1355270	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1355313	1355313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1428817	1428817	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1431329	1431329	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1468082	1468082	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469811	1469811	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469824	1469824	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543100	1543100	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1552634	1552634	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863335		COSM12668	p.Y353H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1576797	1576797	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1584481	1584481	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866724		COSM97192	p.F311L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Leu		
1584485	1584485	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866902		COSM49031	p.L384M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu384Met		
1656922	1656922	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476308	COSV59326265	COSM211677	p.K294delinsRGG	c.880_881delinsCGGGGGGG	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown	9:133747573..133747574		ENSP00000323315.5:p.Lys294delinsArgGlyGly	ENST00000318560.5:c.880_881delinsCGGGGGGG	9:g.133747573_133747574delinsCGGGGGGG
1656923	1656923	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1795113	1795113	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815768	1815768	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1844074	1844074	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1874595	1874595	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2071718	2071718	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469857	COSV59325003	COSM12574	p.E255V	c.764A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364		ENSP00000323315.5:p.Glu255Val	ENST00000318560.5:c.764A>T	9:g.133738364A>T
2071732	2071732	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
2161695	2161695	NF2_ENST00000397789	ENST00000397789.3	No	Afatinib	44925922	COSV58519797	COSM22432	p.R198*	c.592C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000380891.3:p.Arg198Ter	ENST00000397789.3:c.592C>T	22:g.30051658C>T
2161695	2161695	NF2_ENST00000413209	ENST00000413209.2	No	Afatinib	49676141	COSV58528760	COSM3735038	p.?	c.447+22703A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000413209.2:c.447+22703A>T	22:g.30060977A>T
2275245	2275245	SMO	ENST00000249373.3	Yes	Vismodegib	22236243	COSV50837084	COSM4413608	p.D473Y	c.1417G>T	skin	shoulder	NS	carcinoma	basal_cell_carcinoma	NS	25306392		Variant of unknown origin	Tumour Sample	Heterozygous	7:128849189..128849189	1	ENSP00000249373.3:p.Asp473Tyr	ENST00000249373.3:c.1417G>T	7:g.128849189G>T
2313154	2313154	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2318491	2318491	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59870987	COSV52785937	COSM4766050	p.L424Q	c.1271_1272delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921		ENSP00000415934.2:p.Leu424Gln	ENST00000456483.2:c.1271_1272delinsAG	6:g.152419920_152419921delinsAG
2429226	2429226	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2430097	2430097	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2431428	2431428	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431437	2431437	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431454	2431454	KIT	ENST00000288135.5	Yes	Imatinib	173862872		COSM12448	p.D579del	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp579del		
2462453	2462453	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2462455	2462455	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2468255	2468255	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173865042		COSM5413590	p.Y537C	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Cys		
2483279	2483279	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
2525706	2525706	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2525728	2525728	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2528545	2528545	NRAS	ENST00000369535.4	Yes	Pembrolizumab	173862549		COSM28048	p.Q61R	c.?	NS	NS	NS	malignant_melanoma	NS	NS	26524482		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Arg		
2531221	2531221	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
2531273	2531273	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706366	COSV54042636	COSM785	p.?	c.2419-2804G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>C	13:g.28592642C>G
2537729	2537729	AR_ENST00000396044	ENST00000396044.3	No	Enzalutamide	43305748	COSV65955698	COSM5945752	p.V732A	c.2195T>C	prostate	NS	NS	carcinoma	NS	NS	25712683		Variant of unknown origin	Tumour Sample	Unknown	X:66943549..66943549		ENSP00000379359.3:p.Val732Ala	ENST00000396044.3:c.2195T>C	X:g.66943549T>C
2538591	2538591	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2539200	2539200	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43307807	COSV65953158	COSM5570418	p.H733Q	c.2199C>G	prostate	NS	NS	carcinoma	NS	NS	7723794		Previously Reported	Tumour Sample	Unknown	X:66943553..66943553		ENSP00000379359.3:p.His733Gln	ENST00000396044.3:c.2199C>G	X:g.66943553C>G
2584890	2584890	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173863577		COSM25881	p.G12A	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Ala		
2664333	2664333	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2816899	2816899	FGFR4	ENST00000292408.4	Yes	Fisogatinib	27232016	COSV52802492	COSM1066172	p.V550L	c.1648G>T	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551	1	ENSP00000292408.4:p.Val550Leu	ENST00000292408.4:c.1648G>T	5:g.176522551G>T
2831753	2831753	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2838942	2838942	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85396594	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Arg	ENST00000557334.1:c.34G>C	12:g.25398285C>G
NCI-H1975	1028949	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17145836		Previously Reported	Cultured	Unknown		1	ENSP00000275493.2:p.Thr790Met		
14B	2484951	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
AHAX	1311146	KIT	ENST00000288135.5	Yes	Imatinib	25226377	COSV55386862	COSM1311	p.D816H	c.2446G>C	soft_tissue	fibrous_tissue_and_uncertain_origin	mediastinum	gastrointestinal_stromal_tumour	NS	NS	20032375		Confirmed Somatic	Cultured	Heterozygous	4:55599320..55599320	1	ENSP00000288135.5:p.Asp816His	ENST00000288135.5:c.2446G>C	4:g.55599320G>C
BCC6	2531233	SMO	ENST00000249373.3	Yes	Vismodegib	173871648		COSM5885155	p.D473H	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000249373.3:p.Asp473His		
904110	904110	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
904135	904135	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
905171	905171	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27484625	COSV59344652	COSM12603	p.T315N	c.944C>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Asn	ENST00000318560.5:c.944C>A	9:g.133748283C>A
905175	905175	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
905486	905486	ABL1	ENST00000372348.2	Yes	Imatinib	36344588	COSV59343946	COSM12634	p.E478K	c.1432G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133753906..133753906	1	ENSP00000361423.2:p.Glu478Lys	ENST00000372348.2:c.1432G>A	9:g.133753906G>A
905495	905495	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
CTCM62	2468209	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
1024775	1024775	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1209870	1209870	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	pleomorphic_carcinoma	NS	19155283		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1211136	1211136	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1227031	1227031	KIT	ENST00000288135.5	Yes	Imatinib	173864791		COSM24640	p.N822Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Tyr		
1227037	1227037	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1350424	1350424	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1351678	1351678	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1355319	1355319	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426022	1426022	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1426040	1426040	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1428811	1428811	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1469787	1469787	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469797	1469797	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498622	1498622	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1545599	1545599	ABL1	ENST00000372348.2	Yes	Imatinib	36329816	COSV59325261	COSM12631	p.L267V	c.799C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	17008892		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738342..133738342	1	ENSP00000361423.2:p.Leu267Val	ENST00000372348.2:c.799C>G	9:g.133738342C>G
1547776	1547776	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552628	1552628	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1565828	1565828	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
1590011	1590011	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	21995391		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1590011	1590011	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	21995391		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1656921	1656921	ABL1	ENST00000372348.2	Yes	Imatinib	36333256	COSV59326265	COSM211677	p.K313delinsRGG	c.937_938delinsCGGGGGGG	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown	9:133747573..133747574	1	ENSP00000361423.2:p.Lys313delinsArgGlyGly	ENST00000372348.2:c.937_938delinsCGGGGGGG	9:g.133747573_133747574delinsCGGGGGGG
1767083	1767083	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1774688	1774688	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795106	1795106	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1815794	1815794	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1815818	1815818	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173865010		COSM43371	p.E453K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu453Lys		
1816949	1816949	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1844078	1844078	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863449		COSM1169211	p.D325G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1968562	1968562	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
2088655	2088655	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
2255319	2255319	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
2318496	2318496	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2426844	2426844	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2428991	2428991	KIT	ENST00000288135.5	Yes	Imatinib	25225980	COSV55387507	COSM1304	p.K642E	c.1924A>G	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown	4:55594221..55594221	1	ENSP00000288135.5:p.Lys642Glu	ENST00000288135.5:c.1924A>G	4:g.55594221A>G
2429115	2429115	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429194	2429194	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2431465	2431465	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
2468257	2468257	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864263		COSM5415894	p.Y537N	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Asn		
2471408	2471408	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45630124	COSV53563396	COSM5487841	p.C28S	c.83G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	19:4110583..4110583		ENSP00000378336.1:p.Cys28Ser	ENST00000394867.4:c.83G>C	19:g.4110583C>G
2483296	2483296	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	large_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2484529	2484529	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2585570	2585570	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148556	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Ala	ENST00000556131.1:c.35G>C	12:g.25398284C>G
2591441	2591441	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2605636	2605636	MET	ENST00000318493.6	Yes	Crizotinib	173862935		COSM6024204	p.D1246N	c.?	lung	left	NS	carcinoma	adenocarcinoma	NS	27987579		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Asp1246Asn		
2608492	2608492	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812019	COSV58122597	COSM6053939	p.?	c.1039-1482G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>A	X:g.100611164C>T
2635723	2635723	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2637199	2637199	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654364	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Cys	ENST00000206249.3:c.1610A>G	6:g.152419923A>G
2777955	2777955	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25982275		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2824253	2824253	ALK	ENST00000389048.3	Yes	Brigatinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31668326		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
2835705	2835705	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2835713	2835713	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812030	COSV58117643	COSM6053936	p.?	c.1039-1483T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>C	X:g.100611165A>G
2840784	2840784	KRAS	ENST00000256078.4	Yes	Cetuximab	21548742	COSV55498739	COSM552	p.Q61R	c.182A>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380276..25380276	1	ENSP00000256078.4:p.Gln61Arg	ENST00000256078.4:c.182A>G	12:g.25380276T>C
2840784	2840784	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85396070	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Ala	ENST00000557334.1:c.35G>C	12:g.25398284C>G
2841756	2841756	ALK	ENST00000389048.3	Yes	Crizotinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
IIIA	1179821	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19181917		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
IIIA	1179821	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19181917		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
904289	904289	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
904299	904299	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905167	905167	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469857	COSV59325003	COSM12574	p.E255V	c.764A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364		ENSP00000323315.5:p.Glu255Val	ENST00000318560.5:c.764A>T	9:g.133738364A>T
905178	905178	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470710	COSV59323744	COSM12604	p.H396R	c.1187A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356		ENSP00000323315.5:p.His396Arg	ENST00000318560.5:c.1187A>G	9:g.133750356A>G
909245	909245	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
MGH932	2824340	ALK	ENST00000389048.3	Yes	Ceritinib	173867632		COSM9306549	p.G1202del	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1			
WHIM23	2367162	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
1000815	1000815	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1024766	1024766	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1024776	1024776	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1024780	1024780	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1167384	1167384	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1235136	1235136	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350487	1350487	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1351676	1351676	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1351689	1351689	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869345		COSM43379	p.G251D	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly251Asp		
1351691	1351691	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1355272	1355272	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1355311	1355311	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1426030	1426030	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431264	1431264	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1468068	1468068	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1468070	1468070	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1576789	1576789	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1618773	1618773	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1744518	1744518	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1767059	1767059	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1795118	1795118	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1816951	1816951	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1816951	1816951	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1844089	1844089	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1874593	1874593	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1968568	1968568	KRAS	ENST00000256078.4	Yes	Cetuximab	21552111	COSV55499223	COSM555	p.Q61H	c.183A>T	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Heterozygous	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>T	12:g.25380275T>A
1968570	1968570	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
1992092	1992092	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2032221	2032221	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071736	2071736	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471758	COSV59325471	COSM131574	p.L387M	c.1159T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133750328..133750328		ENSP00000323315.5:p.Leu387Met	ENST00000318560.5:c.1159T>A	9:g.133750328T>A
2088660	2088660	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173870883		COSM1738061	p.N368S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown					
2239182	2239182	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2239182	2239182	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2255308	2255308	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2313154	2313154	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2313876	2313876	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457813	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000342630.5:p.Tyr537Asn	ENST00000338799.5:c.1609T>A	6:g.152419922T>A
2318492	2318492	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2429124	2429124	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
2429761	2429761	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right	NS	carcinoma	adenocarcinoma	NS	26400668		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2429891	2429891	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	26413254		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2462445	2462445	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173865042		COSM5413590	p.Y537C	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Cys		
2462451	2462451	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2525712	2525712	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531274	2531274	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706366	COSV54042636	COSM785	p.?	c.2419-2804G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>C	13:g.28592642C>G
2584890	2584890	NRAS	ENST00000369535.4	Yes	Cetuximab	173863060		COSM17611	p.Q61H	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61His		
2585567	2585567	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
2591341	2591341	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2609319	2609319	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2616260	2616260	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2621287	2621287	BTK	ENST00000308731.7	Yes	Ibrutinib	26369574	COSV58117643	COSM6053936	p.C481R	c.1441T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Arg	ENST00000308731.7:c.1441T>C	X:g.100611165A>G
2635720	2635720	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2815053	2815053	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	29807405		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2823495	2823495	TET2_ENST00000394764	ENST00000394764.1	No	Sunitinib	45133840	COSV54407618	COSM3598847	p.P46L	c.137C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236		ENSP00000378245.1:p.Pro46Leu	ENST00000394764.1:c.137C>T	4:g.106155236C>T
2835723	2835723	BTK	ENST00000308731.7	Yes	Ibrutinib	26369565	COSV58122597	COSM6053939	p.C481Y	c.1442G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Tyr	ENST00000308731.7:c.1442G>A	X:g.100611164C>T
2840782	2840782	KRAS	ENST00000256078.4	Yes	Cetuximab	21552111	COSV55499223	COSM555	p.Q61H	c.183A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>T	12:g.25380275T>A
2841737	2841737	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30683630		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
Hep3B_5	2816909	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865048		COSM9274137	p.V510M	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Met		
Pat_70_B	2492907	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928859	COSV54736320	COSM586	p.Q61H	c.183A>C	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256528..115256528	1	ENSP00000358548.4:p.Gln61His	ENST00000369535.4:c.183A>C	1:g.115256528T>G
M5D	2468204	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
904113	904113	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
904285	904285	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
905167	905167	ABL1	ENST00000372348.2	Yes	Imatinib	36319367	COSV59325003	COSM12574	p.E274V	c.821A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364	1	ENSP00000361423.2:p.Glu274Val	ENST00000372348.2:c.821A>T	9:g.133738364A>T
905487	905487	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469595	COSV59323765	COSM12609	p.Q252H	c.756G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>C	9:g.133738356G>C
1043871	1043871	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	17192902		Previously Reported	NS	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1235138	1235138	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1319151	1319151	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	20146086		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1352412	1352412	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355277	1355277	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426026	1426026	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1445175	1445175	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	20682976		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469783	1469783	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498582	1498582	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1543102	1543102	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1543111	1543111	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869699		COSM49140	p.A397P	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown					
1767086	1767086	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1844068	1844068	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1844068	1844068	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844084	1844084	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1844090	1844090	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1859892	1859892	ALK	ENST00000389048.3	Yes	Crizotinib	40290752	COSV66556435	COSM99137	p.L1196M	c.3586C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	23344087		Previously Reported	Tumour Sample	Unknown	2:29443631..29443631	1	ENSP00000373700.3:p.Leu1196Met	ENST00000389048.3:c.3586C>A	2:g.29443631G>T
1992085	1992085	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2032215	2032215	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032225	2032225	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032240	2032240	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071711	2071711	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
2318492	2318492	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2428987	2428987	KIT	ENST00000288135.5	Yes	Imatinib	173863001		COSM18891	p.K642E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Lys642Glu		
2479262	2479262	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
2521260	2521260	SMO	ENST00000249373.3	Yes	Vismodegib	22236309	COSV50825320	COSM4728533	p.T241M	c.722C>T	skin	face	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Confirmed Somatic	Tumour Sample	Unknown	7:128845228..128845228	1	ENSP00000249373.3:p.Thr241Met	ENST00000249373.3:c.722C>T	7:g.128845228C>T
2528551	2528551	NRAS	ENST00000369535.4	Yes	Dabrafenib	173862661		COSM28049	p.Q61K	c.?	NS	NS	NS	malignant_melanoma	NS	NS	26524482		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2584898	2584898	NRAS	ENST00000369535.4	Yes	Cetuximab	173862550		COSM36378	p.Q61L	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Leu		
2608487	2608487	BTK	ENST00000308731.7	Yes	Ibrutinib	26369565	COSV58122597	COSM6053939	p.C481Y	c.1442G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Tyr	ENST00000308731.7:c.1442G>A	X:g.100611164C>T
2608492	2608492	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2608498	2608498	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2611063	2611063	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2616304	2616304	BTK	ENST00000308731.7	Yes	Ibrutinib	173871411		COSM6188655	p.C481R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Arg		
2635652	2635652	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59863320	COSV52784978	COSM1074635	p.Y425N	c.1273T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000415934.2:p.Tyr425Asn	ENST00000456483.2:c.1273T>A	6:g.152419922T>A
2664330	2664330	MET	ENST00000318493.6	Yes	Crizotinib	27419172	COSV59256836	COSM690	p.Y1248H	c.3742T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413	1	ENSP00000317272.6:p.Tyr1248His	ENST00000318493.6:c.3742T>C	7:g.116423413T>C
2684445	2684445	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2816899	2816899	FGFR4_ENST00000502906	ENST00000502906.1	No	Fisogatinib	68519411	COSV52804538	COSM6163	p.V550M	c.1648G>A	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000424960.1:p.Val550Met	ENST00000502906.1:c.1648G>A	5:g.176522551G>A
2835739	2835739	BTK_ENST00000372880	ENST00000372880.1	No	Acalabrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2838942	2838942	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25649084	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Arg	ENST00000311936.3:c.34G>C	12:g.25398285C>G
2838948	2838948	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148384	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Cys	ENST00000556131.1:c.34G>T	12:g.25398285C>A
2840776	2840776	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85585194	COSV104554397	COSM9363035	p.?	c.112-17431_112-17430delinsCC	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Variant of unknown origin	Tumour Sample	Unknown	12:25380275..25380276			ENST00000557334.1:c.112-17431_112-17430delinsCC	12:g.25380275_25380276delinsGG
2840780	2840780	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395965	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Cys	ENST00000557334.1:c.34G>T	12:g.25398285C>A
2841758	2841758	ALK	ENST00000389048.3	Yes	Crizotinib	173863820		COSM9112561	p.T1151R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1			
2841769	2841769	ALK	ENST00000389048.3	Yes	Crizotinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
Hep3B_7	2816911	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865048		COSM9274137	p.V510M	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Met		
Pat_08_B	2492848	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
904075	904075	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
904127	904127	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
905495	905495	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
TCSR-T	2823142	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1031893	1031893	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59098317	COSV51772923	COSM21984	p.D716Y	c.2146G>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Confirmed Somatic	Tumour Sample	Heterozygous	7:55242511..55242511		ENSP00000415559.1:p.Asp716Tyr	ENST00000455089.1:c.2146G>T	7:g.55242511G>T
1167371	1167371	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1319151	1319151	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	20146086		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1350432	1350432	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1351432	1351432	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1351712	1351712	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864009		COSM43368	p.L364I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1352420	1352420	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1426023	1426023	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1431284	1431284	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431327	1431327	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1469782	1469782	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469813	1469813	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479870	1479870	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1543732	1543732	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1565824	1565824	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27471254	COSV59323752	COSM12602	p.D276G	c.827A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Previously Reported	Tumour Sample	Unknown	9:133747520..133747520		ENSP00000323315.5:p.Asp276Gly	ENST00000318560.5:c.827A>G	9:g.133747520A>G
1576789	1576789	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1576795	1576795	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1656923	1656923	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1767054	1767054	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173865559		COSM329082	p.K419E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown					
1844066	1844066	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1844071	1844071	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1844101	1844101	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1968568	1968568	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25654383	COSV55499223	COSM555	p.Q61H	c.183A>T	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Heterozygous	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>T	12:g.25380275T>A
1992084	1992084	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1992085	1992085	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1992088	1992088	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1996265	1996265	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2007336	2007336	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
2076948	2076948	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088661	2088661	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
2156364	2156364	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2313154	2313154	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2318496	2318496	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2429178	2429178	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2430135	2430135	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26130666		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2466820	2466820	BRAF	ENST00000288602.6	Yes	Vemurafenib	173863357		COSM5546575	p.?	c.139_1140del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Unknown		1			
2479268	2479268	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2483236	2483236	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2483286	2483286	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2531268	2531268	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Trp535Leu		
2531512	2531512	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Unknown		1			
2538636	2538636	AR	ENST00000374690.3	Yes	Abiraterone	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2546230	2546230	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22655219	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000206249.3:p.Tyr537Asn	ENST00000206249.3:c.1609T>A	6:g.152419922T>A
2550053	2550053	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2583444	2583444	AR_ENST00000396044	ENST00000396044.3	No	LHRH	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	10363963		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2585567	2585567	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
2591421	2591421	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2605862	2605862	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	27997714		Previously Reported	NS	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2637199	2637199	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280434	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Cys	ENST00000440973.1:c.1610A>G	6:g.152419923A>G
2651874	2651874	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58438229	COSV51834362	COSM6503269	p.L665Q	c.1994T>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Variant of unknown origin	Tumour Sample	Homozygous	7:55241705..55241705		ENSP00000395243.2:p.Leu665Gln	ENST00000454757.2:c.1994T>A	7:g.55241705T>A
2664333	2664333	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2664336	2664336	MET_ENST00000539704	ENST00000539704.1	No	Capmatinib	80943543	COSV59256836	COSM690	p.Y100H	c.298T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413		ENSP00000445020.1:p.Tyr100His	ENST00000539704.1:c.298T>C	7:g.116423413T>C
2664371	2664371	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2819306	2819306	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2831753	2831753	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51330296	COSV66567934	COSM4440758	p.?	c.792-14302T>G	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31943796		Variant of unknown origin	Tumour Sample	Unknown	2:29445213..29445213			ENST00000431873.1:c.792-14302T>G	2:g.29445213A>C
2835717	2835717	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2840780	2840780	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148384	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Cys	ENST00000556131.1:c.34G>T	12:g.25398285C>A
2841744	2841744	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2841756	2841756	ALK	ENST00000389048.3	Yes	Crizotinib	173864072		COSM9278966	p.C1156Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Cys1156Tyr		
Pat_04_A	2492839	MAP2K1	ENST00000307102.5	Yes	Dabrafenib	24777206	COSV61068297	COSM235614	p.P124S	c.370C>T	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	15:66729162..66729162	1	ENSP00000302486.4:p.Pro124Ser	ENST00000307102.5:c.370C>T	15:g.66729162C>T
SC-her2-025	2313847	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
904136	904136	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
905172	905172	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
905488	905488	ABL1	ENST00000372348.2	Yes	Imatinib	36318911	COSV59323765	COSM12609	p.Q271H	c.813G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>C	9:g.133738356G>C
905494	905494	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
905599	905599	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	15381060		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
909215	909215	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Homozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
915621	915621	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16014893		Confirmed Somatic	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1000816	1000816	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1024776	1024776	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211141	1211141	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211147	1211147	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1235144	1235144	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1278400	1278400	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350446	1350446	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351698	1351698	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173870952		COSM43381	p.E279Z	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1352419	1352419	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355318	1355318	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431277	1431277	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431295	1431295	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864313		COSM49139	p.F359X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1431308	1431308	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1469798	1469798	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543104	1543104	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1543109	1543109	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1545600	1545600	ABL1	ENST00000372348.2	Yes	Imatinib	36329816	COSV59325261	COSM12631	p.L267V	c.799C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	17008892		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738342..133738342	1	ENSP00000361423.2:p.Leu267Val	ENST00000372348.2:c.799C>G	9:g.133738342C>G
1576801	1576801	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1767019	1767019	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1795095	1795095	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1844101	1844101	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844104	1844104	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1844106	1844106	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1863613	1863613	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705985	COSV54045249	COSM19844	p.?	c.2419-2804_2419-2803delinsTT	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Variant of unknown origin	Tumour Sample	Unknown	13:28592641..28592642			ENST00000537084.1:c.2419-2804_2419-2803delinsTT	13:g.28592641_28592642delinsAA
1989320	1989320	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Variant of unknown origin	Tumour Sample	Unknown					
1992088	1992088	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1992091	1992091	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1996316	1996316	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2032251	2032251	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088647	2088647	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2088652	2088652	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
2255319	2255319	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2313152	2313152	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2313879	2313879	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2318492	2318492	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2430099	2430099	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Variant of unknown origin	Tumour Sample	Unknown					
2525726	2525726	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2525736	2525736	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531260	2531260	SMO	ENST00000249373.3	Yes	Vismodegib	173868380		COSM5885159	p.W281C	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Trp281Cys		
2546229	2546229	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51798494	COSV52784978	COSM1074635	p.?	c.851-26479T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922			ENST00000427531.2:c.851-26479T>A	6:g.152419922T>A
2621284	2621284	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2635652	2635652	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55281546	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922	1	ENSP00000405330.1:p.Tyr537Asn	ENST00000440973.1:c.1609T>A	6:g.152419922T>A
2635719	2635719	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2635721	2635721	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2664326	2664326	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664327	2664327	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664378	2664378	CTNNB1_ENST00000396183	ENST00000396183.3	No	Imatinib	43851998	COSV62687839	COSM5677	p.S33C	c.98C>G	skin	NS	NS	malignant_melanoma	acral_lentiginous	NS	28421416		Previously Reported	Tumour Sample	Unknown	3:41266101..41266101		ENSP00000379486.3:p.Ser33Cys	ENST00000396183.3:c.98C>G	3:g.41266101C>G
2835721	2835721	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2838944	2838944	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85396070	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Ala	ENST00000557334.1:c.35G>C	12:g.25398284C>G
2840776	2840776	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85396594	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Arg	ENST00000557334.1:c.34G>C	12:g.25398285C>G
2841750	2841750	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2841761	2841761	ALK	ENST00000389048.3	Yes	Crizotinib	173864072		COSM9278966	p.C1156Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Cys1156Tyr		
Pt55_R2	1545631	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928730	COSV54736340	COSM584	p.Q61R	c.182A>G	skin	NS	NS	malignant_melanoma	NS	NS	21107323		Confirmed Somatic	Cultured	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.182A>G	1:g.115256529T>C
Pat_45_B	2492884	MAP2K2_ENST00000394867	ENST00000394867.4	No	Vemurafenib	45629369	COSV53567161	COSM5855836	p.?	c.-189G>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4117617..4117617			ENST00000394867.4:c.-189G>A	19:g.4117617C>T
4A	2529059	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
18a	2428965	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
904114	904114	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
904120	904120	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
905445	905445	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905446	905446	ABL1	ENST00000372348.2	Yes	Imatinib	36318911	COSV59323765	COSM12609	p.Q271H	c.813G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>C	9:g.133738356G>C
MGH065	2824328	ALK	ENST00000389048.3	Yes	Ceritinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
PT09_1	2521256	SMO	ENST00000249373.3	Yes	Vismodegib	22235154	COSV50828671	COSM3942015	p.V321M	c.961G>A	skin	leg	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Confirmed Somatic	Tumour Sample	Unknown	7:128846031..128846031	1	ENSP00000249373.3:p.Val321Met	ENST00000249373.3:c.961G>A	7:g.128846031G>A
1122359	1122359	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1211132	1211132	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1214790	1214790	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18488000		Confirmed Somatic	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
1235144	1235144	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1351704	1351704	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1355271	1355271	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355302	1355302	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869074		COSM43460	p.P480L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown					
1426043	1426043	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866902		COSM49031	p.L384M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu384Met		
1431296	1431296	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864313		COSM49139	p.F359X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1468083	1468083	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469790	1469790	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498584	1498584	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1498600	1498600	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543096	1543096	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1543105	1543105	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1576801	1576801	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1590995	1590995	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1591001	1591001	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767078	1767078	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1795129	1795129	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866188		COSM957506	p.M351K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1815773	1815773	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1815789	1815789	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1815794	1815794	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844077	1844077	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844081	1844081	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844088	1844088	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1844094	1844094	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844101	1844101	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1844103	1844103	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1928094	1928094	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992084	1992084	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1992087	1992087	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1992091	1992091	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1992094	1992094	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2071723	2071723	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
2161695	2161695	NF2	ENST00000338641.4	Yes	Afatinib	30327413	COSV58528760	COSM3735038	p.?	c.811-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977	1		ENST00000338641.4:c.811-2A>T	22:g.30060977A>T
2161695	2161695	NF2_ENST00000361676	ENST00000361676.4	No	Afatinib	34615082	COSV58528760	COSM3735038	p.?	c.685-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000361676.4:c.685-2A>T	22:g.30060977A>T
2313150	2313150	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2313154	2313154	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2313879	2313879	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2426852	2426852	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2429115	2429115	KIT	ENST00000288135.5	Yes	Imatinib	173863717		COSM5351737	p.(P627_G664)Xfs*?	c.(1880_1990)ins?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Variant of unknown origin	Tumour Sample	Unknown		1			
2431450	2431450	KIT	ENST00000288135.5	Yes	Imatinib	25232396	COSV55394297	COSM12709	p.D820E	c.2460T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown	4:55599334..55599334	1	ENSP00000288135.5:p.Asp820Glu	ENST00000288135.5:c.2460T>A	4:g.55599334T>A
2431461	2431461	KIT	ENST00000288135.5	Yes	Imatinib	25228178	COSV55387376	COSM19109	p.N822Y	c.2464A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55599338..55599338	1	ENSP00000288135.5:p.Asn822Tyr	ENST00000288135.5:c.2464A>T	4:g.55599338A>T
2431463	2431463	KIT	ENST00000288135.5	Yes	Imatinib	173862668		COSM5352271	p.K818_D820>N	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	epithelioid	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown		1			
2471413	2471413	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
2479332	2479332	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
2483233	2483233	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2483234	2483234	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2483235	2483235	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2483245	2483245	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
2511759	2511759	BRAF	ENST00000288602.6	Yes	Imatinib	25723279	COSV56056643	COSM476	p.V600E	c.1799T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25182956		Confirmed Somatic	Tumour Sample	Heterozygous	7:140453136..140453136	1	ENSP00000288602.6:p.Val600Glu	ENST00000288602.6:c.1799T>A	7:g.140453136A>T
2517292	2517292	NRAS	ENST00000369535.4	Yes	Vemurafenib	173862661		COSM28049	p.Q61K	c.?	skin	NS	NS	malignant_melanoma	NS	NS	26101714		Previously Reported	Cultured	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2521259	2521259	SMO	ENST00000249373.3	Yes	Vismodegib	22236669	COSV50827270	COSM5890319	p.C469Y	c.1406G>A	skin	face	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Confirmed Somatic	Tumour Sample	Unknown	7:128849178..128849178	1	ENSP00000249373.3:p.Cys469Tyr	ENST00000249373.3:c.1406G>A	7:g.128849178G>A
2539200	2539200	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43288670	COSV65953158	COSM5570418	p.T346S	c.1037C>G	prostate	NS	NS	carcinoma	NS	NS	7723794		Previously Reported	Tumour Sample	Unknown	X:66943553..66943553		ENSP00000379358.2:p.Thr346Ser	ENST00000396043.2:c.1037C>G	X:g.66943553C>G
2546230	2546230	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48231377	COSV52784978	COSM1074635	p.Y276N	c.826T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000384064.1:p.Tyr276Asn	ENST00000406599.1:c.826T>A	6:g.152419922T>A
2585242	2585242	NRAS	ENST00000369535.4	Yes	Panitumumab	173863060		COSM17611	p.Q61H	c.?	large_intestine	colon	right	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61His		
2585567	2585567	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
2605864	2605864	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	27997714		Previously Reported	NS	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2621287	2621287	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812030	COSV58117643	COSM6053936	p.?	c.1039-1483T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>C	X:g.100611165A>G
2624132	2624132	ALK_ENST00000431873	ENST00000431873.1	No	Ceritinib	51339868	COSV66565234	COSM6191344	p.?	c.792-12699G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28434515		Variant of unknown origin	Tumour Sample	Unknown	2:29443610..29443610			ENST00000431873.1:c.792-12699G>A	2:g.29443610C>T
2635720	2635720	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2664330	2664330	MET	ENST00000318493.6	Yes	Crizotinib	27420710	COSV59256021	COSM5015794	p.D1246N	c.3736G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407	1	ENSP00000317272.6:p.Asp1246Asn	ENST00000318493.6:c.3736G>A	7:g.116423407G>A
2816899	2816899	FGFR4	ENST00000292408.4	Yes	Fisogatinib	27233847	COSV52800715	COSM3738141	p.V550L	c.1648G>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551	1	ENSP00000292408.4:p.Val550Leu	ENST00000292408.4:c.1648G>C	5:g.176522551G>C
2835711	2835711	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812019	COSV58122597	COSM6053939	p.?	c.1039-1482G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>A	X:g.100611164C>T
2838948	2838948	KRAS	ENST00000256078.4	Yes	Panitumumab	21547123	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Ala	ENST00000256078.4:c.35G>C	12:g.25398284C>G
2840776	2840776	KRAS	ENST00000256078.4	Yes	Panitumumab	21717762	COSV104554397	COSM9363035	p.Q61P	c.182_183delinsCC	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Variant of unknown origin	Tumour Sample	Unknown	12:25380275..25380276	1	ENSP00000256078.4:p.Gln61Pro	ENST00000256078.4:c.182_183delinsCC	12:g.25380275_25380276delinsGG
CTCM109	2468202	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
SC-her2-019	2313843	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
SC-her2-025	2313847	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
22	1069283	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
898242	898242	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	15728811		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
904118	904118	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904120	904120	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
904128	904128	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
905454	905454	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470710	COSV59323744	COSM12604	p.H396R	c.1187A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356		ENSP00000323315.5:p.His396Arg	ENST00000318560.5:c.1187A>G	9:g.133750356A>G
MGH068	2824330	ALK	ENST00000389048.3	Yes	Ceritinib	173870679		COSM4422790	p.F1174C	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Cys		
1103807	1103807	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1122357	1122357	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1167321	1167321	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1351424	1351424	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863617		COSM43378	p.E450A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Variant of unknown origin	Tumour Sample	Unknown					
1355296	1355296	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426042	1426042	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1428816	1428816	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1431323	1431323	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1431325	1431325	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1468087	1468087	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547747	1547747	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1547782	1547782	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552644	1552644	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1656922	1656922	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1795098	1795098	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1815776	1815776	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1815793	1815793	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1816947	1816947	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1844077	1844077	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1874586	1874586	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1992086	1992086	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2032211	2032211	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032219	2032219	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071732	2071732	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
2313879	2313879	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2429257	2429257	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2431430	2431430	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431443	2431443	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431457	2431457	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2471418	2471418	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20971926	COSV53563396	COSM5487841	p.C125S	c.374G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	19:4110583..4110583	1	ENSP00000262948.3:p.Cys125Ser	ENST00000262948.5:c.374G>C	19:g.4110583C>G
2476862	2476862	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2476870	2476870	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2483291	2483291	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
2525740	2525740	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531257	2531257	SMO	ENST00000249373.3	Yes	Vismodegib	173871648		COSM5885155	p.D473H	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Asp473His		
2538518	2538518	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2616288	2616288	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2635721	2635721	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23300949	COSV51832111	COSM6493934	p.L792H	c.2375T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249077..55249077	1	ENSP00000275493.2:p.Leu792His	ENST00000275493.2:c.2375T>A	7:g.55249077T>A
2684447	2684447	MET	ENST00000318493.6	Yes	Crizotinib	173862935		COSM6024204	p.D1246N	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Asp1246Asn		
2835721	2835721	BTK	ENST00000308731.7	Yes	Ibrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2840307	2840307	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55431730	COSV51832101	COSM6493933	p.?	c.*28+8455C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249076..55249076			ENST00000442591.1:c.*28+8455C>T	7:g.55249076C>T
2841751	2841751	ALK	ENST00000389048.3	Yes	Crizotinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
2841760	2841760	ALK	ENST00000389048.3	Yes	Crizotinib	173870679		COSM4422790	p.F1174C	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Cys		
2841769	2841769	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
Pat_45_B	2492884	MAP2K2	ENST00000262948.5	Yes	Vemurafenib	20971553	COSV53567161	COSM5855836	p.V35M	c.103G>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4117617..4117617	1	ENSP00000262948.3:p.Val35Met	ENST00000262948.5:c.103G>A	19:g.4117617C>T
905496	905496	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
909225	909225	KIT	ENST00000288135.5	Yes	Imatinib	25231390	COSV55410040	COSM12708	p.T670I	c.2009C>T	soft_tissue	fibrous_tissue_and_uncertain_origin	large_intestine	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55595519..55595519	1	ENSP00000288135.5:p.Thr670Ile	ENST00000288135.5:c.2009C>T	4:g.55595519C>T
MGH905	2824337	ALK	ENST00000389048.3	Yes	Ceritinib	173870679		COSM4422790	p.F1174C	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Cys		
1024765	1024765	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211143	1211143	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1227056	1227056	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1350455	1350455	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1355286	1355286	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431260	1431260	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431262	1431262	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431275	1431275	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1469818	1469818	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543098	1543098	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1543741	1543741	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1795104	1795104	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1795120	1795120	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1815789	1815789	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1815824	1815824	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1863615	1863615	FLT3	ENST00000241453.7	Yes	Quizartinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
1874591	1874591	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1892630	1892630	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	23579627		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1989314	1989314	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1992086	1992086	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1996318	1996318	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2027724	2027724	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071718	2071718	ABL1	ENST00000372348.2	Yes	Imatinib	36319367	COSV59325003	COSM12574	p.E274V	c.821A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364	1	ENSP00000361423.2:p.Glu274Val	ENST00000372348.2:c.821A>T	9:g.133738364A>T
2071730	2071730	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471079	COSV59325892	COSM12611	p.E355G	c.1064A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403		ENSP00000323315.5:p.Glu355Gly	ENST00000318560.5:c.1064A>G	9:g.133748403A>G
2144805	2144805	ALK	ENST00000389048.3	Yes	Crizotinib	40288390	COSV66559314	COSM28054	p.F1174V	c.3520T>G	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	24736079		Previously Reported	Tumour Sample	Heterozygous	2:29443697..29443697	1	ENSP00000373700.3:p.Phe1174Val	ENST00000389048.3:c.3520T>G	2:g.29443697A>C
2255323	2255323	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
2275301	2275301	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
2324033	2324033	ABL1	ENST00000372348.2	Yes	Imatinib	36323537	COSV59324514	COSM133668	p.F378I	c.1132T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Ile	ENST00000372348.2:c.1132T>A	9:g.133748414T>A
2426856	2426856	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2428979	2428979	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2432718	2432718	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	22299775		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
2462450	2462450	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2465701	2465701	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	transformed_to_squamous_cell_carcinoma	26746366		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2466787	2466787	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2476866	2476866	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2479328	2479328	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2479330	2479330	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2483290	2483290	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
2522064	2522064	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27130468		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
2525716	2525716	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531203	2531203	FLT3	ENST00000241453.7	Yes	Sorafenib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
2538518	2538518	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43288670	COSV65953158	COSM5570418	p.T346S	c.1037C>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943553..66943553		ENSP00000379358.2:p.Thr346Ser	ENST00000396043.2:c.1037C>G	X:g.66943553C>G
2546229	2546229	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48231377	COSV52784978	COSM1074635	p.Y276N	c.826T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000384064.1:p.Tyr276Asn	ENST00000406599.1:c.826T>A	6:g.152419922T>A
2585232	2585232	NRAS	ENST00000369535.4	Yes	Cetuximab	173862999		COSM46495	p.G12D	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gly12Asp		
2585569	2585569	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
2585569	2585569	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148556	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Ala	ENST00000556131.1:c.35G>C	12:g.25398284C>G
2616264	2616264	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2621274	2621274	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2637198	2637198	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280434	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Cys	ENST00000440973.1:c.1610A>G	6:g.152419923A>G
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23300939	COSV51832101	COSM6493933	p.L792F	c.2374C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249076..55249076	1	ENSP00000275493.2:p.Leu792Phe	ENST00000275493.2:c.2374C>T	7:g.55249076C>T
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59120510	COSV51832101	COSM6493933	p.L747F	c.2239C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249076..55249076		ENSP00000415559.1:p.Leu747Phe	ENST00000455089.1:c.2239C>T	7:g.55249076C>T
2823717	2823717	FLT3	ENST00000241453.7	Yes	Crenolanib	173867043		COSM46499	p.D835I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	27908881		Previously Reported	Tumour Sample	Unknown		1			
2838944	2838944	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148384	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Cys	ENST00000556131.1:c.34G>T	12:g.25398285C>A
2840307	2840307	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59120514	COSV51832111	COSM6493934	p.L747H	c.2240T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249077..55249077		ENSP00000415559.1:p.Leu747His	ENST00000455089.1:c.2240T>A	7:g.55249077T>A
2840778	2840778	KRAS	ENST00000256078.4	Yes	Panitumumab	21547037	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Val	ENST00000256078.4:c.35G>T	12:g.25398284C>A
2841746	2841746	ALK	ENST00000389048.3	Yes	Crizotinib	173868062		COSM9413100	p.T1151M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Thr1151Met		
2841765	2841765	ALK	ENST00000389048.3	Yes	Crizotinib	173864601		COSM4422788	p.S1206Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ser1206Tyr		
MGH086-00	2831779	ALK	ENST00000389048.3	Yes	Crizotinib	173865291		COSM9306548	p.E1210K	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1			
24B	2525710	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
904104	904104	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
904118	904118	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
904123	904123	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904141	904141	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
905449	905449	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
905452	905452	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
905498	905498	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471079	COSV59325892	COSM12611	p.E355G	c.1064A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403		ENSP00000323315.5:p.Glu355Gly	ENST00000318560.5:c.1064A>G	9:g.133748403A>G
915621	915621	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16014893		Confirmed Somatic	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1047910	1047910	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	17335935		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1103803	1103803	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211140	1211140	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1227039	1227039	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
1227041	1227041	KIT	ENST00000288135.5	Yes	Imatinib	173864791		COSM24640	p.N822Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Tyr		
1227056	1227056	KIT	ENST00000288135.5	Yes	Imatinib	25226166	COSV55389584	COSM1321	p.N822K	c.2466T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>A	4:g.55599340T>A
1227065	1227065	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1278399	1278399	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350464	1350464	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1350482	1350482	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1351430	1351430	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1431297	1431297	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866902		COSM49031	p.L384M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu384Met		
1469784	1469784	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543750	1543750	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543754	1543754	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1547762	1547762	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655315	1655315	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1655343	1655343	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
1767051	1767051	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1767100	1767100	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1795123	1795123	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1795124	1795124	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1813215	1813215	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	23079729		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1815774	1815774	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1816947	1816947	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1844066	1844066	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1885137	1885137	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	23466741		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2027720	2027720	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2027820	2027820	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2027826	2027826	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071738	2071738	ABL1	ENST00000372348.2	Yes	Imatinib	36340547	COSV59337395	COSM1732690	p.S457C	c.1370C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753844..133753844	1	ENSP00000361423.2:p.Ser457Cys	ENST00000372348.2:c.1370C>G	9:g.133753844C>G
2313156	2313156	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2318494	2318494	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2318503	2318503	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2324035	2324035	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173870527		COSM1169208	p.T315A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Unknown					
2444269	2444269	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2468265	2468265	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2471430	2471430	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
2476856	2476856	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2480670	2480670	NRAS	ENST00000369535.4	Yes	Vemurafenib	173862661		COSM28049	p.Q61K	c.?	NS	NS	NS	malignant_melanoma	NS	NS	26715644		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2483271	2483271	KIT	ENST00000288135.5	Yes	Imatinib	173863174		COSM28999	p.D820A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Ala		
2485532	2485532	NRAS	ENST00000369535.4	Yes	Dabrafenib	173862549		COSM28048	p.Q61R	c.?	NS	NS	NS	malignant_melanoma	NS	NS	25886620		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Arg		
2493036	2493036	SMO	ENST00000249373.3	Yes	Vismodegib	22235776	COSV50827572	COSM5731073	p.W281L	c.842G>T	skin	shoulder	NS	carcinoma	basal_cell_carcinoma	NS	25199678		Confirmed Somatic	Tumour Sample	Heterozygous	7:128845545..128845545	1	ENSP00000249373.3:p.Trp281Leu	ENST00000249373.3:c.842G>T	7:g.128845545G>T
2537731	2537731	AR_ENST00000396044	ENST00000396044.3	No	Androgen	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2584884	2584884	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862913		COSM25879	p.G12V	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Val		
2591335	2591335	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2608487	2608487	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2635721	2635721	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2664351	2664351	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2776123	2776123	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	25137394		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
2782223	2782223	FGFR2_ENST00000358487	ENST00000358487.5	No	BGJ398	173865513		COSM7412637	p.V564F	c.?	biliary_tract	bile_duct	NS	carcinoma	adenocarcinoma	NS	28034880		Confirmed Somatic	Tumour Sample	Unknown					
2823495	2823495	TET2_ENST00000305737	ENST00000305737.2	No	Sunitinib	26797741	COSV54407618	COSM3598847	p.P46L	c.137C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236		ENSP00000306705.2:p.Pro46Leu	ENST00000305737.2:c.137C>T	4:g.106155236C>T
2824343	2824343	ALK	ENST00000389048.3	Yes	Crizotinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
2835705	2835705	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2838944	2838944	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148556	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Ala	ENST00000556131.1:c.35G>C	12:g.25398284C>G
2840786	2840786	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395944	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Val	ENST00000557334.1:c.35G>T	12:g.25398284C>A
Pat_05_B	2492842	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
Pat_15_B	2492854	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	24777726	COSV61068422	COSM1315861	p.P124L	c.371C>T	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	15:66729163..66729163	1	ENSP00000302486.4:p.Pro124Leu	ENST00000307102.5:c.371C>T	15:g.66729163C>T
NCI-H1975	1047098	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17332333		Previously Reported	Cultured	Unknown		1	ENSP00000275493.2:p.Thr790Met		
HCT-116-MEK-R	1927247	MAP2K1	ENST00000307102.5	Yes	PD0325901	173874074		COSM1570285	p.F129L	c.?	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22402123		Variant of unknown origin	Cultured	Heterozygous		1	ENSP00000302486.4:p.Phe129Leu		
Case_2-Relapse-M464	2730739	JAK2_ENST00000539801	ENST00000539801.1	No	Pembrolizumab	81470497	COSV67689878	COSM7337170	p.?	c.1641+2T>G	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Cultured	Homozygous	9:5070054..5070054			ENST00000539801.1:c.1641+2T>G	9:g.5070054T>G
904075	904075	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
905170	905170	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
905447	905447	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469857	COSV59325003	COSM12574	p.E255V	c.764A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364		ENSP00000323315.5:p.Glu255Val	ENST00000318560.5:c.764A>T	9:g.133738364A>T
905451	905451	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
905488	905488	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
E30650	762156	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	12949711		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
MGH917	2831770	ALK	ENST00000389048.3	Yes	Alectinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1122363	1122363	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
1122367	1122367	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211133	1211133	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1227040	1227040	KIT	ENST00000288135.5	Yes	Imatinib	25226166	COSV55389584	COSM1321	p.N822K	c.2466T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>A	4:g.55599340T>A
1349869	1349869	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	19156415		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1350460	1350460	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1431273	1431273	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431325	1431325	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1543104	1543104	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1552642	1552642	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864293		COSM43364	p.L298V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1576792	1576792	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1677594	1677594	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311428	COSV66556325	COSM28061	p.?	c.792-12784C>G	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	inflammatory_myofibroblastic_tumour	NS	NS	21030459		Confirmed Somatic	Tumour Sample	Homozygous	2:29443695..29443695			ENST00000431873.1:c.792-12784C>G	2:g.29443695G>C
1744514	1744514	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1794529	1794529	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1794535	1794535	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1795119	1795119	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1795126	1795126	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1815796	1815796	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1863615	1863615	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39661661	COSV54042199	COSM784	p.D835V	c.2504A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641		ENSP00000370369.4:p.Asp835Val	ENST00000380982.4:c.2504A>T	13:g.28592641T>A
1996315	1996315	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2007328	2007328	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173873995		COSM1667033	p.L340L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Variant of unknown origin	Tumour Sample	Unknown					
2027740	2027740	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2035481	2035481	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	24034463		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2255316	2255316	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173871693		COSM4386685	p.L324Q	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown					
2293728	2293728	ALK	ENST00000389048.3	Yes	Crizotinib	40305687	COSV66564577	COSM4381100	p.I1171T	c.3512T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	25393798		Variant of unknown origin	Tumour Sample	Heterozygous	2:29445213..29445213	1	ENSP00000373700.3:p.Ile1171Thr	ENST00000389048.3:c.3512T>C	2:g.29445213A>G
2313878	2313878	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457096	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Cys	ENST00000338799.5:c.1610A>G	6:g.152419923A>G
2318502	2318502	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2426836	2426836	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2429186	2429186	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429245	2429245	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
2468261	2468261	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2476864	2476864	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2482439	2482439	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18452195		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
2483277	2483277	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2483311	2483311	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2485687	2485687	KIT	ENST00000288135.5	Yes	Imatinib	25226166	COSV55389584	COSM1321	p.N822K	c.2466T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	26316776		Previously Reported	Tumour Sample	Heterozygous	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>A	4:g.55599340T>A
2531254	2531254	SMO	ENST00000249373.3	Yes	Vismodegib	173873321		COSM5885180	p.V321A	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1			
2531516	2531516	SMO	ENST00000249373.3	Yes	Vismodegib	173867135		COSM5885165	p.Q477E	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Unknown		1			
2585569	2585569	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
2608492	2608492	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2664332	2664332	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664372	2664372	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2777955	2777955	PIK3CB	ENST00000477593.1	Yes	Erlotinib	173869624		COSM7408804	p.D1067V	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25982275		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000418143.1:p.Asp1067Val		
2819306	2819306	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2840786	2840786	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
Pat_73_B	2492909	NRAS	ENST00000369535.4	Yes	Vemurafenib	36935290	COSV54737123	COSM579	p.Q61R	c.181_182delinsAG	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256529..115256530	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.181_182delinsAG	1:g.115256529_115256530delinsCT
904114	904114	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
904295	904295	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
905166	905166	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
905486	905486	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474640	COSV59325261	COSM12631	p.L248V	c.742C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738342..133738342		ENSP00000323315.5:p.Leu248Val	ENST00000318560.5:c.742C>G	9:g.133738342C>G
905488	905488	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905496	905496	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
MGH935	2831773	ALK	ENST00000389048.3	Yes	Alectinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1211143	1211143	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1235142	1235142	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1350442	1350442	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1350481	1350481	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1351421	1351421	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1351680	1351680	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1355285	1355285	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355327	1355327	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1445186	1445186	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	20682976		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1468090	1468090	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498602	1498602	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1543749	1543749	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1547755	1547755	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1655339	1655339	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
1744513	1744513	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1767098	1767098	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1776852	1776852	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	left_upper_lobe	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	23037472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795128	1795128	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1815803	1815803	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1816948	1816948	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1863613	1863613	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39661192	COSV54045249	COSM19844	p.D835F	c.2503_2504delinsTT	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Variant of unknown origin	Tumour Sample	Unknown	13:28592641..28592642		ENSP00000370369.4:p.Asp835Phe	ENST00000380982.4:c.2503_2504delinsTT	13:g.28592641_28592642delinsAA
1874586	1874586	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1992084	1992084	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2027822	2027822	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071727	2071727	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
2088664	2088664	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
2255310	2255310	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
2255317	2255317	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173869086		COSM43386	p.H396P	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Pro		
2324037	2324037	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	27480450	COSV59331301	COSM4767372	p.F317R	c.949_950delinsCG	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	23044928		Variant of unknown origin	Tumour Sample	Unknown	9:133748288..133748289		ENSP00000323315.5:p.Phe317Arg	ENST00000318560.5:c.949_950delinsCG	9:g.133748288_133748289delinsCG
2396139	2396139	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	left_bronchus	NS	carcinoma	adenocarcinoma	NS	24942894		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2427392	2427392	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	26424310		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2468265	2468265	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864263		COSM5415894	p.Y537N	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Asn		
2471710	2471710	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	25705882		Variant of unknown origin	Tumour Sample	Unknown		1			
2483266	2483266	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2525677	2525677	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2525734	2525734	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531250	2531250	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1			
2531277	2531277	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706366	COSV54042636	COSM785	p.?	c.2419-2804G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>C	13:g.28592642C>G
2537730	2537730	AR	ENST00000374690.3	Yes	Androgen	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2552450	2552450	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27553514		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2616302	2616302	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2621287	2621287	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Homozygous	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2637198	2637198	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230888	COSV52782924	COSM1074637	p.Y276C	c.827A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Cys	ENST00000406599.1:c.827A>G	6:g.152419923A>G
2637198	2637198	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210425	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Cys	ENST00000443427.1:c.1610A>G	6:g.152419923A>G
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58464301	COSV51832101	COSM6493933	p.L739F	c.2215C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249076..55249076		ENSP00000395243.2:p.Leu739Phe	ENST00000454757.2:c.2215C>T	7:g.55249076C>T
2835713	2835713	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2840307	2840307	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55418364	COSV51766493	COSM6493937	p.?	c.*28+8470T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249091..55249091			ENST00000442591.1:c.*28+8470T>A	7:g.55249091T>A
2840784	2840784	KRAS	ENST00000256078.4	Yes	Cetuximab	21548455	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>C	12:g.25380275T>G
2840786	2840786	KRAS	ENST00000256078.4	Yes	Panitumumab	21547037	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Val	ENST00000256078.4:c.35G>T	12:g.25398284C>A
SC-her2-014	2313840	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
25	1069287	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
903865	903865	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Previously Reported	Tumour Sample	Heterozygous	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
904095	904095	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
904121	904121	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904133	904133	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904279	904279	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
905168	905168	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
905195	905195	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
MGH093	2831782	ALK	ENST00000389048.3	Yes	Brigatinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1024758	1024758	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1040049	1040049	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	17180521		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1122371	1122371	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1			
1167338	1167338	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
1167381	1167381	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211131	1211131	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1211144	1211144	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1227050	1227050	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1350430	1350430	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1351682	1351682	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1351711	1351711	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1351715	1351715	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868756		COSM43369	p.M388L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met388Leu		
1431321	1431321	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173874710		COSM49142	p.E450X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1431326	1431326	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1498606	1498606	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1498627	1498627	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1547744	1547744	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1547755	1547755	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1576785	1576785	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1576794	1576794	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1584484	1584484	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1706996	1706996	EGFR	ENST00000275493.2	Yes	XL647	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22722787		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1774678	1774678	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795098	1795098	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1844100	1844100	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1863605	1863605	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
1863609	1863609	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39662068	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359		ENSP00000370369.4:p.Phe691Leu	ENST00000380982.4:c.2073T>G	13:g.28601359A>C
1863617	1863617	FLT3	ENST00000241453.7	Yes	Quizartinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
1885380	1885380	ALK	ENST00000389048.3	Yes	Crizotinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23434628		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
1885387	1885387	ALK	ENST00000389048.3	Yes	Crizotinib	40301558	COSV66562303	COSM99136	p.C1156Y	c.3467G>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23434628		Confirmed Somatic	Tumour Sample	Unknown	2:29445258..29445258	1	ENSP00000373700.3:p.Cys1156Tyr	ENST00000389048.3:c.3467G>A	2:g.29445258C>T
1928078	1928078	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968570	1968570	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
1992089	1992089	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1996292	1996292	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1996295	1996295	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
2027754	2027754	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088664	2088664	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869541		COSM43366	p.E355A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown					
2144806	2144806	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	24736079		Previously Reported	Tumour Sample	Heterozygous	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
2161695	2161695	NF2_ENST00000353887	ENST00000353887.4	No	Afatinib	32847319	COSV58528760	COSM3735038	p.?	c.562-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000353887.4:c.562-2A>T	22:g.30060977A>T
2239173	2239173	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2255325	2255325	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2275243	2275243	SMO	ENST00000249373.3	Yes	Vismodegib	22236134	COSV50829974	COSM4413609	p.G497W	c.1489G>T	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25306392		Previously Reported	Tumour Sample	Heterozygous	7:128850226..128850226	1	ENSP00000249373.3:p.Gly497Trp	ENST00000249373.3:c.1489G>T	7:g.128850226G>T
2313878	2313878	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210425	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Cys	ENST00000443427.1:c.1610A>G	6:g.152419923A>G
2367159	2367159	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2426838	2426838	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2428983	2428983	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429112	2429112	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2431434	2431434	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2468258	2468258	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173865042		COSM5413590	p.Y537C	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Cys		
2471408	2471408	MAP2K1	ENST00000307102.5	Yes	Dabrafenib	24777736	COSV61068347	COSM1374186	p.G128D	c.383G>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	15:66729175..66729175	1	ENSP00000302486.4:p.Gly128Asp	ENST00000307102.5:c.383G>A	15:g.66729175G>A
2476872	2476872	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2481266	2481266	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26779618		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2585569	2585569	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648522	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Ala	ENST00000311936.3:c.35G>C	12:g.25398284C>G
2616262	2616262	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Previously Reported	Tumour Sample	Heterozygous	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55416827	COSV51770694	COSM20891	p.?	c.*28+8467G>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249088..55249088			ENST00000442591.1:c.*28+8467G>A	7:g.55249088G>A
2664375	2664375	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2816899	2816899	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	27242174	COSV52800715	COSM3738141	p.V510L	c.1528G>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000292410.3:p.Val510Leu	ENST00000292410.3:c.1528G>C	5:g.176522551G>C
2819289	2819289	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2835718	2835718	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2840778	2840778	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395944	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Val	ENST00000557334.1:c.35G>T	12:g.25398284C>A
Hep3B_3	2816907	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173871374		COSM9274139	p.C512F	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown					
RPC-9	1083085	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17699786		Previously Reported	Cultured	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
903865	903865	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Previously Reported	Tumour Sample	Heterozygous	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
904307	904307	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470710	COSV59323744	COSM12604	p.H396R	c.1187A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356		ENSP00000323315.5:p.His396Arg	ENST00000318560.5:c.1187A>G	9:g.133750356A>G
E29960	762043	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	14645423		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
1000815	1000815	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1024765	1024765	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1311148	1311148	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20028860		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1350428	1350428	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1350468	1350468	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1351426	1351426	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1351674	1351674	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863944		COSM12627	p.V379I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1351713	1351713	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868736		COSM12626	p.F382L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe382Leu		
1352417	1352417	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1426037	1426037	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1445173	1445173	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	20682976		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469806	1469806	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543734	1543734	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown					
1552622	1552622	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1552626	1552626	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1576781	1576781	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1591000	1591000	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655311	1655311	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
1655333	1655333	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1655335	1655335	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1844069	1844069	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844072	1844072	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173869474		COSM1169206	p.V268A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844095	1844095	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1844100	1844100	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1928079	1928079	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992087	1992087	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1996277	1996277	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2032217	2032217	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071729	2071729	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
2161695	2161695	NF2_ENST00000347330	ENST00000347330.5	No	Afatinib	30969336	COSV58519797	COSM22432	p.?	c.199-5536C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658			ENST00000347330.5:c.199-5536C>T	22:g.30051658C>T
2324034	2324034	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	27477628	COSV59324500	COSM4767370	p.L248R	c.743T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133738343..133738343		ENSP00000323315.5:p.Leu248Arg	ENST00000318560.5:c.743T>G	9:g.133738343T>G
2426846	2426846	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2429116	2429116	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429134	2429134	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
2429759	2429759	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right	NS	carcinoma	adenocarcinoma	NS	26400668		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2483278	2483278	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2525718	2525718	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531217	2531217	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39661484	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835His	ENST00000380982.4:c.2503G>C	13:g.28592642C>G
2531277	2531277	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39661484	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835His	ENST00000380982.4:c.2503G>C	13:g.28592642C>G
2591395	2591395	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2623674	2623674	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37813568	COSV58118015	COSM6191212	p.T316A	c.946A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	27626698		Variant of unknown origin	Tumour Sample	Heterozygous	X:100613633..100613633		ENSP00000361971.1:p.Thr316Ala	ENST00000372880.1:c.946A>G	X:g.100613633T>C
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58464320	COSV51832145	COSM6493936	p.C744G	c.2230T>G	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091		ENSP00000395243.2:p.Cys744Gly	ENST00000454757.2:c.2230T>G	7:g.55249091T>G
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59120514	COSV51832111	COSM6493934	p.L747H	c.2240T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249077..55249077		ENSP00000415559.1:p.Leu747His	ENST00000455089.1:c.2240T>A	7:g.55249077T>A
2841750	2841750	ALK	ENST00000389048.3	Yes	Crizotinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
2841771	2841771	ALK	ENST00000389048.3	Yes	Crizotinib	173864072		COSM9278966	p.C1156Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Cys1156Tyr		
2843085	2843085	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51334711	COSV104692577	COSM9501647	p.?	c.792-12702G>C	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Variant of unknown origin	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>C	2:g.29443613C>G
2843086	2843086	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
11	1069271	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	epithelioid	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
903859	903859	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
904117	904117	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904265	904265	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469595	COSV59323765	COSM12609	p.Q252H	c.756G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>C	9:g.133738356G>C
904275	904275	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27477568	COSV59324372	COSM12610	p.Y253F	c.758A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358		ENSP00000323315.5:p.Tyr253Phe	ENST00000318560.5:c.758A>T	9:g.133738358A>T
905491	905491	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
1000816	1000816	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1196036	1196036	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	19272767		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1227042	1227042	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
1350405	1350405	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350407	1350407	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350411	1350411	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350470	1350470	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1350475	1350475	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1350484	1350484	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173865010		COSM43371	p.E453K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu453Lys		
1351708	1351708	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1351710	1351710	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1351723	1351723	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1352430	1352430	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1355274	1355274	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1355310	1355310	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1426025	1426025	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1468562	1468562	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	21030498		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469814	1469814	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479877	1479877	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1498571	1498571	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1498601	1498601	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1543725	1543725	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1547744	1547744	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1547749	1547749	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1565828	1565828	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
1590011	1590011	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	21995391		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1596618	1596618	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22071596		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1618797	1618797	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1633976	1633976	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51322506	COSV66566818	COSM144251	p.?	c.792-12689C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Variant of unknown origin	Tumour Sample	Unknown	2:29443600..29443600			ENST00000431873.1:c.792-12689C>A	2:g.29443600G>T
1655313	1655313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Confirmed Somatic	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
1655331	1655331	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1815804	1815804	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1885388	1885388	ALK	ENST00000389048.3	Yes	Crizotinib	40290752	COSV66556435	COSM99137	p.L1196M	c.3586C>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23434628		Previously Reported	Tumour Sample	Unknown	2:29443631..29443631	1	ENSP00000373700.3:p.Leu1196Met	ENST00000389048.3:c.3586C>A	2:g.29443631G>T
1928073	1928073	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1928093	1928093	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968568	1968568	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85402564	COSV55499223	COSM555	p.?	c.112-17430A>T	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Heterozygous	12:25380275..25380275			ENST00000557334.1:c.112-17430A>T	12:g.25380275T>A
2071716	2071716	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
2076954	2076954	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2161695	2161695	EGFR	ENST00000275493.2	Yes	Afatinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2161695	2161695	NF2_ENST00000403435	ENST00000403435.1	No	Afatinib	45734703	COSV58519797	COSM22432	p.R198*	c.592C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000384029.1:p.Arg198Ter	ENST00000403435.1:c.592C>T	22:g.30051658C>T
2255321	2255321	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2313880	2313880	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2429161	2429161	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2431477	2431477	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2591359	2591359	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2609319	2609319	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2616262	2616262	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Previously Reported	Tumour Sample	Heterozygous	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2635722	2635722	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2635723	2635723	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2757343	2757343	MET	ENST00000318493.6	Yes	Osimertinib	173862802		COSM1737868	p.?	c.?	lung	right	NS	carcinoma	adenocarcinoma	NS	28274743		Previously Reported	Tumour Sample	Unknown		1			
2824227	2824227	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2835717	2835717	BTK	ENST00000308731.7	Yes	Ibrutinib	26369565	COSV58122597	COSM6053939	p.C481Y	c.1442G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Tyr	ENST00000308731.7:c.1442G>A	X:g.100611164C>T
2835739	2835739	BTK_ENST00000372880	ENST00000372880.1	No	Acalabrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
Hep3B_2	2816906	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865400		COSM9274138	p.V510L	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Leu		
903868	903868	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
904131	904131	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
904303	904303	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905454	905454	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905454	905454	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905489	905489	ABL1	ENST00000372348.2	Yes	Imatinib	36318911	COSV59323765	COSM12609	p.Q271H	c.813G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>C	9:g.133738356G>C
1024780	1024780	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211132	1211132	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211135	1211135	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1235144	1235144	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350445	1350445	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1351705	1351705	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1355288	1355288	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1469858	1469858	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479865	1479865	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543103	1543103	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1576797	1576797	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1576799	1576799	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1746448	1746448	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22895145		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795112	1795112	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1795115	1795115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1795127	1795127	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1815790	1815790	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1816949	1816949	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1928086	1928086	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968560	1968560	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
1996289	1996289	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
2032241	2032241	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2076942	2076942	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2076946	2076946	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088648	2088648	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2239182	2239182	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2255324	2255324	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2275306	2275306	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	right	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2290930	2290930	MTOR	ENST00000361445.4	Yes	Everolimus	33757165	COSV63877299	COSM4439845	p.F2108L	c.6324C>A	thyroid	NS	NS	carcinoma	anaplastic_carcinoma	NS	25295501		Confirmed Somatic	Tumour Sample	Heterozygous	1:11187094..11187094	1	ENSP00000354558.4:p.Phe2108Leu	ENST00000361445.4:c.6324C>A	1:g.11187094G>T
2429114	2429114	KIT	ENST00000288135.5	Yes	Imatinib	173863717		COSM5351737	p.(P627_G664)Xfs*?	c.(1880_1990)ins?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Variant of unknown origin	Tumour Sample	Unknown		1			
2431447	2431447	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
2431459	2431459	KIT	ENST00000288135.5	Yes	Imatinib	25232396	COSV55394297	COSM12709	p.D820E	c.2460T>A	soft_tissue	fibrous_tissue_and_uncertain_origin	extra-gastrointestinal_site	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown	4:55599334..55599334	1	ENSP00000288135.5:p.Asp820Glu	ENST00000288135.5:c.2460T>A	4:g.55599334T>A
2462449	2462449	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2466801	2466801	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
2525679	2525679	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531274	2531274	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39661484	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835His	ENST00000380982.4:c.2503G>C	13:g.28592642C>G
2537729	2537729	AR	ENST00000374690.3	Yes	Enzalutamide	38852840	COSV65955698	COSM5945752	p.F877L	c.2629T>C	prostate	NS	NS	carcinoma	NS	NS	25712683		Variant of unknown origin	Tumour Sample	Unknown	X:66943549..66943549	1	ENSP00000363822.3:p.Phe877Leu	ENST00000374690.3:c.2629T>C	X:g.66943549T>C
2539198	2539198	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	14618630		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2546230	2546230	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57211241	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000387500.1:p.Tyr537Asn	ENST00000443427.1:c.1609T>A	6:g.152419922T>A
2585567	2585567	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
2605636	2605636	MET	ENST00000318493.6	Yes	Crizotinib	173862936		COSM6024205	p.Y1248H	c.?	lung	left	NS	carcinoma	adenocarcinoma	NS	27987579		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Tyr1248His		
2608492	2608492	BTK	ENST00000308731.7	Yes	Ibrutinib	26369565	COSV58122597	COSM6053939	p.C481Y	c.1442G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Tyr	ENST00000308731.7:c.1442G>A	X:g.100611164C>T
2621349	2621349	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2635723	2635723	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2642912	2642912	MET	ENST00000318493.6	Yes	Crizotinib	173862934		COSM6476274	p.G1181R	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28522754		Variant of unknown origin	Tumour Sample	Unknown		1			
2664356	2664356	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664376	2664376	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2816899	2816899	FGFR4_ENST00000502906	ENST00000502906.1	No	Fisogatinib	68519299	COSV52802492	COSM1066172	p.V550L	c.1648G>T	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000424960.1:p.Val550Leu	ENST00000502906.1:c.1648G>T	5:g.176522551G>T
2823717	2823717	FLT3	ENST00000241453.7	Yes	Crenolanib	173867044		COSM9278018	p.F691L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	27908881		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000241453.7:p.Phe691Leu		
2840306	2840306	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2840307	2840307	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55407429	COSV51834362	COSM6503269	p.?	c.*28+1084T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Unknown	7:55241705..55241705			ENST00000442591.1:c.*28+1084T>A	7:g.55241705T>A
MGH086-1	2831781	ALK	ENST00000389048.3	Yes	Brigatinib	173863719		COSM9306550	p.D1203N	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Asp1203Asn		
SC-her2-025	2313847	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
SC-her2-025	2313847	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
SC-her2-071	2313875	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
3B	2529056	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
IIIA	1179821	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19181917		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
905451	905451	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
1167406	1167406	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
1227043	1227043	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1350404	1350404	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350441	1350441	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1350471	1350471	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1350479	1350479	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868756		COSM43369	p.M388L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met388Leu		
1350485	1350485	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173872232		COSM43372	p.E459G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Gly		
1351420	1351420	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1351719	1351719	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866470		COSM43377	p.E450G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1355283	1355283	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1426038	1426038	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1428815	1428815	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1543099	1543099	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1565834	1565834	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27471758	COSV59325471	COSM131574	p.L387M	c.1159T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133750328..133750328		ENSP00000323315.5:p.Leu387Met	ENST00000318560.5:c.1159T>A	9:g.133750328T>A
1576789	1576789	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1655319	1655319	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
1655323	1655323	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474640	COSV59325261	COSM12631	p.L248V	c.742C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738342..133738342		ENSP00000323315.5:p.Leu248Val	ENST00000318560.5:c.742C>G	9:g.133738342C>G
1795123	1795123	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862940		COSM53182	p.?	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown					
1813215	1813215	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	23079729		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1816948	1816948	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1844076	1844076	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1863615	1863615	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
1874592	1874592	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1968564	1968564	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	caecum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
1996321	1996321	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2027788	2027788	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088639	2088639	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2255322	2255322	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2313150	2313150	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2318496	2318496	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2429140	2429140	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1			
2474095	2474095	BRAF	ENST00000288602.6	Yes	Vemurafenib	173863357		COSM5546575	p.?	c.139_1140del	skin	NS	NS	malignant_melanoma	NS	NS	25515853		Confirmed Somatic	Tumour Sample	Unknown		1			
2483292	2483292	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
2531251	2531251	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1			
2550052	2550052	AR_ENST00000396044	ENST00000396044.3	No	Ketoconazole	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2585567	2585567	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
2616294	2616294	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2621496	2621496	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869597		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2635697	2635697	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2635722	2635722	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55418364	COSV51766493	COSM6493937	p.?	c.*28+8470T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091			ENST00000442591.1:c.*28+8470T>A	7:g.55249091T>A
2812140	2812140	BRAF	ENST00000288602.6	Yes	Osimertinib	173862544		COSM1131	p.V600E	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29596911		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288602.6:p.Val600Glu		
2822954	2822954	EGFR	ENST00000275493.2	Yes	Osimertinib	173871567		COSM9167608	p.L718Q	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29807405		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Leu718Gln		
2835720	2835720	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2841749	2841749	ALK	ENST00000389048.3	Yes	Crizotinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
2841766	2841766	ALK	ENST00000389048.3	Yes	Crizotinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
Case_1-Relapse	2730736	JAK1	ENST00000342505.4	Yes	Pembrolizumab	29883210	COSV61089823	COSM7336016	p.Q503*	c.1507C>T	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Tumour Sample	Homozygous	1:65321333..65321333	1	ENSP00000343204.4:p.Gln503Ter	ENST00000342505.4:c.1507C>T	1:g.65321333G>A
Case_2-Relapse-WholeTumor	2730738	JAK2	ENST00000381652.3	Yes	Pembrolizumab	41393309	COSV67689878	COSM7337170	p.?	c.1641+2T>G	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Tumour Sample	Homozygous	9:5070054..5070054	1		ENST00000381652.3:c.1641+2T>G	9:g.5070054T>G
18b	2428966	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
BCC5	2531232	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000249373.3:p.Trp535Leu		
904114	904114	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
905447	905447	ABL1	ENST00000372348.2	Yes	Imatinib	36319367	COSV59325003	COSM12574	p.E274V	c.821A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364	1	ENSP00000361423.2:p.Glu274Val	ENST00000372348.2:c.821A>T	9:g.133738364A>T
1122361	1122361	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1162983	1162983	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18992959		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1167306	1167306	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1167382	1167382	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1214796	1214796	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18488000		Confirmed Somatic	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
1227033	1227033	KIT	ENST00000288135.5	Yes	Imatinib	25227346	COSV55387147	COSM1322	p.N822K	c.2466T>G	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>G	4:g.55599340T>G
1350449	1350449	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351722	1351722	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1352422	1352422	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355293	1355293	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426027	1426027	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1469803	1469803	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469860	1469860	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498624	1498624	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1543108	1543108	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1543115	1543115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1543723	1543723	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1565822	1565822	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
1565826	1565826	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1576799	1576799	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1590011	1590011	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	21995391		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1618767	1618767	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1656922	1656922	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1731090	1731090	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22815900		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1774664	1774664	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795103	1795103	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1816949	1816949	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1863605	1863605	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705985	COSV54045249	COSM19844	p.?	c.2419-2804_2419-2803delinsTT	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Variant of unknown origin	Tumour Sample	Unknown	13:28592641..28592642			ENST00000537084.1:c.2419-2804_2419-2803delinsTT	13:g.28592641_28592642delinsAA
1863609	1863609	FLT3	ENST00000241453.7	Yes	Quizartinib	20035364	COSV54042199	COSM784	p.D835V	c.2504A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641	1	ENSP00000241453.7:p.Asp835Val	ENST00000241453.7:c.2504A>T	13:g.28592641T>A
1992094	1992094	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2027818	2027818	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032218	2032218	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2313147	2313147	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2318491	2318491	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57223652	COSV52785937	COSM4766050	p.L536Q	c.1607_1608delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921		ENSP00000387500.1:p.Leu536Gln	ENST00000443427.1:c.1607_1608delinsAG	6:g.152419920_152419921delinsAG
2318492	2318492	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2428973	2428973	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2428981	2428981	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429254	2429254	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2466824	2466824	BRAF	ENST00000288602.6	Yes	Vemurafenib	173863357		COSM5546575	p.?	c.139_1140del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Unknown		1			
2471425	2471425	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45631631	COSV53562848	COSM232757	p.E110K	c.328G>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	19:4101103..4101103		ENSP00000378336.1:p.Glu110Lys	ENST00000394867.4:c.328G>A	19:g.4101103C>T
2476836	2476836	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2483244	2483244	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2525699	2525699	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2539220	2539220	AR	ENST00000374690.3	Yes	Androgen	38851617	COSV65953243	COSM3094417	p.V716M	c.2146G>A	prostate	NS	NS	carcinoma	adenocarcinoma	NS	8145761		Confirmed Somatic	Tumour Sample	Unknown	X:66931504..66931504	1	ENSP00000363822.3:p.Val716Met	ENST00000374690.3:c.2146G>A	X:g.66931504G>A
2585250	2585250	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	173862744		COSM14201	p.Q61H	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61His		
2585570	2585570	NRAS	ENST00000369535.4	Yes	Cetuximab	36928830	COSV54736550	COSM569	p.G13R	c.37G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	1:115258745..115258745	1	ENSP00000358548.4:p.Gly13Arg	ENST00000369535.4:c.37G>C	1:g.115258745C>G
2635721	2635721	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51804600	COSV52795259	COSM6843697	p.?	c.851-26481T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920			ENST00000427531.2:c.851-26481T>A	6:g.152419920T>A
2651873	2651873	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2684448	2684448	MET	ENST00000318493.6	Yes	Crizotinib	173862935		COSM6024204	p.D1246N	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Asp1246Asn		
2815054	2815054	EGFR	ENST00000275493.2	Yes	Osimertinib	173863677		COSM7002300	p.C797G	c.?	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	29807405		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Gly		
2819302	2819302	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2823495	2823495	TET2	ENST00000540549.1	Yes	Sunitinib	80171122	COSV54407618	COSM3598847	p.P46L	c.137C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236	1	ENSP00000442788.1:p.Pro46Leu	ENST00000540549.1:c.137C>T	4:g.106155236C>T
2840307	2840307	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59120510	COSV51832101	COSM6493933	p.L747F	c.2239C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249076..55249076		ENSP00000415559.1:p.Leu747Phe	ENST00000455089.1:c.2239C>T	7:g.55249076C>T
2840776	2840776	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85149412	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Arg	ENST00000556131.1:c.34G>C	12:g.25398285C>G
2840784	2840784	NRAS	ENST00000369535.4	Yes	Cetuximab	36928770	COSV54736624	COSM583	p.Q61L	c.182A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Leu	ENST00000369535.4:c.182A>T	1:g.115256529T>A
2841741	2841741	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2841764	2841764	ALK	ENST00000389048.3	Yes	Crizotinib	173864016		COSM5985119	p.S1206F	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ser1206Phe		
904279	904279	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
MGH913	2831769	ALK	ENST00000389048.3	Yes	Alectinib	173866448		COSM5352215	p.I1171S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Ser		
1000817	1000817	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1024766	1024766	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1024775	1024775	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1167390	1167390	KIT	ENST00000288135.5	Yes	Imatinib	25227111	COSV55402684	COSM19293	p.T670E	c.2008_2009delinsGA	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Variant of unknown origin	Tumour Sample	Unknown	4:55595518..55595519	1	ENSP00000288135.5:p.Thr670Glu	ENST00000288135.5:c.2008_2009delinsGA	4:g.55595518_55595519delinsGA
1211130	1211130	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1235136	1235136	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1278399	1278399	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1319151	1319151	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	20146086		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1351419	1351419	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1351686	1351686	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1352431	1352431	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1355258	1355258	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1543093	1543093	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1584478	1584478	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1655315	1655315	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1794538	1794538	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1815797	1815797	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1816947	1816947	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1816948	1816948	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1844105	1844105	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173870527		COSM1169208	p.T315A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1968562	1968562	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
1989315	1989315	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1992087	1992087	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1996313	1996313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2027734	2027734	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071709	2071709	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470466	COSV59336290	COSM1732692	p.E453A	c.1358A>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753889..133753889		ENSP00000323315.5:p.Glu453Ala	ENST00000318560.5:c.1358A>C	9:g.133753889A>C
2071715	2071715	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2088656	2088656	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869180		COSM1738060	p.G251E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown					
2255324	2255324	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173872831		COSM4386687	p.Q252M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown					
2313156	2313156	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2313876	2313876	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57211241	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000387500.1:p.Tyr537Asn	ENST00000443427.1:c.1609T>A	6:g.152419922T>A
2313878	2313878	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280434	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Cys	ENST00000440973.1:c.1610A>G	6:g.152419923A>G
2429260	2429260	KIT	ENST00000288135.5	Yes	Imatinib	173865694		COSM29477	p.D816A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816Ala		
2474084	2474084	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	NS	NS	NS	malignant_melanoma	NS	NS	23645591		Variant of unknown origin	Tumour Sample	Unknown		1			
2476874	2476874	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2479266	2479266	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2482431	2482431	KIT	ENST00000288135.5	Yes	Imatinib	173863869		COSM28693	p.D820E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18452195		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Glu		
2531201	2531201	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706895	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23392356		Confirmed Somatic	Tumour Sample	Heterozygous	13:28601359..28601359		ENSP00000438139.1:p.Phe691Leu	ENST00000537084.1:c.2073T>G	13:g.28601359A>C
2538591	2538591	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2546229	2546229	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55281546	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922	1	ENSP00000405330.1:p.Tyr537Asn	ENST00000440973.1:c.1609T>A	6:g.152419922T>A
2546463	2546463	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	12860943		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2551720	2551720	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43285761	COSV65953243	COSM3094417	p.V184M	c.550G>A	prostate	NS	NS	carcinoma	NS	NS	19366804		Confirmed Somatic	Tumour Sample	Unknown	X:66931504..66931504		ENSP00000379358.2:p.Val184Met	ENST00000396043.2:c.550G>A	X:g.66931504G>A
2564943	2564943	MET_ENST00000397752	ENST00000397752.3	No	Crizotinib	44821801	COSV59256021	COSM5015794	p.D1228N	c.3682G>A	lung	NS	NS	carcinoma	squamous_cell_carcinoma	NS	27343442		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000380860.3:p.Asp1228Asn	ENST00000397752.3:c.3682G>A	7:g.116423407G>A
2585570	2585570	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648522	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Ala	ENST00000311936.3:c.35G>C	12:g.25398284C>G
2591353	2591353	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2621340	2621340	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2635722	2635722	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2664336	2664336	MET_ENST00000397752	ENST00000397752.3	No	Capmatinib	44821801	COSV59256021	COSM5015794	p.D1228N	c.3682G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000380860.3:p.Asp1228Asn	ENST00000397752.3:c.3682G>A	7:g.116423407G>A
2664376	2664376	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2824264	2824264	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2824344	2824344	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2835717	2835717	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812019	COSV58122597	COSM6053939	p.?	c.1039-1482G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>A	X:g.100611164C>T
2838948	2838948	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
2840776	2840776	KRAS	ENST00000256078.4	Yes	Panitumumab	21547675	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Arg	ENST00000256078.4:c.34G>C	12:g.25398285C>G
2840786	2840786	KRAS	ENST00000256078.4	Yes	Panitumumab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
2840786	2840786	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85149412	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Arg	ENST00000556131.1:c.34G>C	12:g.25398285C>G
2841749	2841749	ALK	ENST00000389048.3	Yes	Crizotinib	173865245		COSM4422791	p.F1174V	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Val		
2843082	2843082	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
GIST-R9	2607433	KIT	ENST00000288135.5	Yes	Imatinib	173867575		COSM28599	p.D820V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	27997714		Variant of unknown origin	Cultured	Unknown		1	ENSP00000288135.5:p.Asp820Val		
MDA-MB-231-MEK-R	1927243	MAP2K1	ENST00000307102.5	Yes	PD0325901	173869444		COSM1570284	p.L115P	c.?	breast	NS	NS	carcinoma	NS	NS	22402123		Variant of unknown origin	Cultured	Heterozygous		1			
904069	904069	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
904073	904073	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
904073	904073	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
904076	904076	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
904084	904084	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
904122	904122	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904125	904125	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904136	904136	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868736		COSM12626	p.F382L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe382Leu		
905171	905171	ABL1	ENST00000372348.2	Yes	Imatinib	36345230	COSV59344652	COSM12603	p.T334N	c.1001C>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Asn	ENST00000372348.2:c.1001C>A	9:g.133748283C>A
905195	905195	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
905497	905497	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471079	COSV59325892	COSM12611	p.E355G	c.1064A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403		ENSP00000323315.5:p.Glu355Gly	ENST00000318560.5:c.1064A>G	9:g.133748403A>G
MGH901	2824335	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1211130	1211130	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211138	1211138	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1227031	1227031	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
1227057	1227057	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
1235125	1235125	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1235132	1235132	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350447	1350447	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351672	1351672	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173865010		COSM43371	p.E453K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu453Lys		
1351676	1351676	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863944		COSM12627	p.V379I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1428808	1428808	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431307	1431307	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1431314	1431314	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1543092	1543092	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1543112	1543112	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1547747	1547747	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1584475	1584475	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862881		COSM133069	p.A399T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown					
1584480	1584480	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1655311	1655311	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
1656921	1656921	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1656923	1656923	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1767050	1767050	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1774670	1774670	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1794537	1794537	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1795099	1795099	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866714		COSM330656	p.T277A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1815819	1815819	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844081	1844081	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1844089	1844089	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1844092	1844092	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
2032223	2032223	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071710	2071710	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
2088641	2088641	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2144805	2144805	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51314308	COSV66559314	COSM28054	p.?	c.792-12786T>G	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	24736079		Previously Reported	Tumour Sample	Heterozygous	2:29443697..29443697			ENST00000431873.1:c.792-12786T>G	2:g.29443697A>C
2255306	2255306	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2255322	2255322	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2313154	2313154	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2313879	2313879	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2431455	2431455	KIT	ENST00000288135.5	Yes	Imatinib	173867826		COSM5352273	p.Y578C	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr578Cys		
2444262	2444262	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2462446	2462446	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2466772	2466772	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
2479260	2479260	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2482433	2482433	KIT	ENST00000288135.5	Yes	Imatinib	173863869		COSM28693	p.D820E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18452195		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Glu		
2483285	2483285	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2484532	2484532	KIT	ENST00000288135.5	Yes	Imatinib	173863869		COSM28693	p.D820E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Glu		
2537729	2537729	AR	ENST00000374690.3	Yes	Enzalutamide	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2538450	2538450	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2546230	2546230	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51798494	COSV52784978	COSM1074635	p.?	c.851-26479T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922			ENST00000427531.2:c.851-26479T>A	6:g.152419922T>A
2585567	2585567	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
2585569	2585569	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
2591451	2591451	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2605858	2605858	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	27997714		Previously Reported	NS	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2628607	2628607	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37813750	COSV58119120	COSM6196566	p.?	c.1039-1482_1039-1481delinsCT	haematopoietic_and_lymphoid_tissue	lymph_node	NS	lymphoid_neoplasm	mantle_cell_lymphoma	NS	25082755		Confirmed Somatic	Tumour Sample	Unknown	X:100611163..100611164			ENST00000372880.1:c.1039-1482_1039-1481delinsCT	X:g.100611163_100611164delinsAG
2651874	2651874	EGFR	ENST00000275493.2	Yes	Osimertinib	23270837	COSV51834362	COSM6503269	p.L718Q	c.2153T>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Variant of unknown origin	Tumour Sample	Homozygous	7:55241705..55241705	1	ENSP00000275493.2:p.Leu718Gln	ENST00000275493.2:c.2153T>A	7:g.55241705T>A
2832843	2832843	ALK	ENST00000389048.3	Yes	Lorlatinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2835713	2835713	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2838944	2838944	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648472	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Cys	ENST00000311936.3:c.34G>T	12:g.25398285C>A
2840307	2840307	EGFR	ENST00000275493.2	Yes	Osimertinib	23300939	COSV51832101	COSM6493933	p.L792F	c.2374C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249076..55249076	1	ENSP00000275493.2:p.Leu792Phe	ENST00000275493.2:c.2374C>T	7:g.55249076C>T
2840774	2840774	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85402564	COSV55499223	COSM555	p.?	c.112-17430A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275			ENST00000557334.1:c.112-17430A>T	12:g.25380275T>A
2840786	2840786	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25649084	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Arg	ENST00000311936.3:c.34G>C	12:g.25398285C>G
SC-her2-071	2313875	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
903859	903859	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904105	904105	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904132	904132	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
904277	904277	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
904287	904287	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
904301	904301	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905445	905445	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
905451	905451	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905485	905485	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
924446	924446	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16198442		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1103803	1103803	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1120916	1120916	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	18509184		Previously Reported	NS	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1167358	1167358	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1211132	1211132	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211140	1211140	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1227063	1227063	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1350439	1350439	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1469855	1469855	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479873	1479873	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1479874	1479874	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1498572	1498572	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1552630	1552630	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1591007	1591007	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1656921	1656921	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1774662	1774662	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1815807	1815807	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844097	1844097	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1992090	1992090	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2071713	2071713	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2088642	2088642	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2156363	2156363	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2255318	2255318	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173873620		COSM4386686	p.P310S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown					
2313156	2313156	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2313156	2313156	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2324034	2324034	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	27471250	COSV59324514	COSM133668	p.F359I	c.1075T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133748414..133748414		ENSP00000323315.5:p.Phe359Ile	ENST00000318560.5:c.1075T>A	9:g.133748414T>A
2426829	2426829	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2426834	2426834	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2431426	2431426	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	extra-gastrointestinal_site	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431454	2431454	KIT	ENST00000288135.5	Yes	Imatinib	173867826		COSM5352273	p.Y578C	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr578Cys		
2431490	2431490	KIT	ENST00000288135.5	Yes	Imatinib	25228178	COSV55387376	COSM19109	p.N822Y	c.2464A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55599338..55599338	1	ENSP00000288135.5:p.Asn822Tyr	ENST00000288135.5:c.2464A>T	4:g.55599338A>T
2483280	2483280	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
2539199	2539199	AR	ENST00000374690.3	Yes	Flutamide	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	14618630		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2585569	2585569	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
2621349	2621349	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23278878	COSV51766509	COSM5945664	p.C797S	c.2390G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092	1	ENSP00000275493.2:p.Cys797Ser	ENST00000275493.2:c.2390G>C	7:g.55249092G>C
2664330	2664330	MET_ENST00000397752	ENST00000397752.3	No	Crizotinib	44821801	COSV59256021	COSM5015794	p.D1228N	c.3682G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000380860.3:p.Asp1228Asn	ENST00000397752.3:c.3682G>A	7:g.116423407G>A
2664336	2664336	MET_ENST00000539704	ENST00000539704.1	No	Capmatinib	80944237	COSV59256021	COSM5015794	p.D98N	c.292G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000445020.1:p.Asp98Asn	ENST00000539704.1:c.292G>A	7:g.116423407G>A
2664364	2664364	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2816899	2816899	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	27244312	COSV104624868	COSM9274136	p.C512R	c.1534T>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Tumour Sample	Unknown	5:176522557..176522557		ENSP00000292410.3:p.Cys512Arg	ENST00000292410.3:c.1534T>C	5:g.176522557T>C
2816899	2816899	FGFR4_ENST00000393637	ENST00000393637.1	No	Fisogatinib	44075961	COSV52802492	COSM1066172	p.V510L	c.1528G>T	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000377254.1:p.Val510Leu	ENST00000393637.1:c.1528G>T	5:g.176522551G>T
2816899	2816899	FGFR4_ENST00000393648	ENST00000393648.2	No	Fisogatinib	44117843	COSV52804538	COSM6163	p.V482M	c.1444G>A	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000377259.2:p.Val482Met	ENST00000393648.2:c.1444G>A	5:g.176522551G>A
TG95755	2823143	NF1	ENST00000358273.4	Yes	Tyrosine kinase inhibitor - NS	34059107	COSV104420542	COSM9274129	p.G2392E	c.7175G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown	17:29670139..29670139	1	ENSP00000351015.4:p.Gly2392Glu	ENST00000358273.4:c.7175G>A	17:g.29670139G>A
Pat_76_B	2492913	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45629379	COSV53566961	COSM1731742	p.N29D	c.85A>G	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4110581..4110581		ENSP00000378336.1:p.Asn29Asp	ENST00000394867.4:c.85A>G	19:g.4110581T>C
3A	2529055	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
898242	898242	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	15728811		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
903853	903853	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469857	COSV59325003	COSM12574	p.E255V	c.764A>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738364..133738364		ENSP00000323315.5:p.Glu255Val	ENST00000318560.5:c.764A>T	9:g.133738364A>T
904120	904120	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904267	904267	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
905173	905173	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905174	905174	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905452	905452	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
E29958	762041	FIP1L1_ENST00000507166	ENST00000507166.1	No	Imatinib	70595482	COSV57264120	COSM736	p.D602V	c.1805A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	14645423		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093		ENSP00000423325.1:p.Asp602Val	ENST00000507166.1:c.1805A>T	4:g.55152093A>T
1031897	1031897	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1140670	1140670	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	squamous_cell_carcinoma	NS	19238633		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1278399	1278399	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1352426	1352426	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1355315	1355315	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1468069	1468069	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1471895	1471895	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	20871262		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1576794	1576794	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1584487	1584487	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1794528	1794528	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1795097	1795097	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866470		COSM43377	p.E450G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1844102	1844102	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1863607	1863607	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
1863611	1863611	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706895	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359		ENSP00000438139.1:p.Phe691Leu	ENST00000537084.1:c.2073T>G	13:g.28601359A>C
1863615	1863615	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
1874587	1874587	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1928090	1928090	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968564	1968564	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	caecum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
1989316	1989316	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1992089	1992089	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1996310	1996310	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2007331	2007331	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2071722	2071722	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476784	COSV59335571	COSM1732689	p.E279A	c.836A>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133747529..133747529		ENSP00000323315.5:p.Glu279Ala	ENST00000318560.5:c.836A>C	9:g.133747529A>C
2156367	2156367	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	left_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2293726	2293726	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51330296	COSV66567934	COSM4440758	p.?	c.792-14302T>G	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25393796		Variant of unknown origin	Tumour Sample	Heterozygous	2:29445213..29445213			ENST00000431873.1:c.792-14302T>G	2:g.29445213A>C
2313152	2313152	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2313878	2313878	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230888	COSV52782924	COSM1074637	p.Y276C	c.827A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Cys	ENST00000406599.1:c.827A>G	6:g.152419923A>G
2368723	2368723	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	25807654		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
2429164	2429164	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
2429177	2429177	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429232	2429232	KIT	ENST00000288135.5	Yes	Imatinib	173863174		COSM28999	p.D820A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Ala		
2431429	2431429	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2431435	2431435	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431441	2431441	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431454	2431454	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2432728	2432728	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476611	COSV59324877	COSM12564	p.H396P	c.1187A>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	22299775		Variant of unknown origin	Tumour Sample	Homozygous	9:133750356..133750356		ENSP00000323315.5:p.His396Pro	ENST00000318560.5:c.1187A>C	9:g.133750356A>C
2468261	2468261	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2476830	2476830	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2511758	2511758	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25182956		Confirmed Somatic	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2552454	2552454	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27553514		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2616266	2616266	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Variant of unknown origin	Tumour Sample	Heterozygous	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2638655	2638655	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28572531		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59104332	COSV51766509	COSM5945664	p.C752S	c.2255G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092		ENSP00000415559.1:p.Cys752Ser	ENST00000455089.1:c.2255G>C	7:g.55249092G>C
2832821	2832821	ALK	ENST00000389048.3	Yes	Lorlatinib	173867168		COSM9311666	p.L1198F	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1198Phe		
2835714	2835714	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2840778	2840778	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
SC-her2-005	2313835	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
SC-her2-019	2313843	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
M14	2468218	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
904082	904082	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904084	904084	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904269	904269	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
905165	905165	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
905196	905196	ABL1	ENST00000372348.2	Yes	Imatinib	36323549	COSV59323752	COSM12602	p.D295G	c.884A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Previously Reported	Tumour Sample	Unknown	9:133747520..133747520	1	ENSP00000361423.2:p.Asp295Gly	ENST00000372348.2:c.884A>G	9:g.133747520A>G
905451	905451	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
MGH092	2824334	ALK	ENST00000389048.3	Yes	Ceritinib	173867632		COSM9306549	p.G1202del	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1			
MGH919	2831771	ALK	ENST00000389048.3	Yes	Alectinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
MGH936	2831774	ALK	ENST00000389048.3	Yes	Alectinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1103805	1103805	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1167391	1167391	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1227060	1227060	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
1351679	1351679	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862880		COSM43389	p.E453D	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1352416	1352416	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1352418	1352418	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431291	1431291	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869809		COSM49138	p.E355X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1431292	1431292	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864313		COSM49139	p.F359X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1469807	1469807	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498628	1498628	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1565828	1565828	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27476096	COSV59325287	COSM131573	p.F317L	c.951C>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>A	9:g.133748290C>A
1767103	1767103	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1815801	1815801	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844103	1844103	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
1863615	1863615	FLT3	ENST00000241453.7	Yes	Quizartinib	20035364	COSV54042199	COSM784	p.D835V	c.2504A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641	1	ENSP00000241453.7:p.Asp835Val	ENST00000241453.7:c.2504A>T	13:g.28592641T>A
1874592	1874592	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1992093	1992093	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2071709	2071709	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470454	COSV59334206	COSM12608	p.M244V	c.730A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330		ENSP00000323315.5:p.Met244Val	ENST00000318560.5:c.730A>G	9:g.133738330A>G
2071721	2071721	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474175	COSV59338309	COSM1732688	p.D276N	c.826G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133747519..133747519		ENSP00000323315.5:p.Asp276Asn	ENST00000318560.5:c.826G>A	9:g.133747519G>A
2071731	2071731	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
2071739	2071739	ABL1	ENST00000372348.2	Yes	Imatinib	36333518	COSV59327102	COSM1460549	p.E478G	c.1433A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753907..133753907	1	ENSP00000361423.2:p.Glu478Gly	ENST00000372348.2:c.1433A>G	9:g.133753907A>G
2071740	2071740	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476494	COSV59327102	COSM1460549	p.E459G	c.1376A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753907..133753907		ENSP00000323315.5:p.Glu459Gly	ENST00000318560.5:c.1376A>G	9:g.133753907A>G
2076950	2076950	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2141402	2141402	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	right_middle_lobe	NS	carcinoma	acinar_adenocarcinoma	NS	24636847		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2161695	2161695	NF2_ENST00000361166	ENST00000361166.4	No	Afatinib	32817924	COSV58528760	COSM3735038	p.?	c.811-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000361166.4:c.811-2A>T	22:g.30060977A>T
2318491	2318491	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55296317	COSV52785937	COSM4766050	p.L536Q	c.1607_1608delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921	1	ENSP00000405330.1:p.Leu536Gln	ENST00000440973.1:c.1607_1608delinsAG	6:g.152419920_152419921delinsAG
2324037	2324037	ABL1	ENST00000372348.2	Yes	Dasatinib	36339297	COSV59331301	COSM4767372	p.F336R	c.1006_1007delinsCG	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	23044928		Variant of unknown origin	Tumour Sample	Unknown	9:133748288..133748289	1	ENSP00000361423.2:p.Phe336Arg	ENST00000372348.2:c.1006_1007delinsCG	9:g.133748288_133748289delinsCG
2429168	2429168	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429207	2429207	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1			
2429242	2429242	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2431455	2431455	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2481261	2481261	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26779618		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2482433	2482433	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18452195		Confirmed Somatic	Tumour Sample	Unknown		1			
2531201	2531201	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39662068	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23392356		Confirmed Somatic	Tumour Sample	Heterozygous	13:28601359..28601359		ENSP00000370369.4:p.Phe691Leu	ENST00000380982.4:c.2073T>G	13:g.28601359A>C
2531261	2531261	SMO	ENST00000249373.3	Yes	Vismodegib	173867430		COSM5885157	p.H231R	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1			
2539199	2539199	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43320907	COSV65961491	COSM5945721	p.Q641*	c.1921C>T	prostate	NS	NS	carcinoma	NS	NS	14618630		Variant of unknown origin	Tumour Sample	Unknown	X:66931279..66931279		ENSP00000379359.3:p.Gln641Ter	ENST00000396044.3:c.1921C>T	X:g.66931279C>T
2546230	2546230	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457813	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000342630.5:p.Tyr537Asn	ENST00000338799.5:c.1609T>A	6:g.152419922T>A
2552456	2552456	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27553514		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2564943	2564943	MET	ENST00000318493.6	Yes	Crizotinib	27420710	COSV59256021	COSM5015794	p.D1246N	c.3736G>A	lung	NS	NS	carcinoma	squamous_cell_carcinoma	NS	27343442		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407	1	ENSP00000317272.6:p.Asp1246Asn	ENST00000318493.6:c.3736G>A	7:g.116423407G>A
2583444	2583444	AR_ENST00000396043	ENST00000396043.2	No	LHRH	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	10363963		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2584888	2584888	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173863850		COSM25880	p.G12S	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Ser		
2635720	2635720	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2637199	2637199	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457096	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Cys	ENST00000338799.5:c.1610A>G	6:g.152419923A>G
2664336	2664336	MET	ENST00000318493.6	Yes	Capmatinib	27420710	COSV59256021	COSM5015794	p.D1246N	c.3736G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407	1	ENSP00000317272.6:p.Asp1246Asn	ENST00000318493.6:c.3736G>A	7:g.116423407G>A
2664348	2664348	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2684446	2684446	MET	ENST00000318493.6	Yes	Osimertinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Previously Reported	Tumour Sample	Unknown		1			
2823495	2823495	TET2_ENST00000513237	ENST00000513237.1	No	Sunitinib	74373943	COSV54407618	COSM3598847	p.P67L	c.200C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236		ENSP00000425443.1:p.Pro67Leu	ENST00000513237.1:c.200C>T	4:g.106155236C>T
2835717	2835717	BTK	ENST00000308731.7	Yes	Ibrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2838944	2838944	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648522	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Ala	ENST00000311936.3:c.35G>C	12:g.25398284C>G
2838948	2838948	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648697	COSV55497461	COSM517	p.G12S	c.34G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Ser	ENST00000311936.3:c.34G>A	12:g.25398285C>T
2838948	2838948	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148556	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Ala	ENST00000556131.1:c.35G>C	12:g.25398284C>G
2841740	2841740	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
Hep3B_8	2816912	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865400		COSM9274138	p.V510L	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Leu		
TG81531	2823155	MTOR	ENST00000361445.4	Yes	Gefitinib	173864179		COSM7410546	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown		1			
SC-her2-025	2313847	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
904273	904273	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
905488	905488	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476382	COSV59339711	COSM12632	p.Q252H	c.756G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>T	9:g.133738356G>T
905494	905494	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470721	COSV59323734	COSM12575	p.F317L	c.951C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290		ENSP00000323315.5:p.Phe317Leu	ENST00000318560.5:c.951C>G	9:g.133748290C>G
WHIM23	2367162	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
1024758	1024758	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1024768	1024768	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211132	1211132	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211136	1211136	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350463	1350463	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1355314	1355314	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1426039	1426039	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431285	1431285	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1468617	1468617	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	21030498		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469805	1469805	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469812	1469812	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469819	1469819	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547745	1547745	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1547746	1547746	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1618761	1618761	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655327	1655327	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
1795116	1795116	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173874360		COSM957504	p.K378R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1815827	1815827	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1844086	1844086	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866902		COSM49031	p.L384M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu384Met		
1863611	1863611	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39662068	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359		ENSP00000370369.4:p.Phe691Leu	ENST00000380982.4:c.2073T>G	13:g.28601359A>C
1863617	1863617	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
1968564	1968564	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	caecum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
1996304	1996304	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2027816	2027816	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032214	2032214	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071720	2071720	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
2156364	2156364	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2293726	2293726	ALK	ENST00000389048.3	Yes	Alectinib	40309001	COSV66567934	COSM4440758	p.I1171S	c.3512T>G	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25393796		Variant of unknown origin	Tumour Sample	Heterozygous	2:29445213..29445213	1	ENSP00000373700.3:p.Ile1171Ser	ENST00000389048.3:c.3512T>G	2:g.29445213A>C
2313147	2313147	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2313152	2313152	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2313876	2313876	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51798494	COSV52784978	COSM1074635	p.?	c.851-26479T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922			ENST00000427531.2:c.851-26479T>A	6:g.152419922T>A
2313876	2313876	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59863320	COSV52784978	COSM1074635	p.Y425N	c.1273T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000415934.2:p.Tyr425Asn	ENST00000456483.2:c.1273T>A	6:g.152419922T>A
2313879	2313879	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
2367159	2367159	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2426837	2426837	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2429152	2429152	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429237	2429237	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2430093	2430093	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2430149	2430149	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26130666		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2466782	2466782	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864391		COSM5546574	p.?	c.505-?_1140+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2474095	2474095	PIK3CA	ENST00000263967.3	Yes	Vemurafenib	22531003	COSV55873239	COSM763	p.E545K	c.1633G>A	skin	NS	NS	malignant_melanoma	NS	NS	25515853		Confirmed Somatic	Tumour Sample	Unknown	3:178936091..178936091	1	ENSP00000263967.3:p.Glu545Lys	ENST00000263967.3:c.1633G>A	3:g.178936091G>A
2484986	2484986	PDGFRA	ENST00000257290.5	Yes	Sunitinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	25735500		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2485540	2485540	NRAS	ENST00000369535.4	Yes	Dabrafenib	173862661		COSM28049	p.Q61K	c.?	NS	NS	NS	malignant_melanoma	NS	NS	25886620		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2531273	2531273	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39661484	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835His	ENST00000380982.4:c.2503G>C	13:g.28592642C>G
2538518	2538518	AR	ENST00000374690.3	Yes	Abiraterone	38854871	COSV65953158	COSM5570418	p.T878S	c.2633C>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943553..66943553	1	ENSP00000363822.3:p.Thr878Ser	ENST00000374690.3:c.2633C>G	X:g.66943553C>G
2585569	2585569	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
2591479	2591479	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2624132	2624132	ALK	ENST00000389048.3	Yes	Ceritinib	40321734	COSV66565234	COSM6191344	p.D1203N	c.3607G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28434515		Variant of unknown origin	Tumour Sample	Unknown	2:29443610..29443610	1	ENSP00000373700.3:p.Asp1203Asn	ENST00000389048.3:c.3607G>A	2:g.29443610C>T
2651874	2651874	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55407429	COSV51834362	COSM6503269	p.?	c.*28+1084T>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Variant of unknown origin	Tumour Sample	Homozygous	7:55241705..55241705			ENST00000442591.1:c.*28+1084T>A	7:g.55241705T>A
2776123	2776123	KRAS	ENST00000256078.4	Yes	Panitumumab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	25137394		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
2824253	2824253	ALK	ENST00000389048.3	Yes	Brigatinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31668326		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2824265	2824265	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2835720	2835720	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
3	1330179	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
904079	904079	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
904121	904121	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173872927		COSM12623	p.Q252R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown					
904285	904285	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
905450	905450	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
915621	915621	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16014893		Confirmed Somatic	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
CTCM72	2468201	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
E30651	762157	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	12949711		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
MGH970	2824341	ALK	ENST00000389048.3	Yes	Ceritinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
WHIM20	2367160	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
1031894	1031894	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1227051	1227051	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
1235142	1235142	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1355269	1355269	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426031	1426031	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431312	1431312	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1431315	1431315	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1444574	1444574	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	20686428		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469795	1469795	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479976	1479976	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1498601	1498601	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1498642	1498642	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547745	1547745	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1552633	1552633	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863335		COSM12668	p.Y353H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1552637	1552637	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1565836	1565836	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36333003	COSV59325302	COSM131577	p.M407L	c.1219A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133750331..133750331	1	ENSP00000361423.2:p.Met407Leu	ENST00000372348.2:c.1219A>T	9:g.133750331A>T
1584483	1584483	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173871179		COSM133070	p.R220H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown					
1655317	1655317	ABL1	ENST00000372348.2	Yes	Imatinib	36323410	COSV59333676	COSM211607	p.F336V	c.1006T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748288..133748288	1	ENSP00000361423.2:p.Phe336Val	ENST00000372348.2:c.1006T>G	9:g.133748288T>G
1656922	1656922	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1767037	1767037	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1795123	1795123	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862941		COSM957505	p.S438C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Ser438Cys		
1844082	1844082	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1844109	1844109	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1863609	1863609	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706895	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359		ENSP00000438139.1:p.Phe691Leu	ENST00000537084.1:c.2073T>G	13:g.28601359A>C
1992090	1992090	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2027744	2027744	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071731	2071731	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
2227123	2227123	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	acinar_adenocarcinoma	NS	25120654		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2239173	2239173	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2313152	2313152	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2313880	2313880	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2318503	2318503	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2431452	2431452	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2468267	2468267	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2483261	2483261	KIT	ENST00000288135.5	Yes	Imatinib	173863668		COSM24641	p.C809G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1			
2517289	2517289	BRAF	ENST00000288602.6	Yes	Vemurafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	26101714		Variant of unknown origin	Cultured	Unknown		1			
2525664	2525664	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531243	2531243	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Trp535Leu		
2539220	2539220	AR_ENST00000396044	ENST00000396044.3	No	Androgen	43304692	COSV65953243	COSM3094417	p.V716M	c.2146G>A	prostate	NS	NS	carcinoma	adenocarcinoma	NS	8145761		Confirmed Somatic	Tumour Sample	Unknown	X:66931504..66931504		ENSP00000379359.3:p.Val716Met	ENST00000396044.3:c.2146G>A	X:g.66931504G>A
2580500	2580500	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	27895763		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2584876	2584876	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862744		COSM14201	p.Q61H	c.?	large_intestine	colon	right	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61His		
2585347	2585347	MET_ENST00000539704	ENST00000539704.1	No	Savolitinib	80948499	COSV59260821	COSM6018872	p.D98V	c.293A>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27694386		Confirmed Somatic	Tumour Sample	Unknown	7:116423408..116423408		ENSP00000445020.1:p.Asp98Val	ENST00000539704.1:c.293A>T	7:g.116423408A>T
2591397	2591397	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2635721	2635721	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59107719	COSV51770694	COSM20891	p.G751S	c.2251G>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249088..55249088		ENSP00000415559.1:p.Gly751Ser	ENST00000455089.1:c.2251G>A	7:g.55249088G>A
2664330	2664330	MET_ENST00000539704	ENST00000539704.1	No	Crizotinib	80943543	COSV59256836	COSM690	p.Y100H	c.298T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413		ENSP00000445020.1:p.Tyr100His	ENST00000539704.1:c.298T>C	7:g.116423413T>C
2730698	2730698	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58434552	COSV51782925	COSM24267	p.L694P	c.2080_2081delinsCC	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29673089		Previously Reported	Tumour Sample	Unknown	7:55242469..55242470		ENSP00000395243.2:p.Leu694Pro	ENST00000454757.2:c.2080_2081delinsCC	7:g.55242469_55242470delinsCC
2835714	2835714	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2835717	2835717	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2841743	2841743	ALK	ENST00000389048.3	Yes	Crizotinib	173864072		COSM9278966	p.C1156Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Cys1156Tyr		
2841747	2841747	ALK	ENST00000389048.3	Yes	Crizotinib	173864072		COSM9278966	p.C1156Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Cys1156Tyr		
2841765	2841765	ALK	ENST00000389048.3	Yes	Crizotinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
SC-her2-071	2313875	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
29	1069291	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	epithelioid	NS	15930355		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000257290.5:p.Asp842Val		
905453	905453	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
905456	905456	ABL1	ENST00000372348.2	Yes	Imatinib	36323146	COSV59325892	COSM12611	p.E374G	c.1121A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403	1	ENSP00000361423.2:p.Glu374Gly	ENST00000372348.2:c.1121A>G	9:g.133748403A>G
905597	905597	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866091		COSM12635	p.Q252E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	15381060		Variant of unknown origin	Tumour Sample	Unknown					
E29958	762041	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	14645423		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
MGH011	2824310	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
WHIM20	2367160	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
1000815	1000815	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1031895	1031895	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1211138	1211138	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211140	1211140	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1355283	1355283	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1469801	1469801	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469804	1469804	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469856	1469856	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469857	1469857	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543097	1543097	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1543110	1543110	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1543116	1543116	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864009		COSM43368	p.L364I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown					
1547746	1547746	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1552645	1552645	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1565826	1565826	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1576795	1576795	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1618752	1618752	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1774672	1774672	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795096	1795096	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173871915		COSM957501	p.E494G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1815772	1815772	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815784	1815784	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815807	1815807	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864993		COSM43380	p.L273M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown					
1844088	1844088	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1874585	1874585	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Heterozygous	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1927115	1927115	MAP2K1	ENST00000307102.5	Yes	Selumetinib	24777726	COSV61068422	COSM1315861	p.P124L	c.371C>T	skin	NS	NS	malignant_melanoma	NS	NS	19915144		Previously Reported	Tumour Sample	Heterozygous	15:66729163..66729163	1	ENSP00000302486.4:p.Pro124Leu	ENST00000307102.5:c.371C>T	15:g.66729163C>T
1968564	1968564	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	caecum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
1989311	1989311	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1996292	1996292	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869533		COSM1666896	p.E275K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown					
1996926	1996926	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	23912954		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071715	2071715	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
2076936	2076936	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2313150	2313150	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2351022	2351022	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	20682399		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2430101	2430101	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Variant of unknown origin	Tumour Sample	Unknown					
2471409	2471409	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20971926	COSV53563396	COSM5487841	p.C125S	c.374G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	19:4110583..4110583	1	ENSP00000262948.3:p.Cys125Ser	ENST00000262948.5:c.374G>C	19:g.4110583C>G
2501810	2501810	ALK	ENST00000389048.3	Yes	Crizotinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	27045755		Variant of unknown origin	Tumour Sample	Homozygous	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
2525722	2525722	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531273	2531273	FLT3	ENST00000241453.7	Yes	Sorafenib	20035351	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835His	ENST00000241453.7:c.2503G>C	13:g.28592642C>G
2611054	2611054	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2664336	2664336	MET	ENST00000318493.6	Yes	Capmatinib	27419172	COSV59256836	COSM690	p.Y1248H	c.3742T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413	1	ENSP00000317272.6:p.Tyr1248His	ENST00000318493.6:c.3742T>C	7:g.116423413T>C
2812140	2812140	MET	ENST00000318493.6	Yes	Osimertinib	173862802		COSM1737868	p.?	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29596911		Previously Reported	Tumour Sample	Unknown		1			
2819302	2819302	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2835713	2835713	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2838948	2838948	KRAS	ENST00000256078.4	Yes	Panitumumab	21547190	COSV55497461	COSM517	p.G12S	c.34G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Ser	ENST00000256078.4:c.34G>A	12:g.25398285C>T
2840784	2840784	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85398033	COSV55498739	COSM552	p.?	c.112-17431A>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380276..25380276			ENST00000557334.1:c.112-17431A>G	12:g.25380276T>C
MGH9003-1	2831784	ALK	ENST00000389048.3	Yes	Brigatinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
SC-her2-005	2313835	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
S_TBL200_R3	2757767	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29106415		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
3	1330179	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
904111	904111	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904114	904114	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
904271	904271	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
904275	904275	ABL1	ENST00000372348.2	Yes	Imatinib	36335402	COSV59324372	COSM12610	p.Y272F	c.815A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358	1	ENSP00000361423.2:p.Tyr272Phe	ENST00000372348.2:c.815A>T	9:g.133738358A>T
905169	905169	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
905490	905490	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27477568	COSV59324372	COSM12610	p.Y253F	c.758A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358		ENSP00000323315.5:p.Tyr253Phe	ENST00000318560.5:c.758A>T	9:g.133738358A>T
1167307	1167307	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1167308	1167308	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1167407	1167407	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1235125	1235125	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1235127	1235127	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1431303	1431303	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1469785	1469785	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469792	1469792	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479974	1479974	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1547778	1547778	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1576799	1576799	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1576801	1576801	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1576801	1576801	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1584487	1584487	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1584489	1584489	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1767018	1767018	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1794536	1794536	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1816949	1816949	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1844095	1844095	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844105	1844105	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173871506		COSM1169209	p.F317C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844110	1844110	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866724		COSM97192	p.F311L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Leu		
1874591	1874591	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1896945	1896945	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23542356		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1968560	1968560	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
1989313	1989313	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
2032222	2032222	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071737	2071737	ABL1	ENST00000372348.2	Yes	Imatinib	36322434	COSV59323744	COSM12604	p.H415R	c.1244A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356	1	ENSP00000361423.2:p.His415Arg	ENST00000372348.2:c.1244A>G	9:g.133750356A>G
2156363	2156363	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2156367	2156367	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	left_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2239173	2239173	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2275241	2275241	SMO	ENST00000249373.3	Yes	Vismodegib	22236134	COSV50829974	COSM4413609	p.G497W	c.1489G>T	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25306392		Previously Reported	Tumour Sample	Unknown	7:128850226..128850226	1	ENSP00000249373.3:p.Gly497Trp	ENST00000249373.3:c.1489G>T	7:g.128850226G>T
2313876	2313876	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55281546	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922	1	ENSP00000405330.1:p.Tyr537Asn	ENST00000440973.1:c.1609T>A	6:g.152419922T>A
2358403	2358403	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173873547		COSM4968669	p.G398R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25740611		Variant of unknown origin	Tumour Sample	Unknown					
2429182	2429182	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2429251	2429251	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2431432	2431432	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
2431475	2431475	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2431488	2431488	KIT	ENST00000288135.5	Yes	Imatinib	173863001		COSM18891	p.K642E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Lys642Glu		
2444260	2444260	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2462454	2462454	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173864892		COSM5413589	p.Y537S	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Ser		
2483297	2483297	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	large_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2484531	2484531	KIT	ENST00000288135.5	Yes	Imatinib	173863869		COSM28693	p.D820E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Glu		
2585569	2585569	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
2591349	2591349	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2621287	2621287	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2621495	2621495	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869597		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2635697	2635697	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2644798	2644798	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2644799	2644799	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59108752	COSV51766493	COSM6493937	p.C752S	c.2254T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091		ENSP00000415559.1:p.Cys752Ser	ENST00000455089.1:c.2254T>A	7:g.55249091T>A
2664329	2664329	MET_ENST00000539704	ENST00000539704.1	No	Crizotinib	80943543	COSV59256836	COSM690	p.Y100H	c.298T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413		ENSP00000445020.1:p.Tyr100His	ENST00000539704.1:c.298T>C	7:g.116423413T>C
2730698	2730698	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55405036	COSV51782925	COSM24267	p.?	c.*28+1848_*28+1849delinsCC	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29673089		Previously Reported	Tumour Sample	Unknown	7:55242469..55242470			ENST00000442591.1:c.*28+1848_*28+1849delinsCC	7:g.55242469_55242470delinsCC
2780949	2780949	FGFR2_ENST00000358487	ENST00000358487.5	No	BGJ398	173865513		COSM7412637	p.V564F	c.?	biliary_tract	bile_duct	NS	carcinoma	adenocarcinoma	NS	28034880		Confirmed Somatic	Tumour Sample	Unknown					
2823495	2823495	LRP1B	ENST00000389484.3	Yes	Sunitinib	41591474	COSV104432001	COSM9274202	p.C1187W	c.3561T>G	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Variant of unknown origin	Tumour Sample	Unknown	2:141660694..141660694	1	ENSP00000374135.3:p.Cys1187Trp	ENST00000389484.3:c.3561T>G	2:g.141660694A>C
2824263	2824263	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2824344	2824344	ALK	ENST00000389048.3	Yes	Lorlatinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
2835739	2835739	BTK	ENST00000308731.7	Yes	Acalabrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2838946	2838946	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148350	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Val	ENST00000556131.1:c.35G>T	12:g.25398284C>A
2840306	2840306	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
CTCM165	2468216	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
Pat_41_B	2513797	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	24781897	COSV61068773	COSM2257209	p.V60E	c.179T>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	15:66727463..66727463	1	ENSP00000302486.4:p.Val60Glu	ENST00000307102.5:c.179T>A	15:g.66727463T>A
SC-her2-014	2313840	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
27	1069289	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
904115	904115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904301	904301	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
909217	909217	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
924446	924446	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16198442		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
E30650	762156	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	12949711		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
1000817	1000817	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1043871	1043871	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	17192902		Previously Reported	NS	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211133	1211133	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211136	1211136	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1211147	1211147	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1227028	1227028	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1286110	1286110	SMO	ENST00000249373.3	Yes	Vismodegib	22235381	COSV50830986	COSM34198	p.D473H	c.1417G>C	central_nervous_system	brain	NS	primitive_neuroectodermal_tumour-medulloblastoma	NS	NS	19726788		Confirmed Somatic	Tumour Sample	Heterozygous	7:128849189..128849189	1	ENSP00000249373.3:p.Asp473His	ENST00000249373.3:c.1417G>C	7:g.128849189G>C
1350399	1350399	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1350450	1350450	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1350456	1350456	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1350488	1350488	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1351425	1351425	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1352427	1352427	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1355317	1355317	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1469810	1469810	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543738	1543738	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863944		COSM12627	p.V379I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown					
1576797	1576797	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1633976	1633976	ALK	ENST00000389048.3	Yes	Crizotinib	40299028	COSV66566818	COSM144251	p.S1206Y	c.3617C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Variant of unknown origin	Tumour Sample	Unknown	2:29443600..29443600	1	ENSP00000373700.3:p.Ser1206Tyr	ENST00000389048.3:c.3617C>A	2:g.29443600G>T
1655319	1655319	ABL1	ENST00000372348.2	Yes	Imatinib	36335402	COSV59324372	COSM12610	p.Y272F	c.815A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358	1	ENSP00000361423.2:p.Tyr272Phe	ENST00000372348.2:c.815A>T	9:g.133738358A>T
1795115	1795115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1795117	1795117	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1815792	1815792	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1816951	1816951	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1844070	1844070	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1844087	1844087	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1844091	1844091	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1859887	1859887	ALK	ENST00000389048.3	Yes	Crizotinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23344087		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
1928099	1928099	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1989321	1989321	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2027728	2027728	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2027857	2027857	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2032242	2032242	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071709	2071709	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
2255305	2255305	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2255312	2255312	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2313156	2313156	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2444266	2444266	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2483272	2483272	KIT	ENST00000288135.5	Yes	Imatinib	173863174		COSM28999	p.D820A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Ala		
2531249	2531249	SMO	ENST00000249373.3	Yes	Vismodegib	173865459		COSM5885183	p.F460L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1			
2531514	2531514	SMO	ENST00000249373.3	Yes	Vismodegib	173865738		COSM5885153	p.D473G	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Unknown		1			
2585569	2585569	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148330	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000451856.1:p.Gly13Asp	ENST00000556131.1:c.38G>A	12:g.25398281C>T
2608487	2608487	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2608498	2608498	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2616267	2616267	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Variant of unknown origin	Tumour Sample	Heterozygous	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2621287	2621287	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Homozygous	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2664363	2664363	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2803992	2803992	EGFR	ENST00000275493.2	Yes	Osimertinib	173874367		COSM9114764	p.M766Q	c.?	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31254668		Variant of unknown origin	Tumour Sample	Unknown		1			
2841755	2841755	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
SC-her2-014	2313840	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
SC-her2-025	2313847	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
SC-her2-045	2313865	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55281546	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922	1	ENSP00000405330.1:p.Tyr537Asn	ENST00000440973.1:c.1609T>A	6:g.152419922T>A
basal_cfDNA	2811748	KDR	ENST00000263923.4	Yes	Cetuximab	22448062	COSV99819063	COSM9179438	p.L840F	c.2518C>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	29588308		Confirmed Somatic	Tumour Sample	Heterozygous	4:55963925..55963925	1	ENSP00000263923.4:p.Leu840Phe	ENST00000263923.4:c.2518C>T	4:g.55963925G>A
4	1330180	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
905486	905486	ABL1	ENST00000372348.2	Yes	Imatinib	36329816	COSV59325261	COSM12631	p.L267V	c.799C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738342..133738342	1	ENSP00000361423.2:p.Leu267Val	ENST00000372348.2:c.799C>G	9:g.133738342C>G
905492	905492	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1024780	1024780	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1031898	1031898	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1167331	1167331	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211144	1211144	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211147	1211147	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1352411	1352411	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1426036	1426036	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1468088	1468088	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469816	1469816	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469864	1469864	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543117	1543117	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1547751	1547751	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1584486	1584486	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862882		COSM133071	p.V289A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown					
1633985	1633985	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51337862	COSV66558491	COSM144252	p.?	c.792-14363_792-14361dup	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Variant of unknown origin	Tumour Sample	Unknown	2:29445275..29445276			ENST00000431873.1:c.792-14363_792-14361dup	2:g.29445273_29445275dup
1655319	1655319	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27477568	COSV59324372	COSM12610	p.Y253F	c.758A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358		ENSP00000323315.5:p.Tyr253Phe	ENST00000318560.5:c.758A>T	9:g.133738358A>T
1794541	1794541	ABL1_ENST00000318560	ENST00000318560.5	No	Bosutinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1815821	1815821	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1928098	1928098	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992092	1992092	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1996322	1996322	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2027722	2027722	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071724	2071724	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
2076944	2076944	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2150406	2150406	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	micropapillary_adenocarcinoma	NS	24729716		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2318492	2318492	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2429128	2429128	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2444264	2444264	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2466825	2466825	BRAF	ENST00000288602.6	Yes	Vemurafenib	173864391		COSM5546574	p.?	c.505-?_1140+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2471429	2471429	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
2474090	2474090	BRAF	ENST00000288602.6	Yes	Vemurafenib	25732281	COSV56178243	COSM243226	p.L505H	c.1514T>A	skin	NS	NS	malignant_melanoma	NS	NS	25515853		Confirmed Somatic	Tumour Sample	Unknown	7:140477794..140477794	1	ENSP00000288602.6:p.Leu505His	ENST00000288602.6:c.1514T>A	7:g.140477794A>T
2484983	2484983	KIT	ENST00000288135.5	Yes	Imatinib	173865467		COSM88195	p.S821F	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	25735500		Variant of unknown origin	Tumour Sample	Unknown		1			
2517289	2517289	BRAF	ENST00000288602.6	Yes	Vemurafenib	173873189		COSM5878724	p.?	c.981-?_?del?	skin	NS	NS	malignant_melanoma	NS	NS	26101714		Variant of unknown origin	Cultured	Unknown		1			
2539014	2539014	EGFR_ENST00000454757	ENST00000454757.2	No	HM61713	58444403	COSV51766509	COSM5945664	p.C744S	c.2231G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	26749488		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092		ENSP00000395243.2:p.Cys744Ser	ENST00000454757.2:c.2231G>C	7:g.55249092G>C
2585570	2585570	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85396070	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Ala	ENST00000557334.1:c.35G>C	12:g.25398284C>G
2635697	2635697	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2635722	2635722	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
2664352	2664352	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2776123	2776123	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	25137394		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
2816899	2816899	FGFR4_ENST00000393648	ENST00000393648.2	No	Fisogatinib	44119197	COSV52800715	COSM3738141	p.V482L	c.1444G>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000377259.2:p.Val482Leu	ENST00000393648.2:c.1444G>C	5:g.176522551G>C
2824225	2824225	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2824226	2824226	BRAF	ENST00000288602.6	Yes	Osimertinib	173862544		COSM1131	p.V600E	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288602.6:p.Val600Glu		
2832818	2832818	ALK	ENST00000389048.3	Yes	Lorlatinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29650534		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
2835719	2835719	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2838948	2838948	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85396070	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Ala	ENST00000557334.1:c.35G>C	12:g.25398284C>G
2841767	2841767	ALK	ENST00000389048.3	Yes	Crizotinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
A375-R1	2755761	BRAF	ENST00000288602.6	Yes	Vemurafenib	173874168		COSM7335424	p.V47_D380del	c.139_1140del1002	skin	NS	NS	malignant_melanoma	NS	NS	29605720		Confirmed Somatic	Cultured	Heterozygous		1			
TG95755	2823143	MTOR	ENST00000361445.4	Yes	Tyrosine kinase inhibitor - NS	173864179		COSM7410546	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown		1			
MGH021-4	2275266	ALK	ENST00000389048.3	Yes	Ceritinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Variant of unknown origin	Cultured	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
H3122-CHR-A1	2245572	ALK_ENST00000431873	ENST00000431873.1	No	Alectinib	51341429	COSV66587894	COSM4381101	p.?	c.792-12768G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	25228534		Variant of unknown origin	Cultured	Unknown	2:29443679..29443679			ENST00000431873.1:c.792-12768G>C	2:g.29443679C>G
4	1330180	KRAS	ENST00000256078.4	Yes	Cetuximab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
904281	904281	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904297	904297	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905178	905178	ABL1	ENST00000372348.2	Yes	Imatinib	36322434	COSV59323744	COSM12604	p.H415R	c.1244A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356	1	ENSP00000361423.2:p.His415Arg	ENST00000372348.2:c.1244A>G	9:g.133750356A>G
CTCM14	2468205	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	25979954		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
WHIM20	2367160	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
1350466	1350466	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869541		COSM43366	p.E355A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1350473	1350473	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1351685	1351685	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355266	1355266	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1431304	1431304	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1469788	1469788	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469862	1469862	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479869	1479869	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1498583	1498583	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1552655	1552655	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1565832	1565832	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1656922	1656922	ABL1	ENST00000372348.2	Yes	Imatinib	36333256	COSV59326265	COSM211677	p.K313delinsRGG	c.937_938delinsCGGGGGGG	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown	9:133747573..133747574	1	ENSP00000361423.2:p.Lys313delinsArgGlyGly	ENST00000372348.2:c.937_938delinsCGGGGGGG	9:g.133747573_133747574delinsCGGGGGGG
1656924	1656924	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1863609	1863609	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706549	COSV54042199	COSM784	p.?	c.2419-2803A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641			ENST00000537084.1:c.2419-2803A>T	13:g.28592641T>A
1928075	1928075	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2027782	2027782	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2027824	2027824	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071710	2071710	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
2071719	2071719	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
2071734	2071734	ABL1	ENST00000372348.2	Yes	Imatinib	36322959	COSV59326146	COSM1732691	p.F378C	c.1133T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748415..133748415	1	ENSP00000361423.2:p.Phe378Cys	ENST00000372348.2:c.1133T>G	9:g.133748415T>G
2076952	2076952	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2144806	2144806	ALK	ENST00000389048.3	Yes	Crizotinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	24736079		Previously Reported	Tumour Sample	Heterozygous	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
2161695	2161695	EGFR_ENST00000455089	ENST00000455089.1	No	Afatinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2313880	2313880	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2318494	2318494	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2368723	2368723	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	25807654		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
2476828	2476828	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2483243	2483243	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2591429	2591429	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2619738	2619738	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	27199251		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2635719	2635719	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2635720	2635720	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2642912	2642912	MET	ENST00000318493.6	Yes	Crizotinib	173862938		COSM6476273	p.Y1248S	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28522754		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Tyr1248Ser		
2664330	2664330	MET_ENST00000539704	ENST00000539704.1	No	Crizotinib	80944237	COSV59256021	COSM5015794	p.D98N	c.292G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000445020.1:p.Asp98Asn	ENST00000539704.1:c.292G>A	7:g.116423407G>A
2664347	2664347	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2824229	2824229	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2835711	2835711	BTK	ENST00000308731.7	Yes	Ibrutinib	26369565	COSV58122597	COSM6053939	p.C481Y	c.1442G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Tyr	ENST00000308731.7:c.1442G>A	X:g.100611164C>T
2835711	2835711	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2835717	2835717	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2835720	2835720	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2835736	2835736	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2835736	2835736	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
Hep3B_1	2816905	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	173865400		COSM9274138	p.V510L	c.?	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Cultured	Unknown			ENSP00000292410.3:p.Val510Leu		
SNU-2535	1859888	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23344087		Variant of unknown origin	Cultured	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
SC-her2-005	2313835	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
SC-her2-014	2313840	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
SC-her2-045	2313865	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57211241	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000387500.1:p.Tyr537Asn	ENST00000443427.1:c.1609T>A	6:g.152419922T>A
3	1330179	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
BCC1	2531228	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000249373.3:p.Trp535Leu		
903863	903863	ABL1	ENST00000372348.2	Yes	Imatinib	36333788	COSV59324877	COSM12564	p.H415P	c.1244A>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133750356..133750356	1	ENSP00000361423.2:p.His415Pro	ENST00000372348.2:c.1244A>C	9:g.133750356A>C
904086	904086	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
905490	905490	ABL1	ENST00000372348.2	Yes	Imatinib	36335402	COSV59324372	COSM12610	p.Y272F	c.815A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358	1	ENSP00000361423.2:p.Tyr272Phe	ENST00000372348.2:c.815A>T	9:g.133738358A>T
1122365	1122365	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1351674	1351674	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1352414	1352414	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355291	1355291	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355292	1355292	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355299	1355299	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355306	1355306	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431316	1431316	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864961		COSM12667	p.D276G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Asp276Gly		
1468084	1468084	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469800	1469800	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498579	1498579	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1565830	1565830	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1601927	1601927	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	22108465		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655331	1655331	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
1677594	1677594	ALK	ENST00000389048.3	Yes	Crizotinib	40285470	COSV66556325	COSM28061	p.F1174L	c.3522C>G	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	inflammatory_myofibroblastic_tumour	NS	NS	21030459		Confirmed Somatic	Tumour Sample	Homozygous	2:29443695..29443695	1	ENSP00000373700.3:p.Phe1174Leu	ENST00000389048.3:c.3522C>G	2:g.29443695G>C
1767075	1767075	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
1794532	1794532	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1795114	1795114	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1844067	1844067	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844071	1844071	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844073	1844073	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844076	1844076	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844093	1844093	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1844106	1844106	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1863609	1863609	FLT3	ENST00000241453.7	Yes	Quizartinib	20035400	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359	1	ENSP00000241453.7:p.Phe691Leu	ENST00000241453.7:c.2073T>G	13:g.28601359A>C
1863619	1863619	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706895	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359		ENSP00000438139.1:p.Phe691Leu	ENST00000537084.1:c.2073T>G	13:g.28601359A>C
1996268	1996268	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2027746	2027746	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2035481	2035481	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	24034463		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2156367	2156367	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	left_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2239173	2239173	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	25130612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2255323	2255323	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
2429198	2429198	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
2429266	2429266	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
2431490	2431490	KIT	ENST00000288135.5	Yes	Imatinib	173870509		COSM308552	p.V569_Y578del	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	epithelioid	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown		1			
2476838	2476838	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2525744	2525744	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531261	2531261	SMO	ENST00000249373.3	Yes	Vismodegib	173867798		COSM5885154	p.D473N	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Variant of unknown origin	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Asp473Asn		
2531279	2531279	FLT3	ENST00000241453.7	Yes	Sorafenib	20035351	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835His	ENST00000241453.7:c.2503G>C	13:g.28592642C>G
2538450	2538450	AR	ENST00000374690.3	Yes	Abiraterone	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2542369	2542369	KRAS	ENST00000256078.4	Yes	Cetuximab	21548455	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	26644315		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>C	12:g.25380275T>G
2546461	2546461	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	12860943		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2585347	2585347	MET_ENST00000397752	ENST00000397752.3	No	Savolitinib	44834651	COSV59260821	COSM6018872	p.D1228V	c.3683A>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27694386		Confirmed Somatic	Tumour Sample	Unknown	7:116423408..116423408		ENSP00000380860.3:p.Asp1228Val	ENST00000397752.3:c.3683A>T	7:g.116423408A>T
2591455	2591455	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2608487	2608487	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812019	COSV58122597	COSM6053939	p.?	c.1039-1482G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>A	X:g.100611164C>T
2616286	2616286	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2635721	2635721	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48234113	COSV52795259	COSM6843697	p.L275H	c.824T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920		ENSP00000384064.1:p.Leu275His	ENST00000406599.1:c.824T>A	6:g.152419920T>A
2635721	2635721	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55431730	COSV51832101	COSM6493933	p.?	c.*28+8455C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249076..55249076			ENST00000442591.1:c.*28+8455C>T	7:g.55249076C>T
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58464307	COSV51832111	COSM6493934	p.L739H	c.2216T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249077..55249077		ENSP00000395243.2:p.Leu739His	ENST00000454757.2:c.2216T>A	7:g.55249077T>A
2664359	2664359	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2684447	2684447	MET	ENST00000318493.6	Yes	Crizotinib	173867670		COSM6024203	p.D1246H	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Asp1246His		
2835721	2835721	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2835723	2835723	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2838944	2838944	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395965	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Cys	ENST00000557334.1:c.34G>T	12:g.25398285C>A
2840307	2840307	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58464301	COSV51832101	COSM6493933	p.L739F	c.2215C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249076..55249076		ENSP00000395243.2:p.Leu739Phe	ENST00000454757.2:c.2215C>T	7:g.55249076C>T
2840784	2840784	KRAS	ENST00000256078.4	Yes	Cetuximab	21547123	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Ala	ENST00000256078.4:c.35G>C	12:g.25398284C>G
SC-her2-005	2313835	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
SC-her2-025	2313847	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
904307	904307	ABL1	ENST00000372348.2	Yes	Imatinib	36322434	COSV59323744	COSM12604	p.H415R	c.1244A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356	1	ENSP00000361423.2:p.His415Arg	ENST00000372348.2:c.1244A>G	9:g.133750356A>G
1047910	1047910	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	17335935		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1122369	1122369	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	17875769		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1162966	1162966	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18992959		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1167341	1167341	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1211134	1211134	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1295792	1295792	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	19692934		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1350443	1350443	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1350467	1350467	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1351702	1351702	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431328	1431328	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1479878	1479878	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1498581	1498581	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1552624	1552624	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1552635	1552635	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1655335	1655335	ABL1	ENST00000372348.2	Yes	Imatinib	36319073	COSV59324758	COSM12605	p.F378V	c.1132T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Val	ENST00000372348.2:c.1132T>G	9:g.133748414T>G
1815771	1815771	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1815822	1815822	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866882		COSM49076	p.T212R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown					
1844064	1844064	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1863605	1863605	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39661661	COSV54042199	COSM784	p.D835V	c.2504A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641		ENSP00000370369.4:p.Asp835Val	ENST00000380982.4:c.2504A>T	13:g.28592641T>A
1863609	1863609	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
1863613	1863613	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
1992092	1992092	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2027786	2027786	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2255300	2255300	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2313878	2313878	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654364	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Cys	ENST00000206249.3:c.1610A>G	6:g.152419923A>G
2313879	2313879	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2318494	2318494	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2318496	2318496	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2396139	2396139	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	left_bronchus	NS	carcinoma	adenocarcinoma	NS	24942894		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2426828	2426828	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2426839	2426839	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2431471	2431471	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2462452	2462452	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26648736		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2466828	2466828	MAP2K2_ENST00000394867	ENST00000394867.4	No	Vemurafenib	45630376	COSV53562150	COSM5546577	p.?	c.-122T>G	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	19:4117550..4117550			ENST00000394867.4:c.-122T>G	19:g.4117550A>C
2483237	2483237	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2525704	2525704	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2585242	2585242	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	173862744		COSM14201	p.Q61H	c.?	large_intestine	colon	right	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61His		
2585569	2585569	KRAS	ENST00000256078.4	Yes	Cetuximab	21547123	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Ala	ENST00000256078.4:c.35G>C	12:g.25398284C>G
2616298	2616298	BTK	ENST00000308731.7	Yes	Ibrutinib	173867400		COSM6188651	p.C481S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	26182309		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000308176.7:p.Cys481Ser		
2621284	2621284	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2635721	2635721	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59867260	COSV52795259	COSM6843697	p.L424H	c.1271T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419920..152419920		ENSP00000415934.2:p.Leu424His	ENST00000456483.2:c.1271T>A	6:g.152419920T>A
2635723	2635723	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2664335	2664335	MET_ENST00000397752	ENST00000397752.3	No	Capmatinib	44821801	COSV59256021	COSM5015794	p.D1228N	c.3682G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000380860.3:p.Asp1228Asn	ENST00000397752.3:c.3682G>A	7:g.116423407G>A
2664351	2664351	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2664367	2664367	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2748659	2748659	MET	ENST00000318493.6	Yes	PF-04217903	173862802		COSM1737868	p.?	c.?	kidney	NS	NS	carcinoma	papillary_renal_cell_carcinoma	solid_variant	23610116		Confirmed Somatic	Tumour Sample	Unknown		1			
2816899	2816899	FGFR4_ENST00000292410	ENST00000292410.3	No	Fisogatinib	27240858	COSV52802492	COSM1066172	p.V510L	c.1528G>T	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000292410.3:p.Val510Leu	ENST00000292410.3:c.1528G>T	5:g.176522551G>T
2816899	2816899	FGFR4_ENST00000393648	ENST00000393648.2	No	Fisogatinib	44117698	COSV52802492	COSM1066172	p.V482L	c.1444G>T	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000377259.2:p.Val482Leu	ENST00000393648.2:c.1444G>T	5:g.176522551G>T
2835717	2835717	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812015	COSV58122516	COSM6191211	p.?	c.1039-1482G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>T	X:g.100611164C>A
2835722	2835722	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2838948	2838948	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
2841747	2841747	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
SC-her2-025	2313847	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
SC-her2-071	2313875	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
S_TBL200_R3	2757767	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29106415		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
904131	904131	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
904283	904283	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469857	COSV59325003	COSM12574	p.E255V	c.764A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364		ENSP00000323315.5:p.Glu255Val	ENST00000318560.5:c.764A>T	9:g.133738364A>T
904303	904303	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
904305	904305	ABL1	ENST00000372348.2	Yes	Imatinib	36323146	COSV59325892	COSM12611	p.E374G	c.1121A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403	1	ENSP00000361423.2:p.Glu374Gly	ENST00000372348.2:c.1121A>G	9:g.133748403A>G
E29959	762042	PDGFRA	ENST00000257290.5	Yes	Imatinib	22554790	COSV57264120	COSM736	p.D842V	c.2525A>T	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	14645423		Previously Reported	Tumour Sample	Unknown	4:55152093..55152093	1	ENSP00000257290.5:p.Asp842Val	ENST00000257290.5:c.2525A>T	4:g.55152093A>T
1024775	1024775	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1227062	1227062	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1227064	1227064	KIT	ENST00000288135.5	Yes	Imatinib	173863817		COSM27127	p.D816H	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816His		
1235142	1235142	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1350490	1350490	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866017		COSM43375	p.F486S	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe486Ser		
1352421	1352421	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355258	1355258	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431267	1431267	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1498604	1498604	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1498640	1498640	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543090	1543090	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1576797	1576797	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1590999	1590999	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1655325	1655325	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469595	COSV59323765	COSM12609	p.Q252H	c.756G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>C	9:g.133738356G>C
1767091	1767091	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1774666	1774666	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1774676	1774676	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22993320		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795100	1795100	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1815822	1815822	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1816950	1816950	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1844073	1844073	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1863605	1863605	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
1992091	1992091	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2027752	2027752	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071736	2071736	ABL1	ENST00000372348.2	Yes	Imatinib	36324786	COSV59325471	COSM131574	p.L406M	c.1216T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133750328..133750328	1	ENSP00000361423.2:p.Leu406Met	ENST00000372348.2:c.1216T>A	9:g.133750328T>A
2313150	2313150	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2429214	2429214	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429255	2429255	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2430089	2430089	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2444268	2444268	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2466814	2466814	BRAF	ENST00000288602.6	Yes	Vemurafenib	173863357		COSM5546575	p.?	c.139_1140del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Unknown		1			
2476834	2476834	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2482428	2482428	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18452195		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
2531277	2531277	FLT3	ENST00000241453.7	Yes	Sorafenib	20035351	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835His	ENST00000241453.7:c.2503G>C	13:g.28592642C>G
2531279	2531279	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39662068	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28601359..28601359		ENSP00000370369.4:p.Phe691Leu	ENST00000380982.4:c.2073T>G	13:g.28601359A>C
2537729	2537729	AR_ENST00000396043	ENST00000396043.2	No	Enzalutamide	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	25712683		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2538518	2538518	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43307807	COSV65953158	COSM5570418	p.H733Q	c.2199C>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943553..66943553		ENSP00000379359.3:p.His733Gln	ENST00000396044.3:c.2199C>G	X:g.66943553C>G
2551720	2551720	AR_ENST00000396044	ENST00000396044.3	No	Flutamide	43304692	COSV65953243	COSM3094417	p.V716M	c.2146G>A	prostate	NS	NS	carcinoma	NS	NS	19366804		Confirmed Somatic	Tumour Sample	Unknown	X:66931504..66931504		ENSP00000379359.3:p.Val716Met	ENST00000396044.3:c.2146G>A	X:g.66931504G>A
2591379	2591379	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2608487	2608487	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2608487	2608487	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2608492	2608492	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2684447	2684447	MET	ENST00000318493.6	Yes	Crizotinib	173872518		COSM6853793	p.D1249Y	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29128427		Variant of unknown origin	Tumour Sample	Unknown		1			
2816899	2816899	FGFR4_ENST00000502906	ENST00000502906.1	No	Fisogatinib	68523078	COSV104624868	COSM9274136	p.C552R	c.1654T>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Tumour Sample	Unknown	5:176522557..176522557		ENSP00000424960.1:p.Cys552Arg	ENST00000502906.1:c.1654T>C	5:g.176522557T>C
2824344	2824344	ALK_ENST00000431873	ENST00000431873.1	No	Lorlatinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
2835740	2835740	BTK	ENST00000308731.7	Yes	Acalabrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2838942	2838942	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85149412	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Arg	ENST00000556131.1:c.34G>C	12:g.25398285C>G
2838948	2838948	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148705	COSV55497461	COSM517	p.G12S	c.34G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000451856.1:p.Gly12Ser	ENST00000556131.1:c.34G>A	12:g.25398285C>T
2840307	2840307	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58464307	COSV51832111	COSM6493934	p.L739H	c.2216T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249077..55249077		ENSP00000395243.2:p.Leu739His	ENST00000454757.2:c.2216T>A	7:g.55249077T>A
2840784	2840784	BRAF	ENST00000288602.6	Yes	Cetuximab	25723279	COSV56056643	COSM476	p.V600E	c.1799T>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	7:140453136..140453136	1	ENSP00000288602.6:p.Val600Glu	ENST00000288602.6:c.1799T>A	7:g.140453136A>T
SC-her2-045	2313865	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48231377	COSV52784978	COSM1074635	p.Y276N	c.826T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000384064.1:p.Tyr276Asn	ENST00000406599.1:c.826T>A	6:g.152419922T>A
metastatis_DNA	2811749	KDR	ENST00000263923.4	Yes	Cetuximab	22448062	COSV99819063	COSM9179438	p.L840F	c.2518C>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	29588308		Confirmed Somatic	Tumour Sample	Heterozygous	4:55963925..55963925	1	ENSP00000263923.4:p.Leu840Phe	ENST00000263923.4:c.2518C>T	4:g.55963925G>A
24B	1069286	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
903861	903861	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_leukaemia_of_ambiguous_lineage	NS	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
904067	904067	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
904299	904299	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905168	905168	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
905485	905485	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
PT09_2	2521257	SMO	ENST00000249373.3	Yes	Vismodegib	22235154	COSV50828671	COSM3942015	p.V321M	c.961G>A	skin	leg	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Confirmed Somatic	Tumour Sample	Unknown	7:128846031..128846031	1	ENSP00000249373.3:p.Val321Met	ENST00000249373.3:c.961G>A	7:g.128846031G>A
1031899	1031899	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1047910	1047910	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	17335935		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1167335	1167335	KIT	ENST00000288135.5	Yes	Imatinib	173863901		COSM28481	p.D816E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816Glu		
1211138	1211138	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211141	1211141	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350461	1350461	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1351423	1351423	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1351429	1351429	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866470		COSM43377	p.E450G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Variant of unknown origin	Tumour Sample	Unknown					
1355278	1355278	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1355289	1355289	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1355314	1355314	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431300	1431300	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1445180	1445180	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	20682976		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1468091	1468091	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479872	1479872	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1498625	1498625	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1552653	1552653	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1633983	1633983	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51316332	COSV66556435	COSM99137	p.?	c.792-12720C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Previously Reported	Tumour Sample	Unknown	2:29443631..29443631			ENST00000431873.1:c.792-12720C>A	2:g.29443631G>T
1794527	1794527	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1794530	1794530	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1863613	1863613	FLT3	ENST00000241453.7	Yes	Quizartinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
1968558	1968558	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	ascending	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
1992088	1992088	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1992090	1992090	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2071733	2071733	ABL1	ENST00000372348.2	Yes	Imatinib	36322959	COSV59326146	COSM1732691	p.F378C	c.1133T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748415..133748415	1	ENSP00000361423.2:p.Phe378Cys	ENST00000372348.2:c.1133T>G	9:g.133748415T>G
2318491	2318491	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51811504	COSV52785937	COSM4766050	p.?	c.851-26481_851-26480delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921			ENST00000427531.2:c.851-26481_851-26480delinsAG	6:g.152419920_152419921delinsAG
2431494	2431494	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
2444270	2444270	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2466828	2466828	MAP2K2	ENST00000262948.5	Yes	Vemurafenib	20972079	COSV53562150	COSM5546577	p.F57C	c.170T>G	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	19:4117550..4117550	1	ENSP00000262948.3:p.Phe57Cys	ENST00000262948.5:c.170T>G	19:g.4117550A>C
2483242	2483242	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2525666	2525666	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2535638	2535638	AR	ENST00000374690.3	Yes	Enzalutamide	173863923		COSM5885971	p.T878A	c.?	prostate	NS	NS	carcinoma	adenocarcinoma	NS	27401243		Previously Reported	Tumour Sample	Unknown		1	ENSP00000363822.3:p.Thr878Ala		
2539198	2539198	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	14618630		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2542369	2542369	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85397552	COSV55498802	COSM554	p.?	c.112-17430A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	26644315		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275			ENST00000557334.1:c.112-17430A>C	12:g.25380275T>G
2550052	2550052	AR_ENST00000396043	ENST00000396043.2	No	Ketoconazole	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2608492	2608492	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Confirmed Somatic	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2635652	2635652	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57211241	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000387500.1:p.Tyr537Asn	ENST00000443427.1:c.1609T>A	6:g.152419922T>A
2635721	2635721	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2637199	2637199	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230888	COSV52782924	COSM1074637	p.Y276C	c.827A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Cys	ENST00000406599.1:c.827A>G	6:g.152419923A>G
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23300952	COSV51832120	COSM6493935	p.G796R	c.2386G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249088..55249088	1	ENSP00000275493.2:p.Gly796Arg	ENST00000275493.2:c.2386G>C	7:g.55249088G>C
2664375	2664375	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2730698	2730698	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59094969	COSV51782925	COSM24267	p.L702P	c.2104_2105delinsCC	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	29673089		Previously Reported	Tumour Sample	Unknown	7:55242469..55242470		ENSP00000415559.1:p.Leu702Pro	ENST00000455089.1:c.2104_2105delinsCC	7:g.55242469_55242470delinsCC
2816899	2816899	FGFR4_ENST00000393637	ENST00000393637.1	No	Fisogatinib	44081652	COSV104624868	COSM9274136	p.C512R	c.1534T>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Tumour Sample	Unknown	5:176522557..176522557		ENSP00000377254.1:p.Cys512Arg	ENST00000393637.1:c.1534T>C	5:g.176522557T>C
2824343	2824343	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
2835723	2835723	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812019	COSV58122597	COSM6053939	p.?	c.1039-1482G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>A	X:g.100611164C>T
2840307	2840307	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58449222	COSV51766493	COSM6493937	p.C744S	c.2230T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249091..55249091		ENSP00000395243.2:p.Cys744Ser	ENST00000454757.2:c.2230T>A	7:g.55249091T>A
2841741	2841741	ALK	ENST00000389048.3	Yes	Crizotinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
2841763	2841763	ALK	ENST00000389048.3	Yes	Crizotinib	173868062		COSM9413100	p.T1151M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Thr1151Met		
Metastasis1	1620041	KIT	ENST00000288135.5	Yes	Sunitinib	25227346	COSV55387147	COSM1322	p.N822K	c.2466T>G	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	21394667		Previously Reported	Tumour Sample	Heterozygous	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>G	4:g.55599340T>G
904137	904137	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904281	904281	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
TCSR-T	2823142	PTEN	ENST00000371953.3	Yes	Tyrosine kinase inhibitor - NS	173862680		COSM14078	p.0	c.1_*del	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Homozygous		1			
1162972	1162972	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18992959		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1167385	1167385	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
1211135	1211135	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1227032	1227032	KIT	ENST00000288135.5	Yes	Imatinib	25227346	COSV55387147	COSM1322	p.N822K	c.2466T>G	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown	4:55599340..55599340	1	ENSP00000288135.5:p.Asn822Lys	ENST00000288135.5:c.2466T>G	4:g.55599340T>G
1319151	1319151	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	20146086		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350417	1350417	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1351420	1351420	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1351431	1351431	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351672	1351672	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868025		COSM43387	p.S417Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Ser417Tyr		
1351675	1351675	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1351676	1351676	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864993		COSM43380	p.L273M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1351717	1351717	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1355287	1355287	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355323	1355323	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1426032	1426032	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431309	1431309	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1468059	1468059	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547758	1547758	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552639	1552639	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1565818	1565818	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
1576783	1576783	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1590997	1590997	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767080	1767080	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1767095	1767095	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1815799	1815799	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1896936	1896936	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23542356		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1928074	1928074	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968562	1968562	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
2007337	2007337	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2032210	2032210	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088653	2088653	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
2318491	2318491	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22665667	COSV52785937	COSM4766050	p.L536Q	c.1607_1608delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921		ENSP00000206249.3:p.Leu536Gln	ENST00000206249.3:c.1607_1608delinsAG	6:g.152419920_152419921delinsAG
2318503	2318503	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
2324034	2324034	ABL1	ENST00000372348.2	Yes	Bosutinib	36323537	COSV59324514	COSM133668	p.F378I	c.1132T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133748414..133748414	1	ENSP00000361423.2:p.Phe378Ile	ENST00000372348.2:c.1132T>A	9:g.133748414T>A
2428995	2428995	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2429183	2429183	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2476840	2476840	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2479258	2479258	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2481262	2481262	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26779618		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2501806	2501806	ALK	ENST00000389048.3	Yes	Crizotinib	40301558	COSV66562303	COSM99136	p.C1156Y	c.3467G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	27045755		Previously Reported	Tumour Sample	Heterozygous	2:29445258..29445258	1	ENSP00000373700.3:p.Cys1156Tyr	ENST00000389048.3:c.3467G>A	2:g.29445258C>T
2531279	2531279	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706895	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28601359..28601359		ENSP00000438139.1:p.Phe691Leu	ENST00000537084.1:c.2073T>G	13:g.28601359A>C
2538591	2538591	AR	ENST00000374690.3	Yes	Abiraterone	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2550054	2550054	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2591355	2591355	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2635697	2635697	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2644798	2644798	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2644799	2644799	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55431734	COSV51832111	COSM6493934	p.?	c.*28+8456T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249077..55249077			ENST00000442591.1:c.*28+8456T>A	7:g.55249077T>A
2780950	2780950	FGFR2_ENST00000358487	ENST00000358487.5	No	BGJ398	173865513		COSM7412637	p.V564F	c.?	biliary_tract	bile_duct	NS	carcinoma	adenocarcinoma	NS	28034880		Confirmed Somatic	Tumour Sample	Unknown					
2823495	2823495	TET2_ENST00000413648	ENST00000413648.2	No	Sunitinib	47004490	COSV54407618	COSM3598847	p.P46L	c.137C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236		ENSP00000391448.2:p.Pro46Leu	ENST00000413648.2:c.137C>T	4:g.106155236C>T
2835714	2835714	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2835719	2835719	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2835723	2835723	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2838946	2838946	KRAS	ENST00000256078.4	Yes	Panitumumab	21547037	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Val	ENST00000256078.4:c.35G>T	12:g.25398284C>A
2838948	2838948	KRAS	ENST00000256078.4	Yes	Panitumumab	21547060	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Cys	ENST00000256078.4:c.34G>T	12:g.25398285C>A
SC-her2-019	2313843	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
SC-her2-025	2313847	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
RPC-9	1083085	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17699786		Previously Reported	Cultured	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
904076	904076	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
904115	904115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
905453	905453	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
909223	909223	KIT	ENST00000288135.5	Yes	Imatinib	25231390	COSV55410040	COSM12708	p.T670I	c.2009C>T	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Homozygous	4:55595519..55595519	1	ENSP00000288135.5:p.Thr670Ile	ENST00000288135.5:c.2009C>T	4:g.55595519C>T
1211131	1211131	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1235138	1235138	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1355275	1355275	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1431282	1431282	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1469821	1469821	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543101	1543101	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866724		COSM97192	p.F311L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Leu		
1543106	1543106	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1543119	1543119	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21221851		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1545600	1545600	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474640	COSV59325261	COSM12631	p.L248V	c.742C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	17008892		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738342..133738342		ENSP00000323315.5:p.Leu248Val	ENST00000318560.5:c.742C>G	9:g.133738342C>G
1547774	1547774	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552625	1552625	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1552632	1552632	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863335		COSM12668	p.Y353H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1794531	1794531	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1795108	1795108	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1795111	1795111	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864314		COSM957503	p.V256L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1815808	1815808	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173866199		COSM53181	p.E279K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu279Lys		
1844080	1844080	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844096	1844096	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1874594	1874594	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1928101	1928101	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992088	1992088	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1996307	1996307	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
2071722	2071722	ABL1	ENST00000372348.2	Yes	Imatinib	36334088	COSV59335571	COSM1732689	p.E298A	c.893A>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133747529..133747529	1	ENSP00000361423.2:p.Glu298Ala	ENST00000372348.2:c.893A>C	9:g.133747529A>C
2071738	2071738	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27481337	COSV59337395	COSM1732690	p.S438C	c.1313C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753844..133753844		ENSP00000323315.5:p.Ser438Cys	ENST00000318560.5:c.1313C>G	9:g.133753844C>G
2318491	2318491	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48237825	COSV52785937	COSM4766050	p.L275Q	c.824_825delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921		ENSP00000384064.1:p.Leu275Gln	ENST00000406599.1:c.824_825delinsAG	6:g.152419920_152419921delinsAG
2318492	2318492	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2426835	2426835	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2429220	2429220	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2468257	2468257	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2471417	2471417	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45630124	COSV53563396	COSM5487841	p.C28S	c.83G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	19:4110583..4110583		ENSP00000378336.1:p.Cys28Ser	ENST00000394867.4:c.83G>C	19:g.4110583C>G
2481264	2481264	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26779618		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2483246	2483246	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2483253	2483253	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2483275	2483275	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2517293	2517293	NRAS	ENST00000369535.4	Yes	Vemurafenib	173862661		COSM28049	p.Q61K	c.?	skin	NS	NS	malignant_melanoma	NS	NS	26101714		Previously Reported	Cultured	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2525697	2525697	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531279	2531279	FLT3	ENST00000241453.7	Yes	Sorafenib	20035400	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28601359..28601359	1	ENSP00000241453.7:p.Phe691Leu	ENST00000241453.7:c.2073T>G	13:g.28601359A>C
2531281	2531281	FLT3_ENST00000537084	ENST00000537084.1	No	Sunitinib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
2585242	2585242	NRAS	ENST00000369535.4	Yes	Panitumumab	173862550		COSM36378	p.Q61L	c.?	large_intestine	colon	right	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Leu		
2585344	2585344	MET_ENST00000397752	ENST00000397752.3	No	Crizotinib	44821463	COSV59257466	COSM699	p.Y1230C	c.3689A>G	lung	NS	NS	carcinoma	adenocarcinoma	NS	27666659		Previously Reported	Tumour Sample	Unknown	7:116423414..116423414		ENSP00000380860.3:p.Tyr1230Cys	ENST00000397752.3:c.3689A>G	7:g.116423414A>G
2611056	2611056	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2611058	2611058	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2628609	2628609	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	lymph_node	NS	lymphoid_neoplasm	mantle_cell_lymphoma	NS	25082755		Confirmed Somatic	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2824227	2824227	BRAF	ENST00000288602.6	Yes	Osimertinib	173862544		COSM1131	p.V600E	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	31542322		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288602.6:p.Val600Glu		
2835717	2835717	BTK	ENST00000308731.7	Yes	Ibrutinib	26369574	COSV58117643	COSM6053936	p.C481R	c.1441T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Arg	ENST00000308731.7:c.1441T>C	X:g.100611165A>G
2835718	2835718	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2840778	2840778	KRAS	ENST00000256078.4	Yes	Panitumumab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
2840782	2840782	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25649957	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>C	12:g.25380275T>G
2840786	2840786	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85396594	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Arg	ENST00000557334.1:c.34G>C	12:g.25398285C>G
2841739	2841739	ROS1	ENST00000368508.3	Yes	Crizotinib	173863967		COSM9413099	p.G2032R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30683630		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000357494.3:p.Gly2032Arg		
SC-her2-014	2313840	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
SC-her2-045	2313865	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457813	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000342630.5:p.Tyr537Asn	ENST00000338799.5:c.1609T>A	6:g.152419922T>A
904263	904263	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
904267	904267	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
905164	905164	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
905486	905486	ABL1	ENST00000372348.2	Yes	Imatinib	36344584	COSV59343940	COSM12633	p.S436Y	c.1307C>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133750419..133750419	1	ENSP00000361423.2:p.Ser436Tyr	ENST00000372348.2:c.1307C>A	9:g.133750419C>A
905598	905598	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	15381060		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
MGH040	2824318	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1040049	1040049	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	17180521		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1211130	1211130	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211145	1211145	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350440	1350440	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1351693	1351693	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1351720	1351720	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173872232		COSM43372	p.E459G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Gly		
1355301	1355301	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355316	1355316	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431289	1431289	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869809		COSM49138	p.E355X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1431324	1431324	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1498580	1498580	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1498600	1498600	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1498629	1498629	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543120	1543120	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1552648	1552648	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1565820	1565820	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
1576783	1576783	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1590993	1590993	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1618770	1618770	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1744516	1744516	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22489663		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844078	1844078	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844107	1844107	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1863609	1863609	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39661661	COSV54042199	COSM784	p.D835V	c.2504A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641		ENSP00000370369.4:p.Asp835Val	ENST00000380982.4:c.2504A>T	13:g.28592641T>A
1863611	1863611	FLT3	ENST00000241453.7	Yes	Quizartinib	20035400	COSV54050694	COSM1191160	p.F691L	c.2073T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28601359..28601359	1	ENSP00000241453.7:p.Phe691Leu	ENST00000241453.7:c.2073T>G	13:g.28601359A>C
1874585	1874585	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Heterozygous	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1874588	1874588	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1896937	1896937	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23542356		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1996301	1996301	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1996312	1996312	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2027736	2027736	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2035481	2035481	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	24034463		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2071726	2071726	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
2071728	2071728	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474650	COSV59325906	COSM12578	p.M351T	c.1052T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391		ENSP00000323315.5:p.Met351Thr	ENST00000318560.5:c.1052T>C	9:g.133748391T>C
2071740	2071740	ABL1	ENST00000372348.2	Yes	Imatinib	36333518	COSV59327102	COSM1460549	p.E478G	c.1433A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753907..133753907	1	ENSP00000361423.2:p.Glu478Gly	ENST00000372348.2:c.1433A>G	9:g.133753907A>G
2076934	2076934	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24369725		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2161695	2161695	NF2	ENST00000338641.4	Yes	Afatinib	30323820	COSV58519797	COSM22432	p.R198*	c.592C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658	1	ENSP00000344666.4:p.Arg198Ter	ENST00000338641.4:c.592C>T	22:g.30051658C>T
2255313	2255313	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2368723	2368723	ABL1	ENST00000372348.2	Yes	Imatinib	36327041	COSV59324360	COSM12577	p.G269E	c.806G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	25807654		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349	1	ENSP00000361423.2:p.Gly269Glu	ENST00000372348.2:c.806G>A	9:g.133738349G>A
2444263	2444263	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2481268	2481268	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	26779618		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
2521248	2521248	SMO	ENST00000249373.3	Yes	Vismodegib	22234504	COSV50825992	COSM3942016	p.A459V	c.1376C>T	skin	face	NS	carcinoma	basal_cell_carcinoma	NS	25759019		Previously Reported	Tumour Sample	Unknown	7:128849148..128849148	1	ENSP00000249373.3:p.Ala459Val	ENST00000249373.3:c.1376C>T	7:g.128849148C>T
2525742	2525742	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531209	2531209	FLT3	ENST00000241453.7	Yes	Sorafenib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
2531274	2531274	FLT3	ENST00000241453.7	Yes	Sorafenib	20035351	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835His	ENST00000241453.7:c.2503G>C	13:g.28592642C>G
2531276	2531276	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706366	COSV54042636	COSM785	p.?	c.2419-2804G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>C	13:g.28592642C>G
2539199	2539199	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	NS	NS	14618630		Previously Reported	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2585234	2585234	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862913		COSM25879	p.G12V	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Val		
2585234	2585234	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173863577		COSM25881	p.G12A	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Ala		
2585344	2585344	MET	ENST00000318493.6	Yes	Crizotinib	27420364	COSV59257466	COSM699	p.Y1248C	c.3743A>G	lung	NS	NS	carcinoma	adenocarcinoma	NS	27666659		Previously Reported	Tumour Sample	Unknown	7:116423414..116423414	1	ENSP00000317272.6:p.Tyr1248Cys	ENST00000318493.6:c.3743A>G	7:g.116423414A>G
2591375	2591375	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2591403	2591403	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2635697	2635697	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2635719	2635719	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
2644798	2644798	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2664342	2664342	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2823495	2823495	TET2_ENST00000545826	ENST00000545826.1	No	Sunitinib	83421637	COSV54407618	COSM3598847	p.P46L	c.137C>T	kidney	NS	NS	carcinoma	clear_cell_renal_cell_carcinoma	NS	30848481		Previously Reported	Tumour Sample	Unknown	4:106155236..106155236		ENSP00000442867.1:p.Pro46Leu	ENST00000545826.1:c.137C>T	4:g.106155236C>T
2824267	2824267	ALK	ENST00000389048.3	Yes	Crizotinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
2835709	2835709	BTK	ENST00000308731.7	Yes	Acalabrutinib	26369558	COSV58122516	COSM6191211	p.C481F	c.1442G>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Variant of unknown origin	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Phe	ENST00000308731.7:c.1442G>T	X:g.100611164C>A
2835737	2835737	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2838946	2838946	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395944	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Val	ENST00000557334.1:c.35G>T	12:g.25398284C>A
2838948	2838948	KRAS	ENST00000256078.4	Yes	Panitumumab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
2840306	2840306	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2840307	2840307	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58438229	COSV51834362	COSM6503269	p.L665Q	c.1994T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Unknown	7:55241705..55241705		ENSP00000395243.2:p.Leu665Gln	ENST00000454757.2:c.1994T>A	7:g.55241705T>A
2840782	2840782	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25654383	COSV55499223	COSM555	p.Q61H	c.183A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>T	12:g.25380275T>A
2840786	2840786	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148350	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Val	ENST00000556131.1:c.35G>T	12:g.25398284C>A
2840786	2840786	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
2840786	2840786	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
MGH067	2824329	ALK	ENST00000389048.3	Yes	Ceritinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
1024768	1024768	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1024776	1024776	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1103807	1103807	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1235138	1235138	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350462	1350462	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1351427	1351427	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1355320	1355320	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1445184	1445184	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	20682976		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1514540	1514540	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	24778614	COSV61069878	COSM1315829	p.C121S	c.362G>C	NS	NS	NS	malignant_melanoma	NS	NS	21383288		Confirmed Somatic	Tumour Sample	Unknown	15:66729154..66729154	1	ENSP00000302486.4:p.Cys121Ser	ENST00000307102.5:c.362G>C	15:g.66729154G>C
1543729	1543729	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862940		COSM53182	p.?	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown					
1552623	1552623	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1552651	1552651	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1584477	1584477	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown					
1591003	1591003	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1731096	1731096	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22815900		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767031	1767031	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1795109	1795109	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1813215	1813215	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	23079729		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1815817	1815817	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1863605	1863605	FLT3	ENST00000241453.7	Yes	Quizartinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
1863607	1863607	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
1874589	1874589	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1928080	1928080	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992090	1992090	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2027718	2027718	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088654	2088654	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
2088657	2088657	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2156363	2156363	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_upper_lobe	NS	carcinoma	squamous_cell_carcinoma	NS	24752053		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2313876	2313876	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22655219	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000206249.3:p.Tyr537Asn	ENST00000206249.3:c.1609T>A	6:g.152419922T>A
2318502	2318502	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2318503	2318503	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2426831	2426831	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2429213	2429213	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2432728	2432728	ABL1	ENST00000372348.2	Yes	Imatinib	36333788	COSV59324877	COSM12564	p.H415P	c.1244A>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	22299775		Variant of unknown origin	Tumour Sample	Homozygous	9:133750356..133750356	1	ENSP00000361423.2:p.His415Pro	ENST00000372348.2:c.1244A>C	9:g.133750356A>C
2444258	2444258	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2471418	2471418	MAP2K2_ENST00000394867	ENST00000394867.4	No	Dabrafenib	45630124	COSV53563396	COSM5487841	p.C28S	c.83G>C	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	19:4110583..4110583		ENSP00000378336.1:p.Cys28Ser	ENST00000394867.4:c.83G>C	19:g.4110583C>G
2525730	2525730	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2546229	2546229	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22655219	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	27551012		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000206249.3:p.Tyr537Asn	ENST00000206249.3:c.1609T>A	6:g.152419922T>A
2550053	2550053	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	NS	NS	25320358		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2585567	2585567	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148362	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Asp	ENST00000556131.1:c.35G>A	12:g.25398284C>T
2591465	2591465	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2621336	2621336	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2628607	2628607	BTK	ENST00000308731.7	Yes	Ibrutinib	26371159	COSV58119120	COSM6196566	p.C481S	c.1442_1443delinsCT	haematopoietic_and_lymphoid_tissue	lymph_node	NS	lymphoid_neoplasm	mantle_cell_lymphoma	NS	25082755		Confirmed Somatic	Tumour Sample	Unknown	X:100611163..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442_1443delinsCT	X:g.100611163_100611164delinsAG
2635652	2635652	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457813	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000342630.5:p.Tyr537Asn	ENST00000338799.5:c.1609T>A	6:g.152419922T>A
2635722	2635722	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
2637199	2637199	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862599	COSV52782924	COSM1074637	p.Y425C	c.1274A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Cys	ENST00000456483.2:c.1274A>G	6:g.152419923A>G
2664329	2664329	MET_ENST00000397752	ENST00000397752.3	No	Crizotinib	44820287	COSV59256836	COSM690	p.Y1230H	c.3688T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423413..116423413		ENSP00000380860.3:p.Tyr1230His	ENST00000397752.3:c.3688T>C	7:g.116423413T>C
2664335	2664335	MET_ENST00000539704	ENST00000539704.1	No	Capmatinib	80944237	COSV59256021	COSM5015794	p.D98N	c.292G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown	7:116423407..116423407		ENSP00000445020.1:p.Asp98Asn	ENST00000539704.1:c.292G>A	7:g.116423407G>A
2824262	2824262	ALK	ENST00000389048.3	Yes	Crizotinib	173862570		COSM4422786	p.L1196M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1196Met		
2840307	2840307	EGFR_ENST00000442591	ENST00000442591.1	No	Osimertinib	55431734	COSV51832111	COSM6493934	p.?	c.*28+8456T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Heterozygous	7:55249077..55249077			ENST00000442591.1:c.*28+8456T>A	7:g.55249077T>A
2840776	2840776	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25814359	COSV104554397	COSM9363035	p.Q61P	c.182_183delinsCC	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Variant of unknown origin	Tumour Sample	Unknown	12:25380275..25380276		ENSP00000308495.3:p.Gln61Pro	ENST00000311936.3:c.182_183delinsCC	12:g.25380275_25380276delinsGG
2840784	2840784	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25650316	COSV55498739	COSM552	p.Q61R	c.182A>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380276..25380276		ENSP00000308495.3:p.Gln61Arg	ENST00000311936.3:c.182A>G	12:g.25380276T>C
2840784	2840784	KRAS_ENST00000556131	ENST00000556131.1	No	Cetuximab	85148556	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Ala	ENST00000556131.1:c.35G>C	12:g.25398284C>G
2841758	2841758	ALK	ENST00000389048.3	Yes	Crizotinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
3037-ca	2823145	MTOR	ENST00000361445.4	Yes	Tyrosine kinase inhibitor - NS	173864179		COSM7410546	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28818608		Confirmed Somatic	Tumour Sample	Unknown		1			
Pat_40_B	2492878	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
SC-her2-005	2313835	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797763	COSV52783938	COSM1074639	p.?	c.851-26478A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>C	6:g.152419923A>C
MCF-7_RR2_cell	2553505	MTOR	ENST00000361445.4	Yes	Rapamycin	173873694		COSM5967349	p.F2108L	c.?	breast	NS	NS	carcinoma	NS	NS	27279227		Confirmed Somatic	Cultured	Unknown		1	ENSP00000354558.4:p.Phe2108Leu		
903861	903861	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_leukaemia_of_ambiguous_lineage	NS	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
903866	903866	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Previously Reported	Tumour Sample	Heterozygous	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
903870	903870	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
904078	904078	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
904291	904291	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
904295	904295	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
905447	905447	ABL1	ENST00000372348.2	Yes	Imatinib	36335402	COSV59324372	COSM12610	p.Y272F	c.815A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738358..133738358	1	ENSP00000361423.2:p.Tyr272Phe	ENST00000372348.2:c.815A>T	9:g.133738358A>T
905449	905449	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
905497	905497	ABL1	ENST00000372348.2	Yes	Imatinib	36323146	COSV59325892	COSM12611	p.E374G	c.1121A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403	1	ENSP00000361423.2:p.Glu374Gly	ENST00000372348.2:c.1121A>G	9:g.133748403A>G
WHIM20	2367160	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductolobular_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
1040049	1040049	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	17180521		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350415	1350415	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350476	1350476	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1350477	1350477	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864009		COSM43368	p.L364I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1351679	1351679	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355312	1355312	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1426044	1426044	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1431256	1431256	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1431261	1431261	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431265	1431265	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1498574	1498574	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1498630	1498630	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543736	1543736	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1547772	1547772	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1576791	1576791	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1584474	1584474	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1655319	1655319	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
1767088	1767088	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173866199		COSM53181	p.E279K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu279Lys		
1815825	1815825	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844075	1844075	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844084	1844084	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844087	1844087	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844109	1844109	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1863615	1863615	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706549	COSV54042199	COSM784	p.?	c.2419-2803A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641			ENST00000537084.1:c.2419-2803A>T	13:g.28592641T>A
1928089	1928089	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992093	1992093	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2071727	2071727	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
2071728	2071728	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
2161695	2161695	NF2_ENST00000403999	ENST00000403999.3	No	Afatinib	46704583	COSV58528760	COSM3735038	p.?	c.811-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000403999.3:c.811-2A>T	22:g.30060977A>T
2313147	2313147	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797269	COSV52781024	COSM94250	p.?	c.851-26475A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926			ENST00000427531.2:c.851-26475A>G	6:g.152419926A>G
2313152	2313152	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
2313152	2313152	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2318503	2318503	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	lobular_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2429227	2429227	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2429272	2429272	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2431490	2431490	KIT	ENST00000288135.5	Yes	Imatinib	25227803	COSV55389496	COSM12706	p.V654A	c.1961T>C	soft_tissue	fibrous_tissue_and_uncertain_origin	peritoneum	gastrointestinal_stromal_tumour	epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55594258..55594258	1	ENSP00000288135.5:p.Val654Ala	ENST00000288135.5:c.1961T>C	4:g.55594258T>C
2531209	2531209	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
2531209	2531209	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78705551	COSV54042116	COSM783	p.?	c.2419-2804G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>T	13:g.28592642C>A
2539014	2539014	EGFR	ENST00000275493.2	Yes	HM61713	23278878	COSV51766509	COSM5945664	p.C797S	c.2390G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	26749488		Previously Reported	Tumour Sample	Unknown	7:55249092..55249092	1	ENSP00000275493.2:p.Cys797Ser	ENST00000275493.2:c.2390G>C	7:g.55249092G>C
2539200	2539200	AR	ENST00000374690.3	Yes	Flutamide	38854871	COSV65953158	COSM5570418	p.T878S	c.2633C>G	prostate	NS	NS	carcinoma	NS	NS	7723794		Previously Reported	Tumour Sample	Unknown	X:66943553..66943553	1	ENSP00000363822.3:p.Thr878Ser	ENST00000374690.3:c.2633C>G	X:g.66943553C>G
2585567	2585567	KRAS	ENST00000256078.4	Yes	Cetuximab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
2621287	2621287	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	28049639		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2623673	2623673	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37813568	COSV58118015	COSM6191212	p.T316A	c.946A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	27626698		Variant of unknown origin	Tumour Sample	Heterozygous	X:100613633..100613633		ENSP00000361971.1:p.Thr316Ala	ENST00000372880.1:c.946A>G	X:g.100613633T>C
2628606	2628606	BTK	ENST00000308731.7	Yes	Ibrutinib	26371159	COSV58119120	COSM6196566	p.C481S	c.1442_1443delinsCT	haematopoietic_and_lymphoid_tissue	lymph_node	NS	lymphoid_neoplasm	mantle_cell_lymphoma	NS	25082755		Confirmed Somatic	Tumour Sample	Unknown	X:100611163..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442_1443delinsCT	X:g.100611163_100611164delinsAG
2635697	2635697	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2637198	2637198	ESR1_ENST00000427531	ENST00000427531.2	No	Endocrine therapy	51797513	COSV52782924	COSM1074637	p.?	c.851-26478A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923			ENST00000427531.2:c.851-26478A>G	6:g.152419923A>G
2816899	2816899	FGFR4_ENST00000502906	ENST00000502906.1	No	Fisogatinib	68520806	COSV52800715	COSM3738141	p.V550L	c.1648G>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000424960.1:p.Val550Leu	ENST00000502906.1:c.1648G>C	5:g.176522551G>C
2819289	2819289	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2823658	2823658	MET_ENST00000397752	ENST00000397752.3	No	Erlotinib	44835526	COSV104627086	COSM9277029	p.?	c.2888-1G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31157314		Variant of unknown origin	Tumour Sample	Unknown	7:116411902..116411902			ENST00000397752.3:c.2888-1G>A	7:g.116411902G>A
2835712	2835712	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2839891	2839891	MET	ENST00000318493.6	Yes	Erlotinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28961830		Previously Reported	Tumour Sample	Unknown		1			
2840307	2840307	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59097511	COSV51834362	COSM6503269	p.L673Q	c.2018T>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31632838		Variant of unknown origin	Tumour Sample	Unknown	7:55241705..55241705		ENSP00000415559.1:p.Leu673Gln	ENST00000455089.1:c.2018T>A	7:g.55241705T>A
2840776	2840776	KRAS_ENST00000311936	ENST00000311936.3	No	Panitumumab	25649084	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Arg	ENST00000311936.3:c.34G>C	12:g.25398285C>G
2840782	2840782	KRAS	ENST00000256078.4	Yes	Cetuximab	21548455	COSV55498802	COSM554	p.Q61H	c.183A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275	1	ENSP00000256078.4:p.Gln61His	ENST00000256078.4:c.183A>C	12:g.25380275T>G
2841752	2841752	ALK	ENST00000389048.3	Yes	Crizotinib	173864072		COSM9278966	p.C1156Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Cys1156Tyr		
Pat_41_B	2513797	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928730	COSV54736340	COSM584	p.Q61R	c.182A>G	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.182A>G	1:g.115256529T>C
SC-her2-045	2313865	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22655219	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000206249.3:p.Tyr537Asn	ENST00000206249.3:c.1609T>A	6:g.152419922T>A
Case_2-Relapse-WholeTumor	2730738	JAK2_ENST00000544510	ENST00000544510.1	No	Pembrolizumab	81765706	COSV67689878	COSM7337170	p.?	c.1194+2T>G	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Tumour Sample	Homozygous	9:5070054..5070054			ENST00000544510.1:c.1194+2T>G	9:g.5070054T>G
898242	898242	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	15728811		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
904143	904143	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
905445	905445	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
905448	905448	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
905488	905488	ABL1	ENST00000372348.2	Yes	Imatinib	36333345	COSV59339711	COSM12632	p.Q271H	c.813G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356	1	ENSP00000361423.2:p.Gln271His	ENST00000372348.2:c.813G>T	9:g.133738356G>T
WHIM23	2367162	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210579	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000387500.1:p.Tyr537Ser	ENST00000443427.1:c.1610A>C	6:g.152419923A>C
1000815	1000815	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1167316	1167316	KIT	ENST00000288135.5	Yes	Imatinib	173871406		COSM28690	p.S709F	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Variant of unknown origin	Tumour Sample	Unknown		1			
1211131	1211131	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1227039	1227039	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1227052	1227052	KIT	ENST00000288135.5	Yes	Imatinib	173863287		COSM24706	p.D820Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Tyr		
1235132	1235132	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1235136	1235136	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1350408	1350408	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1352423	1352423	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1355264	1355264	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1431299	1431299	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1431329	1431329	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1469808	1469808	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469820	1469820	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479876	1479876	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1547748	1547748	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1552641	1552641	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864293		COSM43364	p.L298V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown					
1552643	1552643	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1565816	1565816	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
1576795	1576795	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1655309	1655309	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
1655313	1655313	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Confirmed Somatic	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
1767051	1767051	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1816950	1816950	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1863609	1863609	FLT3	ENST00000241453.7	Yes	Quizartinib	20035285	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835Tyr	ENST00000241453.7:c.2503G>T	13:g.28592642C>A
1874590	1874590	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	23355941		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1928091	1928091	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992093	1992093	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1996274	1996274	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
2007325	2007325	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
2032216	2032216	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	24105277		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071712	2071712	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2071716	2071716	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472994	COSV59324360	COSM12577	p.G250E	c.749G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738349..133738349		ENSP00000323315.5:p.Gly250Glu	ENST00000318560.5:c.749G>A	9:g.133738349G>A
2088638	2088638	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2088644	2088644	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2161695	2161695	EGFR_ENST00000442591	ENST00000442591.1	No	Afatinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2313147	2313147	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2324036	2324036	ABL1	ENST00000372348.2	Yes	Nilotinib	36340039	COSV59329005	COSM4767371	p.T334V	c.1000_1001inv	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133748282..133748283	1	ENSP00000361423.2:p.Thr334Val	ENST00000372348.2:c.1000_1001inv	9:g.133748282_133748283inv
2428975	2428975	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429116	2429116	KIT	ENST00000288135.5	Yes	Imatinib	173863717		COSM5351737	p.(P627_G664)Xfs*?	c.(1880_1990)ins?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Variant of unknown origin	Tumour Sample	Unknown		1			
2430091	2430091	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	26308885		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2431455	2431455	KIT	ENST00000288135.5	Yes	Imatinib	25249036	COSV55396509	COSM5352270	p.N680K	c.2040T>G	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Variant of unknown origin	Tumour Sample	Unknown	4:55595550..55595550	1	ENSP00000288135.5:p.Asn680Lys	ENST00000288135.5:c.2040T>G	4:g.55595550T>G
2471412	2471412	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
2471426	2471426	NRAS	ENST00000369535.4	Yes	Dabrafenib	36928723	COSV54736383	COSM564	p.G12D	c.35G>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Unknown	1:115258747..115258747	1	ENSP00000358548.4:p.Gly12Asp	ENST00000369535.4:c.35G>A	1:g.115258747C>T
2585570	2585570	KRAS	ENST00000256078.4	Yes	Cetuximab	21547123	COSV55497479	COSM522	p.G12A	c.35G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553387		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Ala	ENST00000256078.4:c.35G>C	12:g.25398284C>G
2605636	2605636	MET	ENST00000318493.6	Yes	Crizotinib	173867670		COSM6024203	p.D1246H	c.?	lung	left	NS	carcinoma	adenocarcinoma	NS	27987579		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Asp1246His		
2635720	2635720	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2635723	2635723	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58447965	COSV51770694	COSM20891	p.G743S	c.2227G>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249088..55249088		ENSP00000395243.2:p.Gly743Ser	ENST00000454757.2:c.2227G>A	7:g.55249088G>A
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58464310	COSV51832120	COSM6493935	p.G743R	c.2227G>C	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249088..55249088		ENSP00000395243.2:p.Gly743Arg	ENST00000454757.2:c.2227G>C	7:g.55249088G>C
2664344	2664344	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2822953	2822953	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	29807405		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2835712	2835712	BTK	ENST00000308731.7	Yes	Ibrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2838942	2838942	KRAS	ENST00000256078.4	Yes	Panitumumab	21547675	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Arg	ENST00000256078.4:c.34G>C	12:g.25398285C>G
2840782	2840782	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85397552	COSV55498802	COSM554	p.?	c.112-17430A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275			ENST00000557334.1:c.112-17430A>C	12:g.25380275T>G
SC-her2-025	2313847	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
SC-her2-071	2313875	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862717	COSV52783938	COSM1074639	p.Y425S	c.1274A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Ser	ENST00000456483.2:c.1274A>C	6:g.152419923A>C
3	1330179	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648435	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000308495.3:p.Gly13Asp	ENST00000311936.3:c.38G>A	12:g.25398281C>T
903868	903868	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
904112	904112	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
904115	904115	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
904116	904116	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
904121	904121	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
904293	904293	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
905493	905493	ABL1	ENST00000372348.2	Yes	Imatinib	36322452	COSV59323734	COSM12575	p.F336L	c.1008C>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748290..133748290	1	ENSP00000361423.2:p.Phe336Leu	ENST00000372348.2:c.1008C>G	9:g.133748290C>G
909229	909229	KIT	ENST00000288135.5	Yes	Imatinib	25228597	COSV55387253	COSM12710	p.D820Y	c.2458G>T	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15685537		Previously Reported	Tumour Sample	Heterozygous	4:55599332..55599332	1	ENSP00000288135.5:p.Asp820Tyr	ENST00000288135.5:c.2458G>T	4:g.55599332G>T
1024758	1024758	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1031896	1031896	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1103803	1103803	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1103809	1103809	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1103809	1103809	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1108052	1108052	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	17973572		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1211136	1211136	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350409	1350409	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350486	1350486	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173872232		COSM43372	p.E459G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Gly		
1351419	1351419	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1352425	1352425	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1355268	1355268	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1355325	1355325	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355327	1355327	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1426020	1426020	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1479880	1479880	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21156844		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1498575	1498575	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1543744	1543744	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
1576785	1576785	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1601929	1601929	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	22108465		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795105	1795105	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1815766	1815766	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173869607		COSM1159625	p.L387F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Phe		
1844079	1844079	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1968558	1968558	KRAS	ENST00000256078.4	Yes	Panitumumab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	ascending	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
1989319	1989319	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Variant of unknown origin	Tumour Sample	Unknown					
1992089	1992089	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1992095	1992095	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1996304	1996304	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2088643	2088643	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2161695	2161695	NF2_ENST00000361166	ENST00000361166.4	No	Afatinib	32813647	COSV58519797	COSM22432	p.R198*	c.592C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000354529.4:p.Arg198Ter	ENST00000361166.4:c.592C>T	22:g.30051658C>T
2161695	2161695	NF2_ENST00000361452	ENST00000361452.4	No	Afatinib	33777198	COSV58519797	COSM22432	p.R157*	c.469C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Previously Reported	Tumour Sample	Unknown	22:30051658..30051658		ENSP00000354897.4:p.Arg157Ter	ENST00000361452.4:c.469C>T	22:g.30051658C>T
2313147	2313147	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2396137	2396137	ALK	ENST00000389048.3	Yes	Ceritinib	40319110	COSV66561781	COSM5045108	p.G1123S	c.3367G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	26134233		Variant of unknown origin	Tumour Sample	Homozygous	2:29445466..29445466	1	ENSP00000373700.3:p.Gly1123Ser	ENST00000389048.3:c.3367G>A	2:g.29445466C>T
2426854	2426854	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2430142	2430142	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	26130666		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2431439	2431439	KIT	ENST00000288135.5	Yes	Imatinib	173865353		COSM28692	p.D820G	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp820Gly		
2431445	2431445	KIT	ENST00000288135.5	Yes	Imatinib	25231390	COSV55410040	COSM12708	p.T670I	c.2009C>T	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	25886408		Previously Reported	Tumour Sample	Unknown	4:55595519..55595519	1	ENSP00000288135.5:p.Thr670Ile	ENST00000288135.5:c.2009C>T	4:g.55595519C>T
2517295	2517295	BRAF	ENST00000288602.6	Yes	Vemurafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	26101714		Variant of unknown origin	Cultured	Unknown		1			
2531276	2531276	FLT3	ENST00000241453.7	Yes	Sorafenib	20035351	COSV54042636	COSM785	p.D835H	c.2503G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	23969938		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642	1	ENSP00000241453.7:p.Asp835His	ENST00000241453.7:c.2503G>C	13:g.28592642C>G
2542368	2542368	MAP2K1	ENST00000307102.5	Yes	Cetuximab	24778562	COSV61068437	COSM4756761	p.K57T	c.170A>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	26644315		Previously Reported	Tumour Sample	Unknown	15:66727454..66727454	1	ENSP00000302486.4:p.Lys57Thr	ENST00000307102.5:c.170A>C	15:g.66727454A>C
2582955	2582955	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	transformed_to_small_cell_carcinoma	28031840		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2591345	2591345	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2651874	2651874	EGFR_ENST00000455089	ENST00000455089.1	No	Osimertinib	59097511	COSV51834362	COSM6503269	p.L673Q	c.2018T>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Variant of unknown origin	Tumour Sample	Homozygous	7:55241705..55241705		ENSP00000415559.1:p.Leu673Gln	ENST00000455089.1:c.2018T>A	7:g.55241705T>A
2664343	2664343	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2776123	2776123	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395953	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	25137394		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000452512.1:p.Gly12Asp	ENST00000557334.1:c.35G>A	12:g.25398284C>T
2819302	2819302	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2819309	2819309	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51311661	COSV66557991	COSM1169707	p.?	c.792-1771G>C	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	epithelioid_inflammatory_myofibroblastic_sarcoma	NS	NS	30675302		Variant of unknown origin	Tumour Sample	Unknown	2:29432682..29432682			ENST00000431873.1:c.792-1771G>C	2:g.29432682C>G
2835714	2835714	BTK	ENST00000308731.7	Yes	Ibrutinib	26369119	COSV58117871	COSM6053937	p.C481S	c.1441T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1441T>A	X:g.100611165A>T
2835721	2835721	BTK	ENST00000308731.7	Yes	Ibrutinib	26369565	COSV58122597	COSM6053939	p.C481Y	c.1442G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Tyr	ENST00000308731.7:c.1442G>A	X:g.100611164C>T
2841750	2841750	ALK	ENST00000389048.3	Yes	Crizotinib	173864073		COSM88796	p.F1174L	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Phe1174Leu		
2843086	2843086	ALK	ENST00000389048.3	Yes	Alectinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
Pat_63_B	2492903	MAP2K2_ENST00000394867	ENST00000394867.4	No	Vemurafenib	45629437	COSV53565416	COSM5855814	p.C28S	c.82T>A	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4110584..4110584		ENSP00000378336.1:p.Cys28Ser	ENST00000394867.4:c.82T>A	19:g.4110584A>T
SC-her2-019	2313843	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230771	COSV52781024	COSM94250	p.D277G	c.830A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000384064.1:p.Asp277Gly	ENST00000406599.1:c.830A>G	6:g.152419926A>G
RPC-9	1083085	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17699786		Previously Reported	Cultured	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
904130	904130	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
904136	904136	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868735		COSM12625	p.M343T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown					
905489	905489	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469595	COSV59323765	COSM12609	p.Q252H	c.756G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738356..133738356		ENSP00000323315.5:p.Gln252His	ENST00000318560.5:c.756G>C	9:g.133738356G>C
924446	924446	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16198442		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
MGH970	2824341	ALK	ENST00000389048.3	Yes	Ceritinib	173864107		COSM4422789	p.G1202R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Previously Reported	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1202Arg		
1000816	1000816	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1024765	1024765	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17020982		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1350398	1350398	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1350483	1350483	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173873123		COSM43370	p.A433T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown					
1355280	1355280	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1431311	1431311	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1468060	1468060	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1468063	1468063	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469789	1469789	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543107	1543107	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1552654	1552654	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1576791	1576791	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1584482	1584482	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1655341	1655341	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
1815786	1815786	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1844065	1844065	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864177		COSM1169205	p.F317I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1844083	1844083	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1863605	1863605	FLT3_ENST00000537084	ENST00000537084.1	No	Quizartinib	78706549	COSV54042199	COSM784	p.?	c.2419-2803A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641			ENST00000537084.1:c.2419-2803A>T	13:g.28592641T>A
1928072	1928072	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968558	1968558	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85395930	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	ascending	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281		ENSP00000452512.1:p.Gly13Asp	ENST00000557334.1:c.38G>A	12:g.25398281C>T
1992089	1992089	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1996313	1996313	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
2007335	2007335	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23433665		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2027738	2027738	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2313880	2313880	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2318494	2318494	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2429268	2429268	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
2483267	2483267	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	abdomen	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2517294	2517294	NRAS	ENST00000369535.4	Yes	Vemurafenib	173862661		COSM28049	p.Q61K	c.?	skin	NS	NS	malignant_melanoma	NS	NS	26101714		Previously Reported	Cultured	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2531266	2531266	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Trp535Leu		
2539199	2539199	AR	ENST00000374690.3	Yes	Flutamide	38868827	COSV65961491	COSM5945721	p.Q641*	c.1921C>T	prostate	NS	NS	carcinoma	NS	NS	14618630		Variant of unknown origin	Tumour Sample	Unknown	X:66931279..66931279	1	ENSP00000363822.3:p.Gln641Ter	ENST00000374690.3:c.1921C>T	X:g.66931279C>T
2552452	2552452	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27553514		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2584886	2584886	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862744		COSM14201	p.Q61H	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gln61His		
2635652	2635652	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22655219	COSV52784978	COSM1074635	p.Y537N	c.1609T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000206249.3:p.Tyr537Asn	ENST00000206249.3:c.1609T>A	6:g.152419922T>A
2635722	2635722	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
2635722	2635722	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654496	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000206249.3:p.Tyr537Ser	ENST00000206249.3:c.1610A>C	6:g.152419923A>C
2637198	2637198	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457096	COSV52782924	COSM1074637	p.Y537C	c.1610A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Cys	ENST00000338799.5:c.1610A>G	6:g.152419923A>G
2642912	2642912	MET	ENST00000318493.6	Yes	Crizotinib	173862935		COSM6024204	p.D1246N	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28522754		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000317272.6:p.Asp1246Asn		
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23283678	COSV51770694	COSM20891	p.G796S	c.2386G>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249088..55249088	1	ENSP00000275493.2:p.Gly796Ser	ENST00000275493.2:c.2386G>A	7:g.55249088G>A
2651873	2651873	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	27257132		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2838944	2838944	KRAS	ENST00000256078.4	Yes	Panitumumab	21547060	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Cys	ENST00000256078.4:c.34G>T	12:g.25398285C>A
2838948	2838948	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85396135	COSV55497461	COSM517	p.G12S	c.34G>A	large_intestine	colon	NS	carcinoma	adenocarcinoma	NS	22722843		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Ser	ENST00000557334.1:c.34G>A	12:g.25398285C>T
2840774	2840774	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25649084	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Arg	ENST00000311936.3:c.34G>C	12:g.25398285C>G
GIST004	1311149	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20028860		Previously Reported	Cultured	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
MGH086-0	2831780	ALK	ENST00000389048.3	Yes	Brigatinib	173870550		COSM9311656	p.S1206C	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27432227		Variant of unknown origin	Tumour Sample	Unknown		1			
Pat_76_B	2492913	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20971561	COSV53566961	COSM1731742	p.N126D	c.376A>G	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	19:4110581..4110581	1	ENSP00000262948.3:p.Asn126Asp	ENST00000262948.5:c.376A>G	19:g.4110581T>C
7B	2479673	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	23348204		Previously Reported	Tumour Sample	Homozygous		1	ENSP00000288135.5:p.Val654Ala		
903863	903863	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476611	COSV59324877	COSM12564	p.H396P	c.1187A>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133750356..133750356		ENSP00000323315.5:p.His396Pro	ENST00000318560.5:c.1187A>C	9:g.133750356A>C
904305	904305	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471079	COSV59325892	COSM12611	p.E355G	c.1064A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403		ENSP00000323315.5:p.Glu355Gly	ENST00000318560.5:c.1064A>G	9:g.133748403A>G
905175	905175	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
905176	905176	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27469699	COSV59324758	COSM12605	p.F359V	c.1075T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748414..133748414		ENSP00000323315.5:p.Phe359Val	ENST00000318560.5:c.1075T>G	9:g.133748414T>G
1000817	1000817	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1103809	1103809	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1167392	1167392	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
1227053	1227053	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1235136	1235136	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350397	1350397	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1350419	1350419	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1350436	1350436	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1351422	1351422	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1351679	1351679	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1351679	1351679	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
1351692	1351692	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864695		COSM12622	p.Y253F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253Phe		
1351706	1351706	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868276		COSM43384	p.E352D	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1351707	1351707	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864434		COSM12669	p.E352G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown					
1355279	1355279	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863245		COSM43367	p.F359C	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Cys		
1355294	1355294	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1431305	1431305	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1431306	1431306	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1468067	1468067	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469817	1469817	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469863	1469863	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1479879	1479879	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21156844		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1498577	1498577	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543754	1543754	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864993		COSM43380	p.L273M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Variant of unknown origin	Tumour Sample	Unknown					
1552657	1552657	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
1565824	1565824	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36323549	COSV59323752	COSM12602	p.D295G	c.884A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Previously Reported	Tumour Sample	Unknown	9:133747520..133747520	1	ENSP00000361423.2:p.Asp295Gly	ENST00000372348.2:c.884A>G	9:g.133747520A>G
1576792	1576792	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1618784	1618784	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1795101	1795101	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23053188		Variant of unknown origin	Tumour Sample	Unknown					
1816948	1816948	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23180674		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1859881	1859881	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51316332	COSV66556435	COSM99137	p.?	c.792-12720C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	23344087		Previously Reported	Tumour Sample	Homozygous	2:29443631..29443631			ENST00000431873.1:c.792-12720C>A	2:g.29443631G>T
1885387	1885387	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51324562	COSV66562303	COSM99136	p.?	c.792-14347G>A	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23434628		Confirmed Somatic	Tumour Sample	Unknown	2:29445258..29445258			ENST00000431873.1:c.792-14347G>A	2:g.29445258C>T
1928085	1928085	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1928096	1928096	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1992085	1992085	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2027860	2027860	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2071711	2071711	ABL1	ENST00000372348.2	Yes	Imatinib	36321596	COSV59334206	COSM12608	p.M263V	c.787A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738330..133738330	1	ENSP00000361423.2:p.Met263Val	ENST00000372348.2:c.787A>G	9:g.133738330A>G
2071739	2071739	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27476494	COSV59327102	COSM1460549	p.E459G	c.1376A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753907..133753907		ENSP00000323315.5:p.Glu459Gly	ENST00000318560.5:c.1376A>G	9:g.133753907A>G
2426833	2426833	EGFR	ENST00000275493.2	Yes	Osimertinib	173866287		COSM5010368	p.C797S	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	25939061		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Cys797Ser		
2444265	2444265	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2466812	2466812	BRAF	ENST00000288602.6	Yes	Dabrafenib	173863357		COSM5546575	p.?	c.139_1140del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Unknown		1			
2466822	2466822	BRAF	ENST00000288602.6	Yes	Vemurafenib	173863357		COSM5546575	p.?	c.139_1140del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Unknown		1			
2471425	2471425	MAP2K2	ENST00000262948.5	Yes	Dabrafenib	20972857	COSV53562848	COSM232757	p.E207K	c.619G>A	skin	NS	NS	malignant_melanoma	NS	NS	25452114		Previously Reported	Tumour Sample	Heterozygous	19:4101103..4101103	1	ENSP00000262948.3:p.Glu207Lys	ENST00000262948.5:c.619G>A	19:g.4101103C>T
2476858	2476858	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2538518	2538518	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2538636	2538636	AR_ENST00000396043	ENST00000396043.2	No	Abiraterone	43285476	COSV65953150	COSM236693	p.T346A	c.1036A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379358.2:p.Thr346Ala	ENST00000396043.2:c.1036A>G	X:g.66943552A>G
2546463	2546463	AR	ENST00000374690.3	Yes	Flutamide	38851267	COSV65953150	COSM236693	p.T878A	c.2632A>G	prostate	NS	NS	carcinoma	NS	NS	12860943		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552	1	ENSP00000363822.3:p.Thr878Ala	ENST00000374690.3:c.2632A>G	X:g.66943552A>G
2584906	2584906	NRAS	ENST00000369535.4	Yes	Cetuximab	173862661		COSM28049	p.Q61K	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gln61Lys		
2591445	2591445	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2635652	2635652	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48231377	COSV52784978	COSM1074635	p.Y276N	c.826T>A	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419922..152419922		ENSP00000384064.1:p.Tyr276Asn	ENST00000406599.1:c.826T>A	6:g.152419922T>A
2635720	2635720	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
2635723	2635723	ESR1_ENST00000206249	ENST00000206249.3	No	Endocrine therapy	22654120	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000206249.3:p.Asp538Gly	ENST00000206249.3:c.1613A>G	6:g.152419926A>G
2763255	2763255	ALK	ENST00000389048.3	Yes	Crizotinib	40295553	COSV66582675	COSM98475	p.G1128A	c.3383G>C	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	30089600		Variant of unknown origin	Tumour Sample	Heterozygous	2:29445450..29445450	1	ENSP00000373700.3:p.Gly1128Ala	ENST00000389048.3:c.3383G>C	2:g.29445450C>G
2816899	2816899	FGFR4_ENST00000393648	ENST00000393648.2	No	Fisogatinib	44121766	COSV104624868	COSM9274136	p.C484R	c.1450T>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Variant of unknown origin	Tumour Sample	Unknown	5:176522557..176522557		ENSP00000377259.2:p.Cys484Arg	ENST00000393648.2:c.1450T>C	5:g.176522557T>C
2840780	2840780	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648472	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000308495.3:p.Gly12Cys	ENST00000311936.3:c.34G>T	12:g.25398285C>A
2841768	2841768	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
SC-her2-005	2313835	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280568	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419923..152419923	1	ENSP00000405330.1:p.Tyr537Ser	ENST00000440973.1:c.1610A>C	6:g.152419923A>C
SC-her2-014	2313840	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
904069	904069	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
904126	904126	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
904129	904129	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862757		COSM12624	p.L387M	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12204532		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu387Met		
904269	904269	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
905166	905166	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
905173	905173	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905457	905457	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27477233	COSV59325186	COSM12630	p.F486S	c.1457T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133755488..133755488		ENSP00000323315.5:p.Phe486Ser	ENST00000318560.5:c.1457T>C	9:g.133755488T>C
905491	905491	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
924446	924446	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	16198442		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
WHIM23	2367162	ESR1_ENST00000406599	ENST00000406599.1	No	Endocrine therapy	48230961	COSV52783938	COSM1074639	p.Y276S	c.827A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000384064.1:p.Tyr276Ser	ENST00000406599.1:c.827A>C	6:g.152419923A>C
1043871	1043871	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	mixed_adenosquamous_carcinoma	NS	17192902		Previously Reported	NS	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1103805	1103805	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1122168	1122168	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	18379370		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1167350	1167350	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16551858		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1211143	1211143	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1227036	1227036	KIT	ENST00000288135.5	Yes	Imatinib	173863121		COSM28482	p.A829P	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Ala829Pro		
1227038	1227038	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1227040	1227040	KIT	ENST00000288135.5	Yes	Imatinib	173864791		COSM24640	p.N822Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Tyr		
1235132	1235132	EGFR_ENST00000454757	ENST00000454757.2	No	Gefitinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19589612		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1349871	1349871	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	19156415		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1350444	1350444	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1350457	1350457	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1352410	1352410	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1352424	1352424	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1431290	1431290	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869809		COSM49138	p.E355X	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1431301	1431301	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1431327	1431327	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1469809	1469809	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469865	1469865	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498623	1498623	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1526365	1526365	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21623281		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547790	1547790	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552656	1552656	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864803		COSM43385	p.F359I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Ile		
1576789	1576789	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
1584488	1584488	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21961412		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1655317	1655317	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27471205	COSV59333676	COSM211607	p.F317V	c.949T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133748288..133748288		ENSP00000323315.5:p.Phe317Val	ENST00000318560.5:c.949T>G	9:g.133748288T>G
1655339	1655339	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20367437		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
1731104	1731104	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22815900		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767028	1767028	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1844105	1844105	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173871505		COSM1169210	p.F317V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Val		
1863605	1863605	FLT3	ENST00000241453.7	Yes	Quizartinib	20035364	COSV54042199	COSM784	p.D835V	c.2504A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592641..28592641	1	ENSP00000241453.7:p.Asp835Val	ENST00000241453.7:c.2504A>T	13:g.28592641T>A
1928095	1928095	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968570	1968570	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
1996280	1996280	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
2071723	2071723	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
2071728	2071728	ABL1	ENST00000372348.2	Yes	Imatinib	36329831	COSV59336536	COSM1732693	p.L406F	c.1218G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133750330..133750330	1	ENSP00000361423.2:p.Leu406Phe	ENST00000372348.2:c.1218G>C	9:g.133750330G>C
2071730	2071730	ABL1	ENST00000372348.2	Yes	Imatinib	36323146	COSV59325892	COSM12611	p.E374G	c.1121A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403	1	ENSP00000361423.2:p.Glu374Gly	ENST00000372348.2:c.1121A>G	9:g.133748403A>G
2088649	2088649	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
2255307	2255307	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2275242	2275242	SMO	ENST00000249373.3	Yes	Vismodegib	22236134	COSV50829974	COSM4413609	p.G497W	c.1489G>T	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25306392		Previously Reported	Tumour Sample	Unknown	7:128850226..128850226	1	ENSP00000249373.3:p.Gly497Trp	ENST00000249373.3:c.1489G>T	7:g.128850226G>T
2293728	2293728	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51327825	COSV66564577	COSM4381100	p.?	c.792-14302T>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	25393798		Variant of unknown origin	Tumour Sample	Heterozygous	2:29445213..29445213			ENST00000431873.1:c.792-14302T>C	2:g.29445213A>G
2358404	2358404	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862811		COSM12619	p.E355G	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25740611		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu355Gly		
2429243	2429243	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2466777	2466777	BRAF	ENST00000288602.6	Yes	Dabrafenib	173864720		COSM5546573	p.?	c.139-?_1314+?del	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Variant of unknown origin	Tumour Sample	Unknown		1			
2476842	2476842	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2476860	2476860	EGFR	ENST00000275493.2	Yes	Afatinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	26862733		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531522	2531522	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	NS	Unknown		1	ENSP00000249373.3:p.Trp535Leu		
2664328	2664328	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2664346	2664346	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2819306	2819306	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2835709	2835709	BTK_ENST00000372880	ENST00000372880.1	No	Acalabrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2835721	2835721	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812019	COSV58122597	COSM6053939	p.?	c.1039-1482G>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>A	X:g.100611164C>T
2840774	2840774	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25654383	COSV55499223	COSM555	p.Q61H	c.183A>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380275..25380275		ENSP00000308495.3:p.Gln61His	ENST00000311936.3:c.183A>T	12:g.25380275T>A
2841748	2841748	ALK	ENST00000389048.3	Yes	Crizotinib	173864936		COSM9306547	p.I1171T	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ile1171Thr		
2841756	2841756	ALK	ENST00000389048.3	Yes	Crizotinib	173863782		COSM4422787	p.G1269A	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Gly1269Ala		
4	1330180	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	25648467	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	colon	transverse	carcinoma	adenocarcinoma	NS	20361188		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000308495.3:p.Gly12Asp	ENST00000311936.3:c.35G>A	12:g.25398284C>T
24A	1069285	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	spindle	NS	15930355		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
BCC11	2531238	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000249373.3:p.Trp535Leu		
905164	905164	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
905451	905451	ABL1	ENST00000372348.2	Yes	Imatinib	36329827	COSV59325906	COSM12578	p.M370T	c.1109T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748391..133748391	1	ENSP00000361423.2:p.Met370Thr	ENST00000372348.2:c.1109T>C	9:g.133748391T>C
905498	905498	ABL1	ENST00000372348.2	Yes	Imatinib	36323146	COSV59325892	COSM12611	p.E374G	c.1121A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133748403..133748403	1	ENSP00000361423.2:p.Glu374Gly	ENST00000372348.2:c.1121A>G	9:g.133748403A>G
1031893	1031893	EGFR	ENST00000275493.2	Yes	Gefitinib	23271979	COSV51772923	COSM21984	p.D761Y	c.2281G>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	17085664		Confirmed Somatic	Tumour Sample	Heterozygous	7:55242511..55242511	1	ENSP00000275493.2:p.Asp761Tyr	ENST00000275493.2:c.2281G>T	7:g.55242511G>T
1103807	1103807	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	18271876		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211141	1211141	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1211144	1211144	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1227057	1227057	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1278400	1278400	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	19596957		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1350451	1350451	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1351684	1351684	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863396		COSM12670	p.L248V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Leu248Val		
1351716	1351716	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173869086		COSM43386	p.H396P	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Pro		
1355279	1355279	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355304	1355304	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1431276	1431276	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1431318	1431318	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864293		COSM43364	p.L298V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1444573	1444573	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	20686428		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469852	1469852	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1547752	1547752	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1547766	1547766	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552654	1552654	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1591008	1591008	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	22052230		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767019	1767019	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1794533	1794533	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1794534	1794534	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23086624		Variant of unknown origin	Tumour Sample	Unknown					
1859881	1859881	ALK	ENST00000389048.3	Yes	Crizotinib	40285692	COSV66557991	COSM1169707	p.G1269A	c.3806G>C	lung	NS	NS	carcinoma	adenocarcinoma	NS	23344087		Variant of unknown origin	Tumour Sample	Homozygous	2:29432682..29432682	1	ENSP00000373700.3:p.Gly1269Ala	ENST00000389048.3:c.3806G>C	2:g.29432682C>G
1863605	1863605	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39661192	COSV54045249	COSM19844	p.D835F	c.2503_2504delinsTT	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Variant of unknown origin	Tumour Sample	Unknown	13:28592641..28592642		ENSP00000370369.4:p.Asp835Phe	ENST00000380982.4:c.2503_2504delinsTT	13:g.28592641_28592642delinsAA
1928084	1928084	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968560	1968560	KRAS	ENST00000256078.4	Yes	Cetuximab	21547014	COSV55497388	COSM532	p.G13D	c.38G>A	large_intestine	colon	sigmoid	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398281..25398281	1	ENSP00000256078.4:p.Gly13Asp	ENST00000256078.4:c.38G>A	12:g.25398281C>T
1996319	1996319	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864469		COSM12620	p.F359V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23799845		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe359Val		
2071717	2071717	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472839	COSV59325175	COSM12576	p.Y253H	c.757T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357		ENSP00000323315.5:p.Tyr253His	ENST00000318560.5:c.757T>C	9:g.133738357T>C
2071728	2071728	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27474657	COSV59336536	COSM1732693	p.L387F	c.1161G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133750330..133750330		ENSP00000323315.5:p.Leu387Phe	ENST00000318560.5:c.1161G>C	9:g.133750330G>C
2255314	2255314	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
2318494	2318494	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2396139	2396139	EGFR_ENST00000442591	ENST00000442591.1	No	Erlotinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	left_bronchus	NS	carcinoma	adenocarcinoma	NS	24942894		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
2428977	2428977	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	20043176		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2429269	2429269	KIT	ENST00000288135.5	Yes	Imatinib	173862559		COSM24708	p.T670I	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Thr670Ile		
2429893	2429893	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	26413254		Variant of unknown origin	Tumour Sample	Heterozygous	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
2468266	2468266	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173865042		COSM5413590	p.Y537C	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Tyr537Cys		
2482435	2482435	KIT	ENST00000288135.5	Yes	Imatinib	173863901		COSM28481	p.D816E	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	18452195		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asp816Glu		
2484530	2484530	KIT	ENST00000288135.5	Yes	Imatinib	173864791		COSM24640	p.N822Y	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Tyr		
2531520	2531520	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	NS	Unknown		1	ENSP00000249373.3:p.Trp535Leu		
2538450	2538450	AR_ENST00000396044	ENST00000396044.3	No	Abiraterone	43304491	COSV65953150	COSM236693	p.H733R	c.2198A>G	prostate	NS	NS	carcinoma	adenocarcinoma	NS	26537258		Confirmed Somatic	Tumour Sample	Unknown	X:66943552..66943552		ENSP00000379359.3:p.His733Arg	ENST00000396044.3:c.2198A>G	X:g.66943552A>G
2584882	2584882	NRAS	ENST00000369535.4	Yes	Cetuximab	173872802		COSM46507	p.G60R	c.?	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1	ENSP00000358548.4:p.Gly60Arg		
2608487	2608487	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812030	COSV58117643	COSM6053936	p.?	c.1039-1483T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	28235842		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>C	X:g.100611165A>G
2623673	2623673	BTK	ENST00000308731.7	Yes	Ibrutinib	26370964	COSV58118015	COSM6191212	p.T316A	c.946A>G	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	27626698		Variant of unknown origin	Tumour Sample	Heterozygous	X:100613633..100613633	1	ENSP00000308176.7:p.Thr316Ala	ENST00000308731.7:c.946A>G	X:g.100613633T>C
2644798	2644798	EGFR	ENST00000275493.2	Yes	Erlotinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2644799	2644799	EGFR_ENST00000454757	ENST00000454757.2	No	Osimertinib	58449222	COSV51766493	COSM6493937	p.C744S	c.2230T>A	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091		ENSP00000395243.2:p.Cys744Ser	ENST00000454757.2:c.2230T>A	7:g.55249091T>A
2664328	2664328	MET	ENST00000318493.6	Yes	Gefitinib	173862802		COSM1737868	p.?	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1			
2664378	2664378	CTNNB1_ENST00000396185	ENST00000396185.3	No	Imatinib	43913450	COSV62687839	COSM5677	p.S33C	c.98C>G	skin	NS	NS	malignant_melanoma	acral_lentiginous	NS	28421416		Previously Reported	Tumour Sample	Unknown	3:41266101..41266101		ENSP00000379488.3:p.Ser33Cys	ENST00000396185.3:c.98C>G	3:g.41266101C>G
2763255	2763255	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51319936	COSV66582675	COSM98475	p.?	c.792-14539G>C	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	30089600		Variant of unknown origin	Tumour Sample	Heterozygous	2:29445450..29445450			ENST00000431873.1:c.792-14539G>C	2:g.29445450C>G
2824344	2824344	ALK	ENST00000389048.3	Yes	Lorlatinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	31749991		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
2840784	2840784	NRAS	ENST00000369535.4	Yes	Cetuximab	36928730	COSV54736340	COSM584	p.Q61R	c.182A>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.182A>G	1:g.115256529T>C
Pt55_resistant_DP1	1545628	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928743	COSV54736310	COSM580	p.Q61K	c.181C>A	skin	NS	NS	malignant_melanoma	NS	NS	21107323		Confirmed Somatic	Tumour Sample	Unknown	1:115256530..115256530	1	ENSP00000358548.4:p.Gln61Lys	ENST00000369535.4:c.181C>A	1:g.115256530G>T
903854	903854	ABL1	ENST00000372348.2	Yes	Imatinib	36319367	COSV59325003	COSM12574	p.E274V	c.821A>T	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	11853795		Variant of unknown origin	Tumour Sample	Homozygous	9:133738364..133738364	1	ENSP00000361423.2:p.Glu274Val	ENST00000372348.2:c.821A>T	9:g.133738364A>T
904071	904071	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	11964322		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
904273	904273	ABL1	ENST00000372348.2	Yes	Imatinib	36326762	COSV59325175	COSM12576	p.Y272H	c.814T>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738357..133738357	1	ENSP00000361423.2:p.Tyr272His	ENST00000372348.2:c.814T>C	9:g.133738357T>C
904283	904283	ABL1	ENST00000372348.2	Yes	Imatinib	36319367	COSV59325003	COSM12574	p.E274V	c.821A>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Variant of unknown origin	Tumour Sample	Unknown	9:133738364..133738364	1	ENSP00000361423.2:p.Glu274Val	ENST00000372348.2:c.821A>T	9:g.133738364A>T
904293	904293	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
905169	905169	ABL1	ENST00000372348.2	Yes	Imatinib	36325997	COSV59325418	COSM12573	p.E274K	c.820G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	14745431		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363	1	ENSP00000361423.2:p.Glu274Lys	ENST00000372348.2:c.820G>A	9:g.133738363G>A
905450	905450	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27472363	COSV59325418	COSM12573	p.E255K	c.763G>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133738363..133738363		ENSP00000323315.5:p.Glu255Lys	ENST00000318560.5:c.763G>A	9:g.133738363G>A
905454	905454	ABL1	ENST00000372348.2	Yes	Imatinib	36322434	COSV59323744	COSM12604	p.H415R	c.1244A>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Variant of unknown origin	Tumour Sample	Unknown	9:133750356..133750356	1	ENSP00000361423.2:p.His415Arg	ENST00000372348.2:c.1244A>G	9:g.133750356A>G
WHIM23	2367162	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30457224	COSV52783938	COSM1074639	p.Y537S	c.1610A>C	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24055055		Confirmed Somatic	Cultured	Unknown	6:152419923..152419923		ENSP00000342630.5:p.Tyr537Ser	ENST00000338799.5:c.1610A>C	6:g.152419923A>C
1000817	1000817	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	right_lower_lobe	NS	carcinoma	adenocarcinoma	NS	16983123		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
1349870	1349870	ABL1_ENST00000318560	ENST00000318560.5	No	Nilotinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	19156415		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1350412	1350412	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1350420	1350420	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1351673	1351673	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864887		COSM12616	p.Q252H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Gln252His		
1352415	1352415	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355273	1355273	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1355276	1355276	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1428818	1428818	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1431288	1431288	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1431320	1431320	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863617		COSM43378	p.E450A	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1469854	1469854	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469861	1469861	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498576	1498576	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1543118	1543118	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21221851		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1552638	1552638	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1565834	1565834	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36324786	COSV59325471	COSM131574	p.L406M	c.1216T>A	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21895409		Variant of unknown origin	Tumour Sample	Unknown	9:133750328..133750328	1	ENSP00000361423.2:p.Leu406Met	ENST00000372348.2:c.1216T>A	9:g.133750328T>A
1576783	1576783	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1576794	1576794	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1576799	1576799	EGFR_ENST00000442591	ENST00000442591.1	No	Tyrosine kinase inhibitor - NS	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1633981	1633981	ALK_ENST00000431873	ENST00000431873.1	No	Crizotinib	51308124	COSV66555808	COSM144250	p.?	c.792-12702G>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	22277784		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613			ENST00000431873.1:c.792-12702G>A	2:g.29443613C>T
1656922	1656922	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864435		COSM43365	p.F311I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	21264552		Confirmed Somatic	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe311Ile		
1767022	1767022	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1844094	1844094	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1844104	1844104	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862939		COSM12607	p.F317L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Phe317Leu		
1844108	1844108	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1863617	1863617	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
1928082	1928082	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	22718859		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
1968570	1968570	KRAS	ENST00000256078.4	Yes	Cetuximab	21547048	COSV55497369	COSM521	p.G12D	c.35G>A	large_intestine	rectum	NS	carcinoma	adenocarcinoma	NS	22722830		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284	1	ENSP00000256078.4:p.Gly12Asp	ENST00000256078.4:c.35G>A	12:g.25398284C>T
1992094	1992094	EGFR_ENST00000455089	ENST00000455089.1	No	Gefitinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2027750	2027750	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2035481	2035481	EGFR_ENST00000454757	ENST00000454757.2	No	Erlotinib	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	left_upper_lobe	NS	carcinoma	adenocarcinoma	NS	24034463		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2071709	2071709	ABL1	ENST00000372348.2	Yes	Imatinib	36321627	COSV59336290	COSM1732692	p.E472A	c.1415A>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133753889..133753889	1	ENSP00000361423.2:p.Glu472Ala	ENST00000372348.2:c.1415A>C	9:g.133753889A>C
2071725	2071725	ABL1	ENST00000372348.2	Yes	Imatinib	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
2071734	2071734	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470960	COSV59326146	COSM1732691	p.F359C	c.1076T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23676790		Variant of unknown origin	Tumour Sample	Unknown	9:133748415..133748415		ENSP00000323315.5:p.Phe359Cys	ENST00000318560.5:c.1076T>G	9:g.133748415T>G
2088651	2088651	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
2161695	2161695	NF2_ENST00000347330	ENST00000347330.5	No	Afatinib	30972360	COSV58528760	COSM3735038	p.?	c.334-2A>T	lung	NS	NS	carcinoma	bronchioloalveolar_adenocarcinoma	NS	24813888		Variant of unknown origin	Tumour Sample	Unknown	22:30060977..30060977			ENST00000347330.5:c.334-2A>T	22:g.30060977A>T
2255309	2255309	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	25281405		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
2313878	2313878	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862599	COSV52782924	COSM1074637	p.Y425C	c.1274A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419923..152419923		ENSP00000415934.2:p.Tyr425Cys	ENST00000456483.2:c.1274A>G	6:g.152419923A>G
2313880	2313880	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2318491	2318491	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30468556	COSV52785937	COSM4766050	p.L536Q	c.1607_1608delinsAG	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185510		Confirmed Somatic	Tumour Sample	Unknown	6:152419920..152419921		ENSP00000342630.5:p.Leu536Gln	ENST00000338799.5:c.1607_1608delinsAG	6:g.152419920_152419921delinsAG
2324034	2324034	ABL1	ENST00000372348.2	Yes	Bosutinib	36335504	COSV59324500	COSM4767370	p.L267R	c.800T>G	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	23044928		Variant of unknown origin	Tumour Sample	Homozygous	9:133738343..133738343	1	ENSP00000361423.2:p.Leu267Arg	ENST00000372348.2:c.800T>G	9:g.133738343T>G
2444267	2444267	ABL1_ENST00000318560	ENST00000318560.5	No	Dasatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	21931113		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
2449909	2449909	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	left_lower_lobe	NS	carcinoma	adenocarcinoma	NS	26612314		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531217	2531217	FLT3_ENST00000537084	ENST00000537084.1	No	Sorafenib	78706366	COSV54042636	COSM785	p.?	c.2419-2804G>C	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642			ENST00000537084.1:c.2419-2804G>C	13:g.28592642C>G
2539199	2539199	AR_ENST00000396043	ENST00000396043.2	No	Flutamide	43301381	COSV65961491	COSM5945721	p.Q109*	c.325C>T	prostate	NS	NS	carcinoma	NS	NS	14618630		Variant of unknown origin	Tumour Sample	Unknown	X:66931279..66931279		ENSP00000379358.2:p.Gln109Ter	ENST00000396043.2:c.325C>T	X:g.66931279C>T
2539220	2539220	AR_ENST00000396043	ENST00000396043.2	No	Androgen	43285761	COSV65953243	COSM3094417	p.V184M	c.550G>A	prostate	NS	NS	carcinoma	adenocarcinoma	NS	8145761		Confirmed Somatic	Tumour Sample	Unknown	X:66931504..66931504		ENSP00000379358.2:p.Val184Met	ENST00000396043.2:c.550G>A	X:g.66931504G>A
2585232	2585232	NRAS	ENST00000369535.4	Yes	Cetuximab	173873951		COSM6008999	p.G60D	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown		1			
2611061	2611061	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2616260	2616260	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811593	COSV58117136	COSM6053938	p.?	c.1039-1482G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869598		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164			ENST00000372880.1:c.1039-1482G>C	X:g.100611164C>G
2621496	2621496	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37811599	COSV58117871	COSM6053937	p.?	c.1039-1483T>A	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	24869597		Previously Reported	Tumour Sample	Homozygous	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>A	X:g.100611165A>T
2635721	2635721	ESR1_ENST00000456483	ENST00000456483.2	No	Endocrine therapy	59862474	COSV52781024	COSM94250	p.D426G	c.1277A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	28283903		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000415934.2:p.Asp426Gly	ENST00000456483.2:c.1277A>G	6:g.152419926A>G
2644799	2644799	EGFR	ENST00000275493.2	Yes	Osimertinib	23300960	COSV51832145	COSM6493936	p.C797G	c.2389T>G	lung	right_upper_lobe	NS	carcinoma	adenocarcinoma	NS	28625641		Variant of unknown origin	Tumour Sample	Unknown	7:55249091..55249091	1	ENSP00000275493.2:p.Cys797Gly	ENST00000275493.2:c.2389T>G	7:g.55249091T>G
2664339	2664339	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	28396313		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2819289	2819289	EGFR_ENST00000454757	ENST00000454757.2	No	Tyrosine kinase inhibitor - NS	58433951	COSV51765492	COSM6240	p.T737M	c.2210C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000395243.2:p.Thr737Met	ENST00000454757.2:c.2210C>T	7:g.55249071C>T
2819302	2819302	EGFR_ENST00000455089	ENST00000455089.1	No	Tyrosine kinase inhibitor - NS	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	30711944		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
2835717	2835717	BTK_ENST00000372880	ENST00000372880.1	No	Ibrutinib	37812030	COSV58117643	COSM6053936	p.?	c.1039-1483T>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611165..100611165			ENST00000372880.1:c.1039-1483T>C	X:g.100611165A>G
2840774	2840774	NRAS	ENST00000369535.4	Yes	Cetuximab	36928730	COSV54736340	COSM584	p.Q61R	c.182A>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.182A>G	1:g.115256529T>C
2840774	2840774	KRAS_ENST00000557334	ENST00000557334.1	No	Cetuximab	85396594	COSV55497582	COSM518	p.G12R	c.34G>C	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285		ENSP00000452512.1:p.Gly12Arg	ENST00000557334.1:c.34G>C	12:g.25398285C>G
2840776	2840776	KRAS_ENST00000557334	ENST00000557334.1	No	Panitumumab	85439332	COSV55502677	COSM550	p.?	c.112-17432C>G	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25380277..25380277			ENST00000557334.1:c.112-17432C>G	12:g.25380277G>C
2843082	2843082	ALK	ENST00000389048.3	Yes	Alectinib	40281999	COSV66555808	COSM144250	p.G1202R	c.3604G>A	lung	right_middle_lobe	NS	carcinoma	adenocarcinoma	NS	31374369		Previously Reported	Tumour Sample	Unknown	2:29443613..29443613	1	ENSP00000373700.3:p.Gly1202Arg	ENST00000389048.3:c.3604G>A	2:g.29443613C>T
Pat_74_B	2492911	NRAS	ENST00000369535.4	Yes	Vemurafenib	36928730	COSV54736340	COSM584	p.Q61R	c.182A>G	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	1:115256529..115256529	1	ENSP00000358548.4:p.Gln61Arg	ENST00000369535.4:c.182A>G	1:g.115256529T>C
Case_2-Relapse-M464	2730739	JAK2	ENST00000381652.3	Yes	Pembrolizumab	41393309	COSV67689878	COSM7337170	p.?	c.1641+2T>G	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Cultured	Homozygous	9:5070054..5070054	1		ENST00000381652.3:c.1641+2T>G	9:g.5070054T>G
Case_2-Relapse-WholeTumor	2730738	JAK2_ENST00000539801	ENST00000539801.1	No	Pembrolizumab	81470497	COSV67689878	COSM7337170	p.?	c.1641+2T>G	skin	NS	NS	malignant_melanoma	NS	NS	27433843		Confirmed Somatic	Tumour Sample	Homozygous	9:5070054..5070054			ENST00000539801.1:c.1641+2T>G	9:g.5070054T>G
904287	904287	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12399961		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
905492	905492	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	27470052	COSV59323790	COSM12560	p.T315I	c.944C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	12623848		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283		ENSP00000323315.5:p.Thr315Ile	ENST00000318560.5:c.944C>T	9:g.133748283C>T
1167389	1167389	KIT	ENST00000288135.5	Yes	Imatinib	25227111	COSV55402684	COSM19293	p.T670E	c.2008_2009delinsGA	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	NS	NS	16551858		Variant of unknown origin	Tumour Sample	Unknown	4:55595518..55595519	1	ENSP00000288135.5:p.Thr670Glu	ENST00000288135.5:c.2008_2009delinsGA	4:g.55595518_55595519delinsGA
1211134	1211134	EGFR_ENST00000442591	ENST00000442591.1	No	Gefitinib	55404716	COSV51765492	COSM6240	p.?	c.*28+8450C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071			ENST00000442591.1:c.*28+8450C>T	7:g.55249071C>T
1211135	1211135	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	19381876		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1227044	1227044	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18623623		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
1350401	1350401	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1350422	1350422	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1350426	1350426	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19567878		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1351428	1351428	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864236		COSM43373	p.E459K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20512393		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu459Lys		
1351675	1351675	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19625707		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
1352429	1352429	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862756		COSM12621	p.M244V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met244Val		
1352432	1352432	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20055659		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1355285	1355285	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863529		COSM12617	p.E255K	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19768693		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Lys		
1426029	1426029	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862879		COSM12618	p.Y253H	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19925053		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Tyr253His		
1428810	1428810	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1428817	1428817	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173865615		COSM49068	p.T495R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	19260121		Variant of unknown origin	Tumour Sample	Unknown					
1431317	1431317	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173867522		COSM49141	p.E279Y	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20697894		Variant of unknown origin	Tumour Sample	Unknown					
1468089	1468089	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21062933		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1469815	1469815	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21135146		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1498622	1498622	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	21239056		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1498636	1498636	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21315472		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1543758	1543758	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173863178		COSM12612	p.G250E	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	20673586		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Gly250Glu		
1547753	1547753	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21357704		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1547786	1547786	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	21430269		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1552636	1552636	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173864368		COSM43362	p.E255V	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	21663510		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Glu255Val		
1576785	1576785	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Heterozygous	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1576794	1576794	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	adenocarcinoma	NS	21921847		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
1618792	1618792	EGFR	ENST00000275493.2	Yes	Gefitinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	22215752		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
1767025	1767025	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173862568		COSM12615	p.M351T	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22873741		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.Met351Thr		
1815764	1815764	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815805	1815805	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1815806	1815806	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173862569		COSM12614	p.T315I	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23190221		Previously Reported	Tumour Sample	Unknown			ENSP00000323315.5:p.Thr315Ile		
1844064	1844064	ABL1_ENST00000318560	ENST00000318560.5	No	Tyrosine kinase inhibitor - NS	173864356		COSM49067	p.V299L	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	23223358		Variant of unknown origin	Tumour Sample	Unknown					
1859881	1859881	ALK	ENST00000389048.3	Yes	Crizotinib	40290752	COSV66556435	COSM99137	p.L1196M	c.3586C>A	lung	NS	NS	carcinoma	adenocarcinoma	NS	23344087		Previously Reported	Tumour Sample	Homozygous	2:29443631..29443631	1	ENSP00000373700.3:p.Leu1196Met	ENST00000389048.3:c.3586C>A	2:g.29443631G>T
1863613	1863613	FLT3	ENST00000241453.7	Yes	Quizartinib	20035319	COSV54045249	COSM19844	p.D835F	c.2503_2504delinsTT	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Variant of unknown origin	Tumour Sample	Unknown	13:28592641..28592642	1	ENSP00000241453.7:p.Asp835Phe	ENST00000241453.7:c.2503_2504delinsTT	13:g.28592641_28592642delinsAA
1863613	1863613	FLT3_ENST00000380982	ENST00000380982.4	No	Quizartinib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22504184		Previously Reported	Tumour Sample	Unknown	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
1989312	1989312	ABL1	ENST00000372348.2	Yes	Tyrosine kinase inhibitor - NS	36319921	COSV59323790	COSM12560	p.T334I	c.1001C>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	22870928		Previously Reported	Tumour Sample	Unknown	9:133748283..133748283	1	ENSP00000361423.2:p.Thr334Ile	ENST00000372348.2:c.1001C>T	9:g.133748283C>T
1992084	1992084	EGFR	ENST00000275493.2	Yes	Gefitinib	23266684	COSV51765492	COSM6240	p.T790M	c.2369C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	23886554		Previously Reported	Tumour Sample	Unknown	7:55249071..55249071	1	ENSP00000275493.2:p.Thr790Met	ENST00000275493.2:c.2369C>T	7:g.55249071C>T
2027780	2027780	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24035188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2088658	2088658	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173868084		COSM100087	p.V289F	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown					
2088662	2088662	ABL1_ENST00000318560	ENST00000318560.5	No	Imatinib	173863671		COSM12613	p.H396R	c.?	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	24456693		Variant of unknown origin	Tumour Sample	Unknown			ENSP00000323315.5:p.His396Arg		
2275290	2275290	ALK	ENST00000389048.3	Yes	Crizotinib	173864601		COSM4422788	p.S1206Y	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	24675041		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Ser1206Tyr		
2313150	2313150	ESR1	ENST00000440973.1	Yes	Endocrine therapy	55280228	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926	1	ENSP00000405330.1:p.Asp538Gly	ENST00000440973.1:c.1613A>G	6:g.152419926A>G
2313154	2313154	ESR1_ENST00000443427	ENST00000443427.1	No	Endocrine therapy	57210287	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ductal_carcinoma	NS	24217577		Previously Reported	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000387500.1:p.Asp538Gly	ENST00000443427.1:c.1613A>G	6:g.152419926A>G
2429293	2429293	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	18955458		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2431492	2431492	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	stomach	gastrointestinal_stromal_tumour	spindle	NS	25886408		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2466829	2466829	MAP2K2_ENST00000394867	ENST00000394867.4	No	Vemurafenib	45630376	COSV53562150	COSM5546577	p.?	c.-122T>G	skin	NS	NS	malignant_melanoma	NS	NS	24463458		Previously Reported	Tumour Sample	Heterozygous	19:4117550..4117550			ENST00000394867.4:c.-122T>G	19:g.4117550A>C
2468260	2468260	ESR1	ENST00000440973.1	Yes	Endocrine therapy	173862580		COSM5413588	p.D538G	c.?	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	26434753		Previously Reported	Tumour Sample	Unknown		1	ENSP00000405330.1:p.Asp538Gly		
2479334	2479334	KIT	ENST00000288135.5	Yes	Imatinib	173862562		COSM24709	p.V654A	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	gastrointestinal_tract_(site_indeterminate)	gastrointestinal_stromal_tumour	NS	NS	23456621		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Val654Ala		
2483232	2483232	KIT	ENST00000288135.5	Yes	Imatinib	173863004		COSM19023	p.N822K	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Asn822Lys		
2483255	2483255	KIT	ENST00000288135.5	Yes	Imatinib	173862804		COSM24707	p.Y823D	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	small_intestine	gastrointestinal_stromal_tumour	NS	NS	16954519		Previously Reported	Tumour Sample	Unknown		1	ENSP00000288135.5:p.Tyr823Asp		
2525685	2525685	EGFR	ENST00000275493.2	Yes	Erlotinib	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	adenocarcinoma	NS	27304188		Previously Reported	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2531221	2531221	FLT3_ENST00000380982	ENST00000380982.4	No	Sorafenib	39660755	COSV54042116	COSM783	p.D835Y	c.2503G>T	haematopoietic_and_lymphoid_tissue	NS	NS	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	22368270		Confirmed Somatic	Tumour Sample	Heterozygous	13:28592642..28592642		ENSP00000370369.4:p.Asp835Tyr	ENST00000380982.4:c.2503G>T	13:g.28592642C>A
2531245	2531245	SMO	ENST00000249373.3	Yes	Vismodegib	173864927		COSM3736929	p.W535L	c.?	skin	NS	NS	carcinoma	basal_cell_carcinoma	NS	25759020		Previously Reported	Tumour Sample	Heterozygous		1	ENSP00000249373.3:p.Trp535Leu		
2585246	2585246	KRAS_ENST00000311936	ENST00000311936.3	No	Cetuximab	173862658		COSM25877	p.G12D	c.?	large_intestine	colon	left	carcinoma	adenocarcinoma	NS	27929064		Previously Reported	Tumour Sample	Unknown			ENSP00000308495.3:p.Gly12Asp		
2591415	2591415	EGFR	ENST00000275493.2	Yes	Tyrosine kinase inhibitor - NS	173862575		COSM21943	p.T790M	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	27528220		Confirmed Somatic	Tumour Sample	Unknown		1	ENSP00000275493.2:p.Thr790Met		
2611062	2611062	PDGFRA	ENST00000257290.5	Yes	Imatinib	173862808		COSM12432	p.D842V	c.?	soft_tissue	fibrous_tissue_and_uncertain_origin	NS	gastrointestinal_stromal_tumour	NS	NS	28284172		Previously Reported	Tumour Sample	Unknown		1	ENSP00000257290.5:p.Asp842Val		
2664378	2664378	CTNNB1_ENST00000453024	ENST00000453024.1	No	Imatinib	58226263	COSV62687839	COSM5677	p.S26C	c.77C>G	skin	NS	NS	malignant_melanoma	acral_lentiginous	NS	28421416		Previously Reported	Tumour Sample	Unknown	3:41266101..41266101		ENSP00000411226.1:p.Ser26Cys	ENST00000453024.1:c.77C>G	3:g.41266101C>G
2816899	2816899	FGFR4_ENST00000393637	ENST00000393637.1	No	Fisogatinib	44078102	COSV52800715	COSM3738141	p.V510L	c.1528G>C	liver	NS	NS	carcinoma	hepatocellular_carcinoma	NS	31575540		Previously Reported	Tumour Sample	Unknown	5:176522551..176522551		ENSP00000377254.1:p.Val510Leu	ENST00000393637.1:c.1528G>C	5:g.176522551G>C
2835709	2835709	BTK	ENST00000308731.7	Yes	Acalabrutinib	26369110	COSV58117136	COSM6053938	p.C481S	c.1442G>C	haematopoietic_and_lymphoid_tissue	NS	NS	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	30508305		Previously Reported	Tumour Sample	Unknown	X:100611164..100611164	1	ENSP00000308176.7:p.Cys481Ser	ENST00000308731.7:c.1442G>C	X:g.100611164C>G
2840778	2840778	KRAS_ENST00000556131	ENST00000556131.1	No	Panitumumab	85148350	COSV55497419	COSM520	p.G12V	c.35G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398284..25398284		ENSP00000451856.1:p.Gly12Val	ENST00000556131.1:c.35G>T	12:g.25398284C>A
2840780	2840780	KRAS	ENST00000256078.4	Yes	Cetuximab	21547060	COSV55497469	COSM516	p.G12C	c.34G>T	large_intestine	NS	NS	carcinoma	adenocarcinoma	NS	24553385		Previously Reported	Tumour Sample	Unknown	12:25398285..25398285	1	ENSP00000256078.4:p.Gly12Cys	ENST00000256078.4:c.34G>T	12:g.25398285C>A
2841750	2841750	ALK	ENST00000389048.3	Yes	Crizotinib	173868773		COSM9413102	p.L1152R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1	ENSP00000373700.3:p.Leu1152Arg		
2841769	2841769	ALK	ENST00000389048.3	Yes	Crizotinib	173863820		COSM9112561	p.T1151R	c.?	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	31712133		Variant of unknown origin	Tumour Sample	Unknown		1			
Pat_15_A	2492853	MAP2K1	ENST00000307102.5	Yes	Vemurafenib	24777726	COSV61068422	COSM1315861	p.P124L	c.371C>T	NS	NS	NS	malignant_melanoma	NS	NS	24265153		Confirmed Somatic	Tumour Sample	Unknown	15:66729163..66729163	1	ENSP00000302486.4:p.Pro124Leu	ENST00000307102.5:c.371C>T	15:g.66729163C>T
SC-her2-019	2313843	ESR1_ENST00000338799	ENST00000338799.5	No	Endocrine therapy	30456958	COSV52781024	COSM94250	p.D538G	c.1613A>G	breast	NS	NS	carcinoma	ER-positive_carcinoma	NS	24185512		Confirmed Somatic	Tumour Sample	Unknown	6:152419926..152419926		ENSP00000342630.5:p.Asp538Gly	ENST00000338799.5:c.1613A>G	6:g.152419926A>G
S_TBL200_R3	2757767	EGFR_ENST00000455089	ENST00000455089.1	No	Erlotinib	59094620	COSV51765492	COSM6240	p.T745M	c.2234C>T	lung	NS	NS	carcinoma	non_small_cell_carcinoma	NS	29106415		Confirmed Somatic	Tumour Sample	Unknown	7:55249071..55249071		ENSP00000415559.1:p.Thr745Met	ENST00000455089.1:c.2234C>T	7:g.55249071C>T
